Regan, Meredith
eCommons Login: MMR4
first name: Meredith
last name: Regan
coauthor of: McDermott, David
coauthor of: Gelber, Richard
coauthor of: Mantia, Charlene
coauthor of: Lynce, Filipa
coauthor of: Choueiri, Toni
full name: Meredith M Regan, Sc.D.
has faculty rank: Full Professor
has network: selected publications
has network: research areas
has network: coauthor of
has network: similar to
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 29882
person in primary position: Professor of Medicine
physical neighbor: Antin, Joseph
physical neighbor: Brown, Myles
physical neighbor: Freedman, Arnold
physical neighbor: Garber, Judy
physical neighbor: Reinherz, Ellis
similar to: Choueiri, Toni
similar to: Partridge, Ann
similar to: Tolaney, Sara
similar to: Winer, Eric
similar to: Burstein, Harold
type: Agent
type: Person
selected publications: Authorship 1795320
selected publications: Authorship 1835918
selected publications: Authorship 1835358
selected publications: Authorship 1835659
selected publications: Authorship 1817791
selected publications: Authorship 1809989
selected publications: Authorship 1849400
selected publications: Authorship 1792954
selected publications: Authorship 1830903
selected publications: Authorship 1847803
selected publications: Authorship 1738404
selected publications: Authorship 1827243
selected publications: Authorship 1824763
selected publications: Authorship 1750493
selected publications: Authorship 1844204
selected publications: Authorship 1742847
selected publications: Authorship 1741856
selected publications: Authorship 1724925
selected publications: Authorship 1716982
selected publications: Authorship 1683766
selected publications: Authorship 1697946
selected publications: Authorship 1685771
selected publications: Authorship 1629842
selected publications: Authorship 1670232
selected publications: Authorship 1649802
selected publications: Authorship 1640737
selected publications: Authorship 1635995
selected publications: Authorship 1648694
selected publications: Authorship 1637318
selected publications: Authorship 1626396
selected publications: Authorship 1621983
selected publications: Authorship 1616669
selected publications: Authorship 1589402
selected publications: Authorship 1556293
selected publications: Authorship 1554282
selected publications: Authorship 1567273
selected publications: Authorship 1552512
selected publications: Authorship 1511450
selected publications: Authorship 1508689
selected publications: Authorship 1488264
selected publications: Authorship 1499455
selected publications: Authorship 1500886
selected publications: Authorship 1479665
selected publications: Authorship 1445536
selected publications: Authorship 1446464
selected publications: Authorship 1440601
selected publications: Authorship 1413904
selected publications: Authorship 1426166
selected publications: Authorship 1414185

eCommons Login
tag name: catalyst:eCommonsLogin
type: DatatypeProperty

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

end date
tag name: prns:endDate
type: DatatypeProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

physical neighbor
tag name: prns:physicalNeighborOf
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

principal investigator name
tag name: prns:principalInvestigatorName
type: DatatypeProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

start date
tag name: prns:startDate
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 2
tag name: vivo:address2
type: DatatypeProperty

city
tag name: vivo:addressCity
type: DatatypeProperty
type: FunctionalProperty

postal code
tag name: vivo:addressPostalCode
type: DatatypeProperty
type: FunctionalProperty

state or province
tag name: vivo:addressState
type: DatatypeProperty
type: FunctionalProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

Department
type: Class

Division
type: Class

Grant
type: Class

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

research activities
tag name: vivo:hasResearcherRole
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

middle name or initial
tag name: vivo:middleName
type: DatatypeProperty
type: FunctionalProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

Researcher Role
type: Class

researcher role of
tag name: vivo:researcherRoleOf
type: ObjectProperty

contributes to
tag name: vivo:roleContributesTo
type: ObjectProperty

sponsor award id
tag name: vivo:sponsorAwardId
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomates.
PubMed Identifier: 10584050
author list: Metges CC, Petzke KJ, El-Khoury AE, Henneman L, Grant I, Bedri S, Regan MM, Fuller MF, Young VR
published in: The American journal of clinical nutrition
information resource reference: Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomates. Am J Clin Nutr. 1999 Dec; 70(6):1046-58.
journal title abbreviation: Am J Clin Nutr
publication date: 1999-12-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Inhaled albuterol, but not intravenous lidocaine, protects against intubation-induced bronchoconstriction in asthma.
PubMed Identifier: 11046206
author list: Maslow AD, Regan MM, Israel E, Darvish A, Mehrez M, Boughton R, Loring SH
published in: Anesthesiology
information resource reference: Inhaled albuterol, but not intravenous lidocaine, protects against intubation-induced bronchoconstriction in asthma. Anesthesiology. 2000 Nov; 93(5):1198-204.
journal title abbreviation: Anesthesiology
publication date: 2000-11-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1045450
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.
PubMed Identifier: 29443653
author list: Wapnir IL, Price KN, Anderson SJ, Robidoux A, Martín M, Nortier JWR, Paterson AHG, Rimawi MF, Láng I, Baena-Cañada JM, Thürlimann B, Mamounas EP, Geyer CE, Gelber S, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. J Clin Oncol. 2018 04 10; 36(11):1073-1079.
journal title abbreviation: J Clin Oncol
publication date: 2018-02-14T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.
PubMed Identifier: 15017206
author list: San Francisco IF, Regan MM, Olumi AF, DeWolf WC
published in: The Journal of urology
information resource reference: Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen. J Urol. 2004 Apr; 171(4):1492-9.
journal title abbreviation: J Urol
publication date: 2004-04-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered.
PubMed Identifier: 15358638
author list: Zaman MM, Gelrud A, Junaidi O, Regan MM, Warny M, Shea JC, Kelly C, O'Sullivan BP, Freedman SD
published in: Clinical and diagnostic laboratory immunology
information resource reference: Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol. 2004 Sep; 11(5):819-24.
journal title abbreviation: Clin Diagn Lab Immunol
publication date: 2004-09-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach.
PubMed Identifier: 16087981
author list: Kurpad AV, Regan MM, Raj TD, Gnanou JV, Rao VN, Young VR
published in: The American journal of clinical nutrition
information resource reference: The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach. Am J Clin Nutr. 2005 Aug; 82(2):373-9.
journal title abbreviation: Am J Clin Nutr
publication date: 2005-08-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Statistical considerations and challenges
author list: Regan MM
published in: Castiglione M, Piccart M, editors. Adjuvant Therapy for Breast Cancer
information resource reference: Statistical considerations and challenges. Castiglione M, Piccart M, editors. Adjuvant Therapy for Breast Cancer. 2008; In press.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Carbonic anhydrase IX (CA IX) and pathologic features as predictors of outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving VEGF-targeted therapy
author list: Choueiri T, Regan MM, Brick AJ, Clement JM, Kwabi C, Shah K, Amato A, McDermott DF, Atkins MB, Signoretti S
published in: J Clin Oncol
information resource reference: Carbonic anhydrase IX (CA IX) and pathologic features as predictors of outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving VEGF-targeted therapy. J Clin Oncol. 2008; 26(May 20 suppl):abstr 16042.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of oral CDP-choline on plasma choline and uridine levels in humans.
PubMed Identifier: 10974208
author list: Wurtman RJ, Regan M, Ulus I, Yu L
published in: Biochemical pharmacology
information resource reference: Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol. 2000 Oct 01; 60(7):989-92.
journal title abbreviation: Biochem Pharmacol
publication date: 2000-10-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
PubMed Identifier: 18423743
author list: Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O
published in: The Journal of urology
information resource reference: Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol. 2008 Jun; 179(6):2181-5; discussion 2185-6.
journal title abbreviation: J Urol
publication date: 2008-04-18T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Why do older women discontinue hormone replacement therapy?
PubMed Identifier: 11445025
author list: Regan MM, Emond SK, Attardo MJ, Parker RA, Greenspan SL
published in: Journal of women's health & gender-based medicine
information resource reference: Why do older women discontinue hormone replacement therapy? J Womens Health Gend Based Med. 2001 May; 10(4):343-50.
journal title abbreviation: J Womens Health Gend Based Med
publication date: 2001-05-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
PubMed Identifier: 19561607
author list: Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, Henderson BE, Frenkel B, Barretina J, Bass A, Tabernero J, Baselga J, Regan MM, Manak JR, Shivdasani R, Coetzee GA, Freedman ML
published in: Nature genetics
information resource reference: The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet. 2009 Aug; 41(8):882-4.
journal title abbreviation: Nat Genet
publication date: 2009-06-28T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1057543
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5.

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5.
PubMed Identifier: 29676944
author list: Dowsett M, Sestak I, Regan MM, Dodson A, Viale G, Thürlimann B, Colleoni M, Cuzick J
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5. J Clin Oncol. 2018 07 01; 36(19):1941-1948.
journal title abbreviation: J Clin Oncol
publication date: 2018-04-20T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate.
PubMed Identifier: 15151957
author list: Tay MH, Kaufman DS, Regan MM, Leibowitz SB, George DJ, Febbo PG, Manola J, Smith MR, Kaplan ID, Kantoff PW, Oh WK
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. Ann Oncol. 2004 Jun; 15(6):974-8.
journal title abbreviation: Ann Oncol
publication date: 2004-06-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 102838
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?
PubMed Identifier: 19474376
author list: Schor-Bardach R, Alsop DC, Pedrosa I, Solazzo SA, Wang X, Marquis RP, Atkins MB, Regan M, Signoretti S, Lenkinski RE, Goldberg SN
published in: Radiology
information resource reference: Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? Radiology. 2009 Jun; 251(3):731-42.
journal title abbreviation: Radiology
publication date: 2009-06-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
PubMed Identifier: 19549893
author list: Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer MJ, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML
published in: Cancer research
information resource reference: Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res. 2009 Jul 01; 69(13):5568-74.
journal title abbreviation: Cancer Res
publication date: 2009-06-23T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Quantitative gene expression at the 8q24 prostate cancer risk locus
author list: Pomerantz M, Beckwith C, Regan MM, Xie W, Herman P, Chan J, Ardlie K, Oh WK, Kantoff PW, Freedman ML
published in: J Clin Oncol
information resource reference: Quantitative gene expression at the 8q24 prostate cancer risk locus. J Clin Oncol. 2008; 26(May 20 suppl):abstr 5055.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

A randomized controlled trial of 503 couples assigned to conventional infertility treatment or an accelerated track to IVF: preliminary results of the fast track and standard treatment (FASTT) trial
author list: Reindollar RH, Regan MM, Neumannn PJ, Thornton KL, Alper MM, Goldman MB
published in: Fertil Steril
information resource reference: A randomized controlled trial of 503 couples assigned to conventional infertility treatment or an accelerated track to IVF: preliminary results of the fast track and standard treatment (FASTT) trial. Fertil Steril. 2007; 18(Suppl 1):S41 (abstr 0-108; prize paper).
publication date: 2007-01-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1064602
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).

Authorship 1064165
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
PubMed Identifier: 29733336
author list: Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2018 Oct 01; 29(10):2153.
journal title abbreviation: Ann Oncol
publication date: 2018-10-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
PubMed Identifier: 29765151
author list: Rosenberg JE, Hahn NM, Regan MM, Werner L, Alva A, George S, Picus J, Alter R, Balar A, Hoffman-Censits J, Grivas P, Lauer R, Guancial EA, Hoimes C, Sonpavde G, Albany C, Stein MN, Breen T, Jacobs C, Anderson K, Bellmunt J, Lalani AA, Pal S, Choueiri TK
published in: British journal of cancer
information resource reference: Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2). Br J Cancer. 2018 05; 118(11):1434-1441.
journal title abbreviation: Br J Cancer
publication date: 2018-05-16T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.
PubMed Identifier: 16862573
author list: Nakabayashi M, Xie W, Regan MM, Jackman DM, Kantoff PW, Oh WK
published in: Cancer
information resource reference: Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer. Cancer. 2006 Sep 01; 107(5):975-81.
journal title abbreviation: Cancer
publication date: 2006-09-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/1039740
PubMed Identifier: 18349391
author list: Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. J Clin Oncol. 2008 Mar 20; 26(9):1404-10.
journal title abbreviation: J Clin Oncol
publication date: 2008-03-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.
PubMed Identifier: 19280340
author list: Maiorano E, Regan MM, Viale G, Mastropasqua MG, Colleoni M, Castiglione-Gertsch M, Price KN, Gelber RD, Goldhirsch A, Coates AS
published in: Breast cancer research and treatment
information resource reference: Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy. Breast Cancer Res Treat. 2010 May; 121(1):211-8.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2009-03-12T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial.
PubMed Identifier: 19531445
author list: Reindollar RH, Regan MM, Neumann PJ, Levine BS, Thornton KL, Alper MM, Goldman MB
published in: Fertility and sterility
information resource reference: A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril. 2010 Aug; 94(3):888-99.
journal title abbreviation: Fertil Steril
publication date: 2009-06-16T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer.
PubMed Identifier: 19863532
author list: Nakabayashi M, Oh WK, Jacobus S, Regan MM, Taplin ME, Kantoff PW, Rosenberg JE
published in: BJU international
information resource reference: Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer. BJU Int. 2010 May; 105(10):1392-6.
journal title abbreviation: BJU Int
publication date: 2009-10-23T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1068365
type: Authorship
author rank in publication: 13
linked author: Regan, Meredith
linked information resource: Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
PubMed Identifier: 29589138
author list: Munzone E, Gray KP, Fumagalli C, Guerini-Rocco E, Láng I, Ruhstaller T, Gianni L, Kammler R, Viale G, Di Leo A, Coates AS, Gelber RD, Regan MM, Goldhirsch A, Barberis M, Colleoni M
published in: Breast cancer research and treatment
information resource reference: Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00. Breast Cancer Res Treat. 2018 Jul; 170(2):351-360.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2018-03-27T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.
PubMed Identifier: 21085629
author list: Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, Oh WK, Kantoff PW, Hahn WC, Freedman ML
published in: PLoS genetics
information resource reference: Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet. 2010 Nov 11; 6(11):e1001204.
journal title abbreviation: PLoS Genet
publication date: 2010-11-11T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.
PubMed Identifier: 21282282
author list: Aebi S, Sun Z, Braun D, Price KN, Castiglione-Gertsch M, Rabaglio M, Gelber RD, Crivellari D, Lindtner J, Snyder R, Karlsson P, Simoncini E, Gusterson BA, Viale G, Regan MM, Coates AS, Goldhirsch A
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Ann Oncol. 2011 Sep; 22(9):1981-1987.
journal title abbreviation: Ann Oncol
publication date: 2011-01-31T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1071599
type: Authorship
author rank in publication: 36
linked author: Regan, Meredith
linked information resource: Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
PubMed Identifier: 29863451
author list: Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM
published in: The New England journal of medicine
information resource reference: Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. N Engl J Med. 2018 Jul 12; 379(2):122-137.
journal title abbreviation: N Engl J Med
publication date: 2018-06-04T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 105110
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach.

Starting at the beginning: Designing clinical investigations
author list: Parker RA, Regan MM
published in: ASA 2000 Proceedings of the Section on Statistical Education the Section on Teaching Statistics in the Health Sciences and Section on Statistical Consulting
information resource reference: Starting at the beginning: Designing clinical investigations. ASA 2000 Proceedings of the Section on Statistical Education the Section on Teaching Statistics in the Health Sciences and Section on Statistical Consulting. 2000; 1-8.
publication date: 2000-01-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Melatonin treatment for age-related insomnia.
PubMed Identifier: 11600532
author list: Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU
published in: The Journal of clinical endocrinology and metabolism
information resource reference: Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001 Oct; 86(10):4727-30.
journal title abbreviation: J Clin Endocrinol Metab
publication date: 2001-10-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Gender bias in the disposition of frozen embryos.
PubMed Identifier: 11730747
author list: Klipstein S, Reindollar RH, Regan MM, Alper MM
published in: Fertility and sterility
information resource reference: Gender bias in the disposition of frozen embryos. Fertil Steril. 2001 Dec; 76(6):1181-4.
journal title abbreviation: Fertil Steril
publication date: 2001-12-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique.
PubMed Identifier: 12499329
author list: Kurpad AV, Regan MM, Raj T, Vasudevan J, Kuriyan R, Gnanou J, Young VR
published in: The American journal of clinical nutrition
information resource reference: Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique. Am J Clin Nutr. 2003 Jan; 77(1):101-8.
journal title abbreviation: Am J Clin Nutr
publication date: 2003-01-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1073683
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/105515714

https://connects.catalyst.harvard.edu/Profiles/profile/105515714
PubMed Identifier: 29902286
author list: Luen SJ, Asher R, Lee CK, Savas P, Kammler R, Dell'Orto P, Biasi OM, Demanse D, JeBailey L, Dolan S, Hackl W, Thuerlimann B, Viale G, Colleoni M, Regan MM, Loi S
published in: JAMA oncology
information resource reference: Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial. JAMA Oncol. 2018 10 01; 4(10):1335-1343.
journal title abbreviation: JAMA Oncol
publication date: 2018-10-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.

Authorship 108871
type: Authorship
author rank in publication: 16
linked author: Regan, Meredith
linked information resource: 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.

Authorship 1075964
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP.

Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP.
PubMed Identifier: 29935957
author list: Mihalcik SA, Chipman JJ, Sanda MG, Regan MM, Kaplan ID, Wagner AA, Crociani CM, Chang P
published in: Practical radiation oncology
information resource reference: Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP. Pract Radiat Oncol. 2018 Nov - Dec; 8(6):445-451.
journal title abbreviation: Pract Radiat Oncol
publication date: 2018-04-14T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 113268
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Prediction of erectile function following treatment for prostate cancer.

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.
PubMed Identifier: 22749924
author list: Dellapasqua S, Bagnardi V, Regan MM, Rotmensz N, Mastropasqua MG, Viale G, Maiorano E, Price KN, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Colleoni M
published in: Breast (Edinburgh, Scotland)
information resource reference: A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer. Breast. 2012 Oct; 21(5):621-8.
journal title abbreviation: Breast
publication date: 2012-06-29T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of cystine on the methionine requirement of healthy Indian men determined by using the 24-h indicator amino acid balance approach.
PubMed Identifier: 15585764
author list: Kurpad AV, Regan MM, Varalakshmi S, Gnanou J, Lingappa A, Young VR
published in: The American journal of clinical nutrition
information resource reference: Effect of cystine on the methionine requirement of healthy Indian men determined by using the 24-h indicator amino acid balance approach. Am J Clin Nutr. 2004 Dec; 80(6):1526-35.
journal title abbreviation: Am J Clin Nutr
publication date: 2004-12-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PubMed Identifier: 18325918
author list: Regan MM, Pagani O, Walley B, Torrisi R, Perez EA, Francis P, Fleming GF, Price KN, Thürlimann B, Maibach R, Castiglione-Gertsch M, Coates AS, Goldhirsch A, Gelber RD
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Ann Oncol. 2008 Jul; 19(7):1231-1241.
journal title abbreviation: Ann Oncol
publication date: 2008-03-05T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 109386
type: Authorship
author rank in publication: 13
linked author: Regan, Meredith
linked information resource: Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.

Authorship 113082
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Cysteine kinetics and oxidation at different intakes of methionine and cystine in young adults.

Impact of patient and physician factors on oncologists’ recommendations for adjuvant chemotherapy in stage III colon cancer
author list: Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC
published in: Proc Am Soc Clin Oncol
information resource reference: Impact of patient and physician factors on oncologists’ recommendations for adjuvant chemotherapy in stage III colon cancer. Proc Am Soc Clin Oncol. 2006; 24(18S Part I of II):313s (abstract 6051).
publication date: 2006-01-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Models for clustered discrete and continuous outcomes in developmental toxicology [dissertation]
author list: Regan MM
published in: Models for clustered discrete and continuous outcomes in developmental toxicology [dissertation]
information resource reference: Models for clustered discrete and continuous outcomes in developmental toxicology [dissertation]. 1998.
publication date: 1998-01-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource

TMPRSS2-ERG fusion prostate cancer prevalence, association with PSA density, and histologic features in a multi-center US cohort of men undergoing prostate biopsy
author list: Mosquera JM, Mehra R, Regan M, Genega EM, Gaston S, Perner S, Bueti G, Tomlins SA, Shah RB, Wei J, Kearney M, Johnson LA, Tang JM, Chinnaiyan AM, Rubin MA, Sanda MG
published in: 2008 AUA Annual Meeting,. May 17-22 2008, Orlando, FL (Podium Session 47)
information resource reference: TMPRSS2-ERG fusion prostate cancer prevalence, association with PSA density, and histologic features in a multi-center US cohort of men undergoing prostate biopsy. 2008 AUA Annual Meeting,. May 17-22 2008, Orlando, FL (Podium Session 47). 2008.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Developmental toxicity study
author list: Regan MM
published in: El-Shaarawi AH, Piegorsch WW, editors. Encyclopedia of Environmetrics. Volume 1.
information resource reference: Developmental toxicity study. El-Shaarawi AH, Piegorsch WW, editors. Encyclopedia of Environmetrics. Volume 1. 2002; 515-518.
publication date: 2002-01-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 111677
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.

Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.
PubMed Identifier: 18430120
author list: Signoretti S, Regan M, Atkins M
published in: BJU international
information resource reference: Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy. BJU Int. 2008 Jun; 101 Suppl 4:31-5.
journal title abbreviation: BJU Int
publication date: 2008-06-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.
PubMed Identifier: 7655127
author list: Oster G, Huse DM, Lacey MJ, Regan MM, Fuchs HJ
published in: The Annals of pharmacotherapy
information resource reference: Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis. Ann Pharmacother. 1995 May; 29(5):459-64.
journal title abbreviation: Ann Pharmacother
publication date: 1995-05-01T00:00:00
year: 1995
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 113914
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate.

Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer.
PubMed Identifier: 19887483
author list: Taplin ME, Regan MM, Ko YJ, Bubley GJ, Duggan SE, Werner L, Beer TM, Ryan CW, Mathew P, Tu SM, Denmeade SR, Oh WK, Sartor O, Mantzoros CS, Rittmaster R, Kantoff PW, Balk SP
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. Clin Cancer Res. 2009 Nov 15; 15(22):7099-105.
journal title abbreviation: Clin Cancer Res
publication date: 2009-11-03T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
PubMed Identifier: 20477822
author list: Abe M, Xie W, Regan MM, King IB, Stampfer MJ, Kantoff PW, Oh WK, Chan JM
published in: BJU international
information resource reference: Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU Int. 2011 Jan; 107(1):126-34.
journal title abbreviation: BJU Int
publication date: 2011-01-01T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1090623
type: Authorship
author rank in publication: 13
linked author: Regan, Meredith
linked information resource: Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.

Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
PubMed Identifier: 30171067
author list: Van Asten K, Slembrouck L, Olbrecht S, Jongen L, Brouckaert O, Wildiers H, Floris G, Van Limbergen E, Weltens C, Smeets A, Paridaens R, Giobbie-Hurder A, Regan MM, Viale G, Thürlimann B, Vergote I, Christodoulou E, Van Calster B, Neven P
published in: The oncologist
information resource reference: Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer. Oncologist. 2019 02; 24(2):165-171.
journal title abbreviation: Oncologist
publication date: 2018-08-31T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1091457
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/109758700

Authorship 1091470
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: Sequential treatment approaches in the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysis.

https://connects.catalyst.harvard.edu/Profiles/profile/109758700
PubMed Identifier: 30191365
author list: McDermott DF, Shah R, Gupte-Singh K, Sabater J, Luo L, Botteman M, Rao S, Regan MM, Atkins M
published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
information resource reference: Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma: a quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis. Qual Life Res. 2019 Jan; 28(1):109-119.
journal title abbreviation: Qual Life Res
publication date: 2018-09-06T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma: a quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis.

Sequential treatment approaches in the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysis.
PubMed Identifier: 30175642
author list: Tarhini A, Benedict A, McDermott D, Rao S, Ambavane A, Gupte-Singh K, Sabater J, Ritchings C, Aponte-Ribero V, Regan MM, Atkins M
published in: Immunotherapy
information resource reference: Sequential treatment approaches in the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysis. Immunotherapy. 2018 10; 10(14):1241-1252.
journal title abbreviation: Immunotherapy
publication date: 2018-09-03T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Secondary hormonal therapy in men with castration-resistant prostate cancer.
PubMed Identifier: 21958520
author list: Nakabayashi M, Werner L, Oh WK, Regan MM, Kantoff PW, Taplin ME
published in: Clinical genitourinary cancer
information resource reference: Secondary hormonal therapy in men with castration-resistant prostate cancer. Clin Genitourin Cancer. 2011 Dec; 9(2):95-103.
journal title abbreviation: Clin Genitourin Cancer
publication date: 2011-09-29T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Uncertainty and perception of danger among patients undergoing treatment for prostate cancer.
PubMed Identifier: 22985348
author list: Kazer MW, Bailey DE, Chipman J, Psutka SP, Hardy J, Hembroff L, Regan M, Dunn RL, Crociani C, Sanda MG
published in: BJU international
information resource reference: Uncertainty and perception of danger among patients undergoing treatment for prostate cancer. BJU Int. 2013 Mar; 111(3 Pt B):E84-91.
journal title abbreviation: BJU Int
publication date: 2012-09-18T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/1101911
PubMed Identifier: 18293426
author list: Ross RW, Xie W, Regan MM, Pomerantz M, Nakabayashi M, Daskivich TJ, Sartor O, Taplin ME, Kantoff PW, Oh WK
published in: Cancer
information resource reference: Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect. Cancer. 2008 Mar 15; 112(6):1247-53.
journal title abbreviation: Cancer
publication date: 2008-03-15T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.
PubMed Identifier: 20230385
author list: Choueiri TK, Regan MM, Rosenberg JE, Oh WK, Clement J, Amato AM, McDermott D, Cho DC, Atkins MB, Signoretti S
published in: BJU international
information resource reference: Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy. BJU Int. 2010 Sep; 106(6):772-8.
journal title abbreviation: BJU Int
publication date: 2010-03-02T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1094539
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK.

Authorship 1093223
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Provision of services to asylum seekers. Are there lessons from the experience with Kosovan refugees?

Authorship 1092397
type: Authorship
author rank in publication: 12
linked author: Regan, Meredith
linked information resource: National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.

Authorship 1093109
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Vomiting calls to NHS Direct provide an early warning of norovirus outbreaks in hospitals.

Authorship 1093218
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: [Chronic constrictive pericarditis. A retrospective study of a series of 84 patients].

Authorship 1093892
type: Authorship
author rank in publication: 16
linked author: Regan, Meredith
linked information resource: Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

Authorship 1094544
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: The changing epidemiology of cryptosporidiosis in North West England.

Provision of services to asylum seekers. Are there lessons from the experience with Kosovan refugees?
PubMed Identifier: 11854346
author list: Ghebrehewet S, Regan M, Benons L, Knowles J
published in: Journal of epidemiology and community health
information resource reference: Provision of services to asylum seekers. Are there lessons from the experience with Kosovan refugees? J Epidemiol Community Health. 2002 Mar; 56(3):223-6.
journal title abbreviation: J Epidemiol Community Health
publication date: 2002-03-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

The changing epidemiology of cryptosporidiosis in North West England.
PubMed Identifier: 16181496
author list: Sopwith W, Osborn K, Chalmers R, Regan M
published in: Epidemiology and infection
information resource reference: The changing epidemiology of cryptosporidiosis in North West England. Epidemiol Infect. 2005 Oct; 133(5):785-93.
journal title abbreviation: Epidemiol Infect
publication date: 2005-10-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Vomiting calls to NHS Direct provide an early warning of norovirus outbreaks in hospitals.
PubMed Identifier: 20172625
author list: Loveridge P, Cooper D, Elliot AJ, Harris J, Gray J, Large S, Regan M, Smith GE, Lopman B
published in: The Journal of hospital infection
information resource reference: Vomiting calls to NHS Direct provide an early warning of norovirus outbreaks in hospitals. J Hosp Infect. 2010 Apr; 74(4):385-93.
journal title abbreviation: J Hosp Infect
publication date: 2010-02-20T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

[Chronic constrictive pericarditis. A retrospective study of a series of 84 patients].
PubMed Identifier: 7802532
author list: Nataf P, Cacoub P, Dorent R, Jault F, Fontanel M, Regan M, Bors V, Pavie A, Cabrol C, Gandjbakhch I
published in: Archives des maladies du coeur et des vaisseaux
information resource reference: [Chronic constrictive pericarditis. A retrospective study of a series of 84 patients]. Arch Mal Coeur Vaiss. 1994 Feb; 87(2):241-5.
journal title abbreviation: Arch Mal Coeur Vaiss
publication date: 1994-02-01T00:00:00
year: 1994
type: Academic Article
type: Article
type: Document
type: Information Resource

National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.
PubMed Identifier: 30212295
author list: Seidman AD, Bordeleau L, Fehrenbacher L, Barlow WE, Perlmutter J, Rubinstein L, Wedam SB, Hershman DL, Hayes JF, Butler LP, Smith ML, Regan MM, Beaver JA, Amiri-Kordestani L, Rastogi P, Zujewski JA, Korde LA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer. J Clin Oncol. 2018 Nov 10; 36(32):3259-3268.
journal title abbreviation: J Clin Oncol
publication date: 2018-09-13T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
PubMed Identifier: 30196031
author list: Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A
published in: The Lancet. Oncology
information resource reference: Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018 10; 19(10):1385-1393.
journal title abbreviation: Lancet Oncol
publication date: 2018-09-05T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK.
PubMed Identifier: 21473803
author list: Harcourt SE, Smith GE, Elliot AJ, Pebody R, Charlett A, Ibbotson S, Regan M, Hippisley-Cox J
published in: Epidemiology and infection
information resource reference: Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK. Epidemiol Infect. 2012 Jan; 140(1):100-5.
journal title abbreviation: Epidemiol Infect
publication date: 2011-04-08T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.
PubMed Identifier: 16977322
author list: Kim WY, Safran M, Buckley MR, Ebert BL, Glickman J, Bosenberg M, Regan M, Kaelin WG
published in: The EMBO journal
information resource reference: Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. EMBO J. 2006 Oct 04; 25(19):4650-62.
journal title abbreviation: EMBO J
publication date: 2006-09-14T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/1125383
PubMed Identifier: 21635709
author list: Regan MM, Price KN, Giobbie-Hurder A, Thürlimann B, Gelber RD
published in: Breast cancer research : BCR
information resource reference: Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast Cancer Res. 2011 May 26; 13(3):209.
journal title abbreviation: Breast Cancer Res
publication date: 2011-05-26T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.
PubMed Identifier: 21986093
author list: Ejlertsen B, Aldridge J, Nielsen KV, Regan MM, Henriksen KL, Lykkesfeldt AE, Müller S, Gelber RD, Price KN, Rasmussen BB, Viale G, Mouridsen H
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial. Ann Oncol. 2012 May; 23(5):1138-1144.
journal title abbreviation: Ann Oncol
publication date: 2011-10-10T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
PubMed Identifier: 22395644
author list: Regan MM, Leyland-Jones B, Bouzyk M, Pagani O, Tang W, Kammler R, Dell'orto P, Biasi MO, Thürlimann B, Lyng MB, Ditzel HJ, Neven P, Debled M, Maibach R, Price KN, Gelber RD, Coates AS, Goldhirsch A, Rae JM, Viale G
published in: Journal of the National Cancer Institute
information resource reference: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial. J Natl Cancer Inst. 2012 Mar 21; 104(6):441-51.
journal title abbreviation: J Natl Cancer Inst
publication date: 2012-03-06T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
PubMed Identifier: 22707751
author list: Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, Öhlschlegel C, Price KN, Gelber RD, Regan MM, Thürlimann B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol. 2012 Nov; 23(11):2843-2851.
journal title abbreviation: Ann Oncol
publication date: 2012-06-14T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Outcome of patients after radical prostatectomy: a comparison of prostate cancer diagnosed using extended needle biopsy technique versus non-extended needle biopsy technique
author list: San Francisco IF, Regan MM, DeWolf WC, Olumi AF
published in: UroOncol
information resource reference: Outcome of patients after radical prostatectomy: a comparison of prostate cancer diagnosed using extended needle biopsy technique versus non-extended needle biopsy technique. UroOncol. 2004; 4:85-90.
publication date: 2004-06-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Prevalence of TMPRSS2-ERG fusion prostate cancer in men undergoing prostate biopsy in the US
author list: Mosquera JM, Mehra R, Regan M, Genega E, Gaston S, Perner S, Connor M, Bueti G, Tomlins SA, Shah RB, Wei J, Kearney M, Johnson LM, Tang JM, Chinnaiyan AM, Sanda MG, Rubin MA
published in: United States and Canadian Academy of Pathology 2008 Annual Meeting, Mar 1-7 2008, Denver, CO (abstract 786)
information resource reference: Prevalence of TMPRSS2-ERG fusion prostate cancer in men undergoing prostate biopsy in the US. United States and Canadian Academy of Pathology 2008 Annual Meeting, Mar 1-7 2008, Denver, CO (abstract 786). 2008.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Lysine requirements of healthy adult Indian subjects receiving long-term feeding, measured with a 24-h indicator amino acid oxidation and balance technique.
PubMed Identifier: 12145014
author list: Kurpad AV, Regan MM, Raj T, El-Khoury A, Kuriyan R, Vaz M, Chandakudlu D, Venkataswamy VG, Borgonha S, Young VR
published in: The American journal of clinical nutrition
information resource reference: Lysine requirements of healthy adult Indian subjects receiving long-term feeding, measured with a 24-h indicator amino acid oxidation and balance technique. Am J Clin Nutr. 2002 Aug; 76(2):404-12.
journal title abbreviation: Am J Clin Nutr
publication date: 2002-08-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Survey of breast-feeding practices and outcomes in the cystic fibrosis population.
PubMed Identifier: 15022134
author list: Parker EM, O'Sullivan BP, Shea JC, Regan MM, Freedman SD
published in: Pediatric pulmonology
information resource reference: Survey of breast-feeding practices and outcomes in the cystic fibrosis population. Pediatr Pulmonol. 2004 Apr; 37(4):362-7.
journal title abbreviation: Pediatr Pulmonol
publication date: 2004-04-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1116345
type: Authorship
author rank in publication: 29
linked author: Regan, Meredith
linked information resource: Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
PubMed Identifier: 30475668
author list: Ruhstaller T, Giobbie-Hurder A, Colleoni M, Jensen MB, Ejlertsen B, de Azambuja E, Neven P, Láng I, Jakobsen EH, Gladieff L, Bonnefoi H, Harvey VJ, Spazzapan S, Tondini C, Del Mastro L, Veyret C, Simoncini E, Gianni L, Rochlitz C, Kralidis E, Zaman K, Jassem J, Piccart-Gebhart M, Di Leo A, Gelber RD, Coates AS, Goldhirsch A, Thürlimann B, Regan MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial. J Clin Oncol. 2019 01 10; 37(2):105-114.
journal title abbreviation: J Clin Oncol
publication date: 2018-11-26T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Factors associated with enrollment in cancer genetics research.
PubMed Identifier: 16835336
author list: Ford BM, Evans JS, Stoffel EM, Balmaña J, Regan MM, Syngal S
published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
information resource reference: Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomarkers Prev. 2006 Jul; 15(7):1355-9.
journal title abbreviation: Cancer Epidemiol Biomarkers Prev
publication date: 2006-07-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer.
PubMed Identifier: 18184327
author list: Nakabayashi M, Sartor O, Jacobus S, Regan MM, McKearn D, Ross RW, Kantoff PW, Taplin ME, Oh WK
published in: BJU international
information resource reference: Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer. BJU Int. 2008 Feb; 101(3):308-12.
journal title abbreviation: BJU Int
publication date: 2008-02-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.
PubMed Identifier: 20862742
author list: Oh WK, Vargas R, Jacobus S, Leitzel K, Regan MM, Hamer P, Pierce K, Brown-Shimer S, Carney W, Ali SM, Kantoff PW, Lipton A
published in: Cancer
information resource reference: Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients. Cancer. 2011 Feb 01; 117(3):517-25.
journal title abbreviation: Cancer
publication date: 2010-09-22T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article.
PubMed Identifier: 21121759
author list: Drzymalski DM, Oh WK, Werner L, Regan MM, Kantoff P, Tuli S
published in: Journal of neurosurgery. Spine
information resource reference: Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article. J Neurosurg Spine. 2010 Dec; 13(6):789-94.
journal title abbreviation: J Neurosurg Spine
publication date: 2010-12-01T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance.
PubMed Identifier: 21167525
author list: San Francisco IF, Werner L, Regan MM, Garnick MB, Bubley G, DeWolf WC
published in: The Journal of urology
information resource reference: Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance. J Urol. 2011 Feb; 185(2):471-6.
journal title abbreviation: J Urol
publication date: 2010-12-17T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1120722
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma.

Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma.
PubMed Identifier: 30563395
author list: Tarhini A, McDermott D, Ambavane A, Gupte-Singh K, Aponte-Ribero V, Ritchings C, Benedict A, Rao S, Regan MM, Atkins M
published in: Immunotherapy
information resource reference: Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma. Immunotherapy. 2019 03; 11(4):283-295.
journal title abbreviation: Immunotherapy
publication date: 2018-12-19T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Bivariate dose-response modeling and risk estimation in developmental toxicology
author list: Regan MM, Catalano PJ
published in: J Agric Biol Environ Stat
information resource reference: Bivariate dose-response modeling and risk estimation in developmental toxicology. J Agric Biol Environ Stat. 1999; 4:217-37.
publication date: 1999-01-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1122376
type: Authorship
author rank in publication: 17
linked author: Regan, Meredith
linked information resource: Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial.

Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial.
PubMed Identifier: 30589600
author list: Dellapasqua S, Gray KP, Munzone E, Rubino D, Gianni L, Johansson H, Viale G, Ribi K, Bernhard J, Kammler R, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Regan MM, Goldhirsch A, Colleoni M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. J Clin Oncol. 2019 02 10; 37(5):386-395.
journal title abbreviation: J Clin Oncol
publication date: 2018-12-27T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 122261
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.

Inotropes improve right heart function in patients undergoing aortic valve replacement for aortic stenosis.
PubMed Identifier: 15041568
author list: Maslow AD, Regan MM, Schwartz C, Bert A, Singh A
published in: Anesthesia and analgesia
information resource reference: Inotropes improve right heart function in patients undergoing aortic valve replacement for aortic stenosis. Anesth Analg. 2004 Apr; 98(4):891-902.
journal title abbreviation: Anesth Analg
publication date: 2004-04-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma.
PubMed Identifier: 15448028
author list: Atkins MB, Regan M, McDermott D
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 2):6342S-6S.
journal title abbreviation: Clin Cancer Res
publication date: 2004-09-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/1167568
PubMed Identifier: 17679725
author list: Viale G, Regan MM, Maiorano E, Mastropasqua MG, Dell'Orto P, Rasmussen BB, Raffoul J, Neven P, Orosz Z, Braye S, Ohlschlegel C, Thürlimann B, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. J Clin Oncol. 2007 Sep 01; 25(25):3846-52.
journal title abbreviation: J Clin Oncol
publication date: 2007-08-06T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

Authorship 1125997
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
PubMed Identifier: 30624592
author list: Curigliano G, Burstein HJ, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2019 07 01; 30(7):1181.
journal title abbreviation: Ann Oncol
publication date: 2019-07-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Physicians' experiences with BRCA1/2 testing in community settings.
PubMed Identifier: 19001322
author list: Keating NL, Stoeckert KA, Regan MM, DiGianni L, Garber JE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Physicians' experiences with BRCA1/2 testing in community settings. J Clin Oncol. 2008 Dec 10; 26(35):5789-96.
journal title abbreviation: J Clin Oncol
publication date: 2008-11-10T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
PubMed Identifier: 19528373
author list: Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol. 2009 Aug 01; 27(22):3577-83.
journal title abbreviation: J Clin Oncol
publication date: 2009-06-15T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 116173
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma.

Authorship 1131852
type: Authorship
author rank in publication: 19
linked author: Regan, Meredith
linked information resource: Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.
PubMed Identifier: 30765258
author list: Loi S, Giobbie-Hurder A, Gombos A, Bachelot T, Hui R, Curigliano G, Campone M, Biganzoli L, Bonnefoi H, Jerusalem G, Bartsch R, Rabaglio-Poretti M, Kammler R, Maibach R, Smyth MJ, Di Leo A, Colleoni M, Viale G, Regan MM, André F
published in: The Lancet. Oncology
information resource reference: Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial. Lancet Oncol. 2019 03; 20(3):371-382.
journal title abbreviation: Lancet Oncol
publication date: 2019-02-11T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer.
PubMed Identifier: 30790648
author list: Einstein DJ, Patil D, Chipman J, Regan MM, Davis K, Crociani CM, Wagner AA, Sanda MG, Chang P
published in: Urology
information resource reference: Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer. Urology. 2019 05; 127:53-60.
journal title abbreviation: Urology
publication date: 2019-02-18T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1137355
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows.

Authorship 1136892
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate Cancer.

Authorship 1136318
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.

Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98.
PubMed Identifier: 30795773
author list: Kensler KH, Regan MM, Heng YJ, Baker GM, Pyle ME, Schnitt SJ, Hazra A, Kammler R, Thürlimann B, Colleoni M, Viale G, Brown M, Tamimi RM
published in: Breast cancer research : BCR
information resource reference: Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98. Breast Cancer Res. 2019 02 22; 21(1):30.
journal title abbreviation: Breast Cancer Res
publication date: 2019-02-22T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows.
PubMed Identifier: 30811287
author list: Regan MM, Fleming GF, Walley B, Francis PA, Pagani O
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows. J Clin Oncol. 2019 04 10; 37(11):862-866.
journal title abbreviation: J Clin Oncol
publication date: 2019-02-27T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Tamoxifen
MeSH DescriptorUI: D013629
MeSH semantic group name: Chemicals & Drugs
number of authors: 401
number of publications: 893
uniqueness weight: 0.724611
type: Concept

Breast Neoplasms
MeSH DescriptorUI: D001943
MeSH semantic group name: Disorders
number of authors: 2945
number of publications: 21206
uniqueness weight: 0.145992
type: Concept

Premenopause
MeSH DescriptorUI: D017697
MeSH semantic group name: Physiology
number of authors: 294
number of publications: 1044
uniqueness weight: 0.721443
type: Concept

Authorship 124151
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

Authorship 1145437
type: Authorship
author rank in publication: 28
linked author: Regan, Meredith
linked information resource: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

Authorship 1142747
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Prevalence of germline variants in inflammatory breast cancer.

Prevalence of germline variants in inflammatory breast cancer.
PubMed Identifier: 30933323
author list: Rana HQ, Sacca R, Drogan C, Gutierrez S, Schlosnagle E, Regan MM, Speare V, LaDuca H, Dolinsky J, Garber JE, Overmoyer BA
published in: Cancer
information resource reference: Prevalence of germline variants in inflammatory breast cancer. Cancer. 2019 07 01; 125(13):2194-2202.
journal title abbreviation: Cancer
publication date: 2019-04-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
PubMed Identifier: 30967649
author list: Ribi K, Luo W, Colleoni M, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Di Lauro V, Gomez HL, Ruhstaller T, Abdi E, Biganzoli L, Müller B, Barbeaux A, Graas MP, Rabaglio M, Francis PA, Foukakis T, Pagani O, Graiff C, Vorobiof D, Maibach R, Di Leo A, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J
published in: British journal of cancer
information resource reference: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. Br J Cancer. 2019 05; 120(10):959-967.
journal title abbreviation: Br J Cancer
publication date: 2019-04-10T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Receptors, Estrogen
MeSH DescriptorUI: D011960
MeSH semantic group name: Chemicals & Drugs
number of authors: 680
number of publications: 2260
uniqueness weight: 0.550598
type: Concept

Authorship 1150179
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Reply to K.-D. Yu et al.

Reply to K.-D. Yu et al.
PubMed Identifier: 31034299
author list: Ruhstaller T, Regan MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Reply to K.-D. Yu et al. J Clin Oncol. 2019 06 10; 37(17):1516-1517.
journal title abbreviation: J Clin Oncol
publication date: 2019-04-29T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Antineoplastic Agents, Hormonal
MeSH DescriptorUI: D018931
MeSH semantic group name: Chemicals & Drugs
number of authors: 450
number of publications: 1504
uniqueness weight: 0.548511
type: Concept

Authorship 1151676
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII?+?IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.

Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII?+?IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.
PubMed Identifier: 31065870
author list: Denkert C, Budczies J, Regan MM, Loibl S, Dell'Orto P, von Minckwitz G, Mastropasqua MG, Solbach C, Thürlimann B, Mehta K, Blohmer JU, Colleoni M, Müller V, Klauschen F, Ataseven B, Engels K, Kammler R, Pfitzner BM, Dietel M, Fasching PA, Viale G
published in: Breast cancer research and treatment
information resource reference: Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII?+?IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial. Breast Cancer Res Treat. 2019 Aug; 176(3):557-568.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2019-05-07T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Emeritus
type: Department
type: Organization

Medicine
type: Department
type: Organization

Pediatrics
type: Department
type: Organization

Adult Oncology
type: Division
type: Organization

Oncology
type: Division
type: Organization

Beth Israel Deaconess Medical Center
type: Organization

Dana-Farber Cancer Institute
type: Organization

Harvard Medical School
type: Organization

Partridge, Ann
eCommons Login: AHP1
first name: Ann
last name: Partridge
full name: Ann Hart Partridge, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 84598
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 395
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/113
predicate: selected publications
type: Network

research areas
maximum weight: 6.17169
minimum weight: 0.00171383
number of connections: 895
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/217
predicate: research areas
type: Network

coauthor of
maximum weight: 4.92484
minimum weight: 0.00994075
number of connections: 132
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/363
predicate: coauthor of
type: Network

similar to
maximum weight: 315.321
minimum weight: 36.7909
number of connections: 60
predicate node: https://connects.catalyst.harvard.edu/Profiles/profile/494
predicate: similar to
type: Network

Antin, Joseph
eCommons Login: JHA4
first name: Joseph
last name: Antin
full name: Joseph Harry Antin, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 78492
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Brown, Myles
eCommons Login: MAB3
first name: Myles
last name: Brown
full name: Myles A. Brown, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 36041
person in primary position: Emil Frei III Professor of Medicine
type: Agent
type: Person
preferred title: Emil Frei III Professor of Medicine

Freedman, Arnold
eCommons Login: ASF4
first name: Arnold
last name: Freedman
full name: Arnold Stephen Freedman, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 18697
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Choueiri, Toni
eCommons Login: TKC6
first name: Toni
last name: Choueiri
full name: Toni K. Choueiri, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 77491
person in primary position: Jerome and Nancy Kohlberg Professor of Medicine
type: Agent
type: Person
preferred title: Jerome and Nancy Kohlberg Professor of Medicine

Gelber, Richard
eCommons Login: RDG4
first name: Richard
last name: Gelber
full name: Richard David Gelber, Ph.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 86027
person in primary position: Professor of Pediatrics (Biostatistics)
type: Agent
type: Person
preferred title: Professor of Pediatrics (Biostatistics)

Garber, Judy
eCommons Login: JEG4
first name: Judy
last name: Garber
full name: Judy Ellen Garber, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 646
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Winer, Eric
eCommons Login: EPW2
first name: Eric
last name: Winer
full name: Eric Paul Winer, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 5538
person in primary position: Professor of Medicine, Emeritus
type: Agent
type: Person
preferred title: Professor of Medicine, Emeritus

Tolaney, Sara
eCommons Login: SMT9
first name: Sara
last name: Tolaney
full name: Sara Michell Tolaney, M.D.
has faculty rank: Associate Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 67909
person in primary position: Associate Professor of Medicine
type: Agent
type: Person
preferred title: Associate Professor of Medicine

Burstein, Harold
eCommons Login: HJB1
first name: Harold
last name: Burstein
full name: Harold John Burstein, M.D., Ph.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 51067
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

Reinherz, Ellis
eCommons Login: ELR4
first name: Ellis
last name: Reinherz
full name: Ellis Leonard Reinherz, M.D.
has faculty rank: Full Professor
latitude: 42.33789600000000
longitude: -71.10724930000000
Person ID: 33835
person in primary position: Professor of Medicine
type: Agent
type: Person
preferred title: Professor of Medicine

McDermott, David
eCommons Login: DFM7
first name: David
last name: McDermott
full name: David Francis McDermott, M.D.
has faculty rank: Full Professor
Person ID: 83685
person in primary position: Victor J. Aresty Professor of Medicine
type: Agent
type: Person
preferred title: Victor J. Aresty Professor of Medicine

Authorship 1178166
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.

Authorship 1177752
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.

A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.
PubMed Identifier: 31360890
author list: Xie W, Halabi S, Tierney JF, Sydes MR, Collette L, Dignam JJ, Buyse M, Sweeney CJ, Regan MM
published in: JNCI cancer spectrum
information resource reference: A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses. JNCI Cancer Spectr. 2019 Mar; 3(1):pkz002.
journal title abbreviation: JNCI Cancer Spectr
publication date: 2019-02-06T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
PubMed Identifier: 31373601
author list: Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Ann Oncol. 2019 10 01; 30(10):1541-1557.
journal title abbreviation: Ann Oncol
publication date: 2019-10-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 140968
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.

Authorship 1186030
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.

Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
PubMed Identifier: 31448540
author list: Nakhlis F, Regan MM, Chun YS, Dominici LS, Caterson S, Bellon JR, Warren L, Yeh ED, Jacene HA, King TA, Overmoyer B
published in: The breast journal
information resource reference: Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience. Breast J. 2020 03; 26(3):384-390.
journal title abbreviation: Breast J
publication date: 2019-08-25T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1191243
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma.

Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma.
PubMed Identifier: 31498030
author list: Regan MM, Werner L, Rao S, Gupte-Singh K, Hodi FS, Kirkwood JM, Kluger HM, Larkin J, Postow MA, Ritchings C, Sznol M, Tarhini AA, Wolchok JD, Atkins MB, McDermott DF
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma. J Clin Oncol. 2019 12 10; 37(35):3350-3358.
journal title abbreviation: J Clin Oncol
publication date: 2019-09-09T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 148424
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.

Authorship 150678
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.

Authorship 1196804
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.
PubMed Identifier: 31618131
author list: Pagani O, Francis PA, Fleming GF, Walley BA, Viale G, Colleoni M, Láng I, Gómez HL, Tondini C, Pinotti G, Di Leo A, Coates AS, Goldhirsch A, Gelber RD, Regan MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT. J Clin Oncol. 2020 04 20; 38(12):1293-1303.
journal title abbreviation: J Clin Oncol
publication date: 2019-10-16T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 132769
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Adult Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Adult Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Adult Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Emil Frei III Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Adult Oncology
sort order: 1
type: Position
HR job title: Emil Frei III Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Adult Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 144711
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.

Authorship 143091
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Intravenously infused 13C-leucine is retained in fasting healthy adult men.

Authorship 1212775
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Risk stratification according to stage and pathology.

Risk stratification according to stage and pathology.
PubMed Identifier: 31839154
author list: Regan MM
published in: Breast (Edinburgh, Scotland)
information resource reference: Risk stratification according to stage and pathology. Breast. 2019 Nov; 48 Suppl 1:S23-S25.
journal title abbreviation: Breast
publication date: 2019-11-01T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1218377
type: Authorship
author rank in publication: 12
linked author: Regan, Meredith
linked information resource: Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.

Authorship 1219016
type: Authorship
author rank in publication: 12
linked author: Regan, Meredith
linked information resource: Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

Authorship 1217858
type: Authorship
author rank in publication: 28
linked author: Regan, Meredith
linked information resource: Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.
PubMed Identifier: 31928354
author list: Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM, Regan MM, Rimm DL, Symmans WF, Torlakovic EE, Varella L, Viale G, Weisberg TF, McShane LM, Wolff AC
published in: Archives of pathology & laboratory medicine
information resource reference: Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update. Arch Pathol Lab Med. 2020 05; 144(5):545-563.
journal title abbreviation: Arch Pathol Lab Med
publication date: 2020-01-13T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
PubMed Identifier: 31949268
author list: Ribi K, Luo W, Colleoni M, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Di Lauro V, Gomez HL, Ruhstaller T, Abdi E, Biganzoli L, Müller B, Barbeaux A, Graas MP, Rabaglio M, Francis PA, Foukakis T, Pagani O, Graiff C, Vorobiof D, Maibach R, Di Leo A, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J
published in: British journal of cancer
information resource reference: Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. Br J Cancer. 2020 Mar; 122(7):1119.
journal title abbreviation: Br J Cancer
publication date: 2020-03-01T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
PubMed Identifier: 31928404
author list: Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM, Regan MM, Rimm DL, Symmans WF, Torlakovic EE, Varella L, Viale G, Weisberg TF, McShane LM, Wolff AC
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. J Clin Oncol. 2020 04 20; 38(12):1346-1366.
journal title abbreviation: J Clin Oncol
publication date: 2020-01-13T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 157131
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

Authorship 1221188
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Corrections to "De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017".

Authorship 1221234
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinoma.

Authorship 1221502
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
PubMed Identifier: 31987446
author list: Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Ann Oncol. 2019 Oct; 30(10):1541-1557.
journal title abbreviation: Ann Oncol
publication date: 2019-12-27T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Corrections to "De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017".
PubMed Identifier: 31987391
author list: Curigliano G, Burstein HJ, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Corrections to "De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017". Ann Oncol. 2019 Jul; 30(7):1181.
journal title abbreviation: Ann Oncol
publication date: 2019-12-04T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinoma.
PubMed Identifier: 31992108
author list: Ambavane A, Yang S, Atkins MB, Rao S, Shah A, Regan MM, McDermott DF, Michaelson MD
published in: Immunotherapy
information resource reference: Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinoma. Immunotherapy. 2020 01; 12(1):37-51.
journal title abbreviation: Immunotherapy
publication date: 2020-01-29T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1223526
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.

Authorship 1223634
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Authorship 1223854
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.
PubMed Identifier: 32025567
author list: Fackler MJ, Cho S, Cope L, Gabrielson E, Visvanathan K, Wilsbach K, Meir-Levi D, Lynch CF, Marks J, Geradts J, Regan MM, Viale G, Wolff AC, Sukumar S, Umbricht CB
published in: NPJ breast cancer
information resource reference: DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ Breast Cancer. 2020; 6:3.
journal title abbreviation: NPJ Breast Cancer
publication date: 2020-01-31T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.
PubMed Identifier: 32018568
author list: Ejlertsen B, Aldridge J, Nielsen KV, Regan MM, Henriksen KL, Lykkesfeldt AE, Müller S, Gelber RD, Price KN, Rasmussen BB, Viale G, Mouridsen H
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial. Ann Oncol. 2012 May; 23(5):1138-1144.
journal title abbreviation: Ann Oncol
publication date: 2019-12-04T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
PubMed Identifier: 32018737
author list: Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, Öhlschlegel C, Price KN, Gelber RD, Regan MM, Thürlimann B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol. 2012 Nov; 23(11):2843-2851.
journal title abbreviation: Ann Oncol
publication date: 2019-12-04T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 121296
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/1101911

Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response.
PubMed Identifier: 23741308
author list: Jeselsohn RM, Werner L, Regan MM, Fatima A, Gilmore L, Collins LC, Beck AH, Bailey ST, He HH, Buchwalter G, Brown M, Iglehart JD, Richardson A, Come SE
published in: PloS one
information resource reference: Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response. PLoS One. 2013; 8(5):e64225.
journal title abbreviation: PLoS One
publication date: 2013-05-31T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1238673
type: Authorship
author rank in publication: 21
linked author: Regan, Meredith
linked information resource: Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
PubMed Identifier: 32274665
author list: Ribi K, Luo W, Walley BA, Burstein HJ, Chirgwin J, Ansari RH, Salim M, van der Westhuizen A, Abdi E, Francis PA, Chia S, Harvey VJ, Giobbie-Hurder A, Fleming GF, Pagani O, Di Leo A, Colleoni M, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J
published in: Breast cancer research and treatment
information resource reference: Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy. Breast Cancer Res Treat. 2020 Jun; 181(2):347-359.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2020-04-09T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1243143
type: Authorship
author rank in publication: 25
linked author: Regan, Meredith
linked information resource: Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.

Authorship 1243082
type: Authorship
author rank in publication: 24
linked author: Regan, Meredith
linked information resource: Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.

Authorship 1243613
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/151798504

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
PubMed Identifier: 32337478
author list: Dowling RJO, Sparano JA, Goodwin PJ, Bidard FC, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M, Gray RJ, Henry NL, Meric-Bernstam F, Perlmutter J, Sledge GW, Thorat MA, Bratman SV, Carey LA, Chang MC, DeMichele A, Ennis M, Jerzak KJ, Korde LA, Lohmann AE, Mamounas EP, Parulekar WR, Regan MM, Schramek D, Stambolic V, Whelan TJ, Wolff AC, Woodgett JR, Kalinsky K, Hayes DF
published in: JNCI cancer spectrum
information resource reference: Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI Cancer Spectr. 2019 Dec; 3(4):pkz049.
journal title abbreviation: JNCI Cancer Spectr
publication date: 2019-08-10T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
PubMed Identifier: 32337479
author list: Dowling RJO, Kalinsky K, Hayes DF, Bidard FC, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M, Gray RJ, Henry NL, Meric-Bernstam F, Perlmutter J, Sledge GW, Bratman SV, Carey LA, Chang MC, DeMichele A, Ennis M, Jerzak KJ, Korde LA, Lohmann AE, Mamounas EP, Parulekar WR, Regan MM, Schramek D, Stambolic V, Thorat MA, Whelan TJ, Wolff AC, Woodgett JR, Sparano JA, Goodwin PJ
published in: JNCI cancer spectrum
information resource reference: Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations. JNCI Cancer Spectr. 2019 Dec; 3(4):pkz050.
journal title abbreviation: JNCI Cancer Spectr
publication date: 2019-08-10T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/151798504
PubMed Identifier: 32337480
author list: Buechler SA, Gray KP, Gökmen-Polar Y, Willis S, Thürlimann B, Kammler R, Viale G, Leyland-Jones B, Badve SS, Regan MM
published in: JNCI cancer spectrum
information resource reference: Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer. JNCI Cancer Spectr. 2019 Dec; 3(4):pkz051.
journal title abbreviation: JNCI Cancer Spectr
publication date: 2019-08-16T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer.

Authorship 177549
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Effect of oral CDP-choline on plasma choline and uridine levels in humans.

Authorship 181422
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Gender bias in the disposition of frozen embryos.

Authorship 180049
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.

Authorship 1256004
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial.

Authorship 1256799
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.

Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial.
PubMed Identifier: 32535486
author list: Sun Z, Niman SM, Pagani O, Partridge AH, Azim HA, Peccatori FA, Ruggeri M, Di Leo A, Colleoni M, Gelber RD, Regan MM
published in: Breast (Edinburgh, Scotland)
information resource reference: Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial. Breast. 2020 Oct; 53:1-7.
journal title abbreviation: Breast
publication date: 2020-06-02T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.
PubMed Identifier: 32552276
author list: Xie W, Regan MM, Buyse M, Halabi S, Kantoff PW, Sartor O, Soule H, Berry D, Clarke N, Collette L, D'Amico A, Lourenco RA, Dignam J, Eisenberger M, James N, Fizazi K, Gillessen S, Loriot Y, Mottet N, Parulekar W, Sandler H, Spratt DE, Sydes MR, Tombal B, Williams S, Sweeney CJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. J Clin Oncol. 2020 09 10; 38(26):3032-3041.
journal title abbreviation: J Clin Oncol
publication date: 2020-06-18T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 143612
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet.

Authorship 133823
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Daily methionine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique.

Authorship 19999
type: Authorship
linked author: Regan, Meredith
linked information resource: Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.

Authorship 157453
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4.

Authorship 164786
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.

Authorship 1268187
type: Authorship
author rank in publication: 14
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/162739960

https://connects.catalyst.harvard.edu/Profiles/profile/162739960
PubMed Identifier: 32652112
author list: Luen SJ, Asher R, Lee CK, Savas P, Kammler R, Dell'Orto P, Biasi OM, Demanse D, Hackl W, Thuerlimann B, Viale G, Di Leo A, Colleoni M, Regan MM, Loi S
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study. Ann Oncol. 2020 10; 31(10):1359-1365.
journal title abbreviation: Ann Oncol
publication date: 2020-07-08T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study.

Authorship 1270865
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses.

DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses.
PubMed Identifier: 32723153
author list: Hertz DL, Kidwell KM, Douglas JA, Viale G, Leyland-Jones B, Regan M, Rae JM
published in: Pharmacogenomics
information resource reference: DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses. Pharmacogenomics. 2020 08; 21(13):899-902.
journal title abbreviation: Pharmacogenomics
publication date: 2020-07-29T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Instructor in Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Instructor in Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 206322
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/996619

Authorship 138030
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.

Authorship 1286318
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.

Authorship 1288239
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib.

Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib.
PubMed Identifier: 32943461
author list: Tripathi A, Supko JG, Gray KP, Melnick ZJ, Regan MM, Taplin ME, Choudhury AD, Pomerantz MM, Bellmunt J, Yu C, Sun Z, Srinivas S, Kantoff PW, Sweeney CJ, Harshman LC
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib. Clin Cancer Res. 2020 12 01; 26(23):6122-6131.
journal title abbreviation: Clin Cancer Res
publication date: 2020-09-17T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers.
PubMed Identifier: 32913979
author list: Willis S, Sun Y, Abramovitz M, Fei T, Young B, Lin X, Ni M, Achua J, Regan MM, Gray KP, Gray R, Wang V, Long B, Kammler R, Sparano JA, Williams C, Goldstein LJ, Salgado R, Loi S, Pruneri G, Viale G, Brown M, Leyland-Jones B
published in: JCO precision oncology
information resource reference: High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers. JCO Precis Oncol. 2017; 1.
journal title abbreviation: JCO Precis Oncol
publication date: 2017-10-13T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Associate Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Associate Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Lynce, Filipa
eCommons Login: FL128
first name: Filipa
last name: Lynce
full name: Filipa Lynce, M.D.
has faculty rank: Assistant Professor
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 194602
person in primary position: Assistant Professor of Medicine
type: Agent
type: Person
preferred title: Assistant Professor of Medicine

Authorship 1297449
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors.

Authorship 1296325
type: Authorship
author rank in publication: 32
linked author: Regan, Meredith
linked information resource: Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
PubMed Identifier: 33082214
author list: Guerini-Rocco E, Gray KP, Fumagalli C, Reforgiato MR, Leone I, Rafaniello Raviele P, Munzone E, Kammler R, Neven P, Hitre E, Jerusalem G, Simoncini E, Gombos A, Deleu I, Karlsson P, Aebi S, Chirgwin J, Di Lauro V, Thompson A, Graas MP, Barber M, Fontaine C, Loibl S, Gavilá J, Kuroi K, Müller B, O'Reilly S, Di Leo A, Goldhirsch A, Viale G, Barberis M, Regan MM, Colleoni M
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial. Clin Cancer Res. 2021 01 15; 27(2):504-512.
journal title abbreviation: Clin Cancer Res
publication date: 2020-10-20T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors.
PubMed Identifier: 33052755
author list: Piccart MJ, Hilbers FS, Bliss JM, Caballero C, Frank ES, Renault P, Naït Kaoudjt R, Schumacher E, Spears PA, Regan MM, Gelber RD, Davidson NE, Norton L, Winer EP
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors. J Clin Oncol. 2020 12 01; 38(34):4120-4129.
journal title abbreviation: J Clin Oncol
publication date: 2020-10-14T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 143450
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.

Authorship 1303326
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
PubMed Identifier: 33159633
author list: Rabaglio M, Sun Z, Maibach R, Giobbie-Hurder A, Ejlertsen B, Harvey VJ, Neven P, Láng I, Bonnefoi H, Wardley A, Ruepp B, Castiglione M, Coates AS, Gelber RD, Goldhirsch A, Colleoni M, Thürlimann B, Regan MM
published in: Breast cancer research and treatment
information resource reference: Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial. Breast Cancer Res Treat. 2021 Feb; 185(3):697-707.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2020-11-07T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
PubMed Identifier: 33290610
author list: Leone JP, Cole BF, Regan MM, Thürlimann B, Coates AS, Rabaglio M, Giobbie-Hurder A, Gelber RD, Ejlertsen B, Harvey VJ, Neven P, Láng I, Bonnefoi H, Wardley A, Goldhirsch A, Di Leo A, Colleoni M, Vaz-Luis I, Lin NU
published in: Cancer
information resource reference: Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial. Cancer. 2021 03 01; 127(5):700-708.
journal title abbreviation: Cancer
publication date: 2020-12-08T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1313453
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.

Authorship 1324564
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.

Authorship 1324507
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer.
PubMed Identifier: 33514703
author list: Fackler MJ, Cho S, Cope L, Gabrielson E, Visvanathan K, Wilsbach K, Meir-Levi D, Lynch CF, Marks J, Geradts J, Regan MM, Viale G, Wolff AC, Sukumar S, Umbricht CB
published in: NPJ breast cancer
information resource reference: DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ Breast Cancer. 2020 Jan 31; 6(1):3.
journal title abbreviation: NPJ Breast Cancer
publication date: 2020-01-31T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
PubMed Identifier: 33507815
author list: Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA, Loibl S, Morris EA, Perez A, Regan MM, Spears PA, Sudheendra PK, Symmans WF, Yung RL, Harvey BE, Hershman DL
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. J Clin Oncol. 2021 05 01; 39(13):1485-1505.
journal title abbreviation: J Clin Oncol
publication date: 2021-01-28T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1331583
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer.

Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer.
PubMed Identifier: 33585999
author list: Lynce F, Williams JT, Regan MM, Bunnell CA, Freedman RA, Tolaney SM, Chen WY, Mayer EL, Partridge AH, Winer EP, Overmoyer B
published in: Cancer chemotherapy and pharmacology
information resource reference: Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer. Cancer Chemother Pharmacol. 2021 05; 87(5):673-679.
journal title abbreviation: Cancer Chemother Pharmacol
publication date: 2021-02-14T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 197390
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: Lysine requirements of healthy adult Indian subjects, measured by an indicator amino acid balance technique.

Authorship 160819
type: Authorship
author rank in publication: 23
linked author: Regan, Meredith
linked information resource: Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Authorship 1362388
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.
PubMed Identifier: 34117261
author list: Paoletti C, Regan MM, Niman SM, Dolce EM, Darga EP, Liu MC, Marcom PK, Hart LL, Smith JW, Tedesco KL, Amir E, Krop IE, DeMichele AM, Goodwin PJ, Block M, Aung K, Brown ME, McCormack RT, Hayes DF
published in: NPJ breast cancer
information resource reference: Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients. NPJ Breast Cancer. 2021 Jun 11; 7(1):77.
journal title abbreviation: NPJ Breast Cancer
publication date: 2021-06-11T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1371779
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.

Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.
PubMed Identifier: 34149037
author list: Hirko KA, Regan MM, Remolano MC, Schlossman J, Harrison B, Yeh E, Jacene H, Nakhlis F, Block C, Rosenbluth JM, Garrido-Castro AC, Overmoyer BA
published in: American journal of clinical oncology
information resource reference: Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer. Am J Clin Oncol. 2021 09 01; 44(9):449-455.
journal title abbreviation: Am J Clin Oncol
publication date: 2021-09-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 198509
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.

Authorship 1378969
type: Authorship
author rank in publication: 19
linked author: Regan, Meredith
linked information resource: A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.
PubMed Identifier: 34312215
author list: Von Hoff DD, Clark GM, Coltman CA, Disis ML, Eckhardt SG, Ellis LM, Foti M, Garrett-Mayer E, Gönen M, Hidalgo M, Hilsenbeck SG, Littlefield JH, LoRusso PM, Lyerly HK, Meropol NJ, Patel JD, Piantadosi S, Post DA, Regan MM, Shyr Y, Tempero MA, Tepper JE, Von Roenn J, Weiner LM, Young DC, Vu NV
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop. Clin Cancer Res. 2021 10 15; 27(20):5472-5481.
journal title abbreviation: Clin Cancer Res
publication date: 2021-07-26T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1388506
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.

Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
PubMed Identifier: 34433304
author list: Chang P, Wagner AA, Regan MM, Smith JA, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Partin AW, Wood DP, Crociani CM, Greenfield TK, Patil D, Hembroff LA, Davis K, Stork L, Spratt DE, Wei JT, Sanda MG
published in: The Journal of urology
information resource reference: Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. J Urol. 2022 01; 207(1):127-136.
journal title abbreviation: J Urol
publication date: 2021-08-26T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1390674
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/185063236

https://connects.catalyst.harvard.edu/Profiles/profile/185063236
PubMed Identifier: 34475143
author list: Kappos EA, Schulz A, Regan MM, Moffa G, Harder Y, Ribi K, Potter S, Pusic AL, Fehr MK, Hemkens LG, Holzbach T, Farhadi J, Simonson C, Knauer M, Verstappen R, Bucher HC, Zwahlen D, Zimmermann F, Schwenkglenks M, Mucklow R, Shaw J, Bjelic-Radisic V, Chiorescu A, Chun YS, Farah S, Xiaosong C, Nigard L, Kuemmel S, Reitsamer R, Hauschild M, Fulco I, Tausch C, Fischer T, Sarlos D, Constantinescu MA, Lupatsch JE, Fitzal F, Heil J, Matrai Z, de Boniface J, Kurzeder C, Haug M, Weber WP
published in: BMJ open
information resource reference: Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial. BMJ Open. 2021 09 02; 11(9):e045239.
journal title abbreviation: BMJ Open
publication date: 2021-09-02T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial.

Authorship 1411185
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067.

Authorship 1412473
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial.

Authorship 1413904
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors.

Authorship 1414185
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Accelerating progress to innovation for patients: Trial design and risk stratification.

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors.
PubMed Identifier: 34855329
author list: Mantia CM, Werner L, Stwalley B, Ritchings C, Tarhini AA, Atkins MB, McDermott DF, Regan MM
published in: Melanoma research
information resource reference: Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors. Melanoma Res. 2022 02 01; 32(1):35-44.
journal title abbreviation: Melanoma Res
publication date: 2022-02-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067.
PubMed Identifier: 34799400
author list: Regan MM, Mantia CM, Werner L, Tarhini AA, Larkin J, Stephen Hodi F, Wolchok J, Postow MA, Stwalley B, Moshyk A, Ritchings C, Re S, van Dijck W, McDermott DF, Atkins MB
published in: Journal for immunotherapy of cancer
information resource reference: Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067. J Immunother Cancer. 2021 11; 9(11).
journal title abbreviation: J Immunother Cancer
publication date: 2021-11-01T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Accelerating progress to innovation for patients: Trial design and risk stratification.
PubMed Identifier: 34836764
author list: Regan MM
published in: Breast (Edinburgh, Scotland)
information resource reference: Accelerating progress to innovation for patients: Trial design and risk stratification. Breast. 2022 Mar; 62 Suppl 1:S80-S83.
journal title abbreviation: Breast
publication date: 2021-11-20T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial.
PubMed Identifier: 34759043
author list: Regan MM, Jegede OA, Mantia CM, Powles T, Werner L, Motzer RJ, Tannir NM, Lee CH, Tomita Y, Voss MH, Plimack ER, Choueiri TK, Rini BI, Hammers HJ, Escudier B, Albiges L, Huo S, Del Tejo V, Stwalley B, Atkins MB, McDermott DF
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial. Clin Cancer Res. 2021 12 15; 27(24):6687-6695.
journal title abbreviation: Clin Cancer Res
publication date: 2021-11-10T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?
PubMed Identifier: 35012846
author list: Regan MM
published in: Breast (Edinburgh, Scotland)
information resource reference: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions? Breast. 2022 Apr; 62:179.
journal title abbreviation: Breast
publication date: 2022-01-03T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1426166
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

Authorship 1440601
type: Authorship
author rank in publication: 33
linked author: Regan, Meredith
linked information resource: Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.

Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant.
PubMed Identifier: 35172272
author list: Malorni L, Tyekucheva S, Hilbers FS, Ignatiadis M, Neven P, Colleoni M, Henry S, Ballestrero A, Bonetti A, Jerusalem G, Papadimitriou K, Bernardo A, Seles E, Duhoux FP, MacPherson IR, Thomson A, Davies DM, Bergqvist M, Migliaccio I, Gebhart G, Zoppoli G, Bliss JM, Benelli M, McCartney A, Kammler R, De Swert H, Ruepp B, Fumagalli D, Maibach R, Cameron D, Loi S, Piccart M, Regan MM
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant. Eur J Cancer. 2022 03; 164:39-51.
journal title abbreviation: Eur J Cancer
publication date: 2022-02-13T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1445536
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer.

Authorship 1446464
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.

A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer.
PubMed Identifier: 35465733
author list: Pérez-Fidalgo JA, Criscitiello C, Carrasco E, Regan MM, Di Leo A, Ribi K, Adam V, Bedard PL
published in: Future oncology (London, England)
information resource reference: A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancer. Future Oncol. 2022 06; 18(19):2339-2349.
journal title abbreviation: Future Oncol
publication date: 2022-04-25T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.
PubMed Identifier: 35380717
author list: Buyse M, Saad ED, Burzykowski T, Regan MM, Sweeney CS
published in: The oncologist
information resource reference: Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy. Oncologist. 2022 04 05; 27(4):266-271.
journal title abbreviation: Oncologist
publication date: 2022-04-05T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications.
PubMed Identifier: 36116830
author list: Tarantino P, Niman SM, Erick TK, Priedigkeit N, Harrison BT, Giordano A, Nakhlis F, Bellon JR, Parker T, Strauss S, Jin Q, King TA, Overmoyer BA, Curigliano G, Regan MM, Tolaney SM, Lynce F
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications. Eur J Cancer. 2022 10; 174:277-286.
journal title abbreviation: Eur J Cancer
publication date: 2022-10-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.
PubMed Identifier: 35923923
author list: Pernas S, Guerriero JL, Naumenko S, Goel S, Regan MM, Hu J, Harrison BT, Lynce F, Lin NU, Partridge A, Morikawa A, Hutchinson J, Mittendorf EA, Sokolov A, Overmoyer B
published in: Therapeutic advances in medical oncology
information resource reference: Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221113269.
journal title abbreviation: Ther Adv Med Oncol
publication date: 2022-07-30T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1479665
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.

Authorship 1488264
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.

Authorship 1500886
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).

Authorship 1499455
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications.

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).
PubMed Identifier: 36175037
author list: Atkins MB, Abu-Sbeih H, Ascierto PA, Bishop MR, Chen DS, Dhodapkar M, Emens LA, Ernstoff MS, Ferris RL, Greten TF, Gulley JL, Herbst RS, Humphrey RW, Larkin J, Margolin KA, Mazzarella L, Ramalingam SS, Regan MM, Rini BI, Sznol M
published in: Journal for immunotherapy of cancer
information resource reference: Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). J Immunother Cancer. 2022 09; 10(9).
journal title abbreviation: J Immunother Cancer
publication date: 2022-09-01T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.
PubMed Identifier: 36210737
author list: Warren LEG, Niman SM, Remolano MC, Landry JM, Nakhlis F, Bellon JR, Aizer AA, Lin NU, Tolaney SM, Regan MM, Overmoyer BA, Lynce F
published in: Cancer
information resource reference: Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer. Cancer. 2022 12 01; 128(23):4085-4094.
journal title abbreviation: Cancer
publication date: 2022-10-10T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1508689
type: Authorship
author rank in publication: 27
linked author: Regan, Meredith
linked information resource: Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
PubMed Identifier: 36493334
author list: Francis PA, Fleming GF, Láng I, Ciruelos EM, Bonnefoi HR, Bellet M, Bernardo A, Climent MA, Martino S, Bermejo B, Burstein HJ, Davidson NE, Geyer CE, Walley BA, Ingle JN, Coleman RE, Müller B, Le Du F, Loibl S, Winer EP, Ruepp B, Loi S, Colleoni M, Coates AS, Gelber RD, Goldhirsch A, Regan MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. J Clin Oncol. 2023 03 01; 41(7):1370-1375.
journal title abbreviation: J Clin Oncol
publication date: 2022-12-09T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 193344
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.

Authorship 1511450
type: Authorship
author rank in publication: 25
linked author: Regan, Meredith
linked information resource: Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
PubMed Identifier: 36521078
author list: Pagani O, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Goetz MP, Ciruelos EM, Stearns V, Bonnefoi HR, Martino S, Geyer CE, Chini C, Puglisi F, Spazzapan S, Ruhstaller T, Winer EP, Ruepp B, Loi S, Coates AS, Gelber RD, Goldhirsch A, Regan MM, Francis PA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. J Clin Oncol. 2023 03 01; 41(7):1376-1382.
journal title abbreviation: J Clin Oncol
publication date: 2022-12-15T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 193802
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

Authorship 20087
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/872233

Authorship 1556293
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/215505796

Authorship 1552512
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.

Authorship 1567273
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/215502727

Authorship 1554282
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.

https://connects.catalyst.harvard.edu/Profiles/profile/215502727
PubMed Identifier: 37391304
author list: Regan MM, Atkins MB, McDermott DF
published in: European urology
information resource reference: Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116. Eur Urol. 2023 10; 84(4):e96-e97.
journal title abbreviation: Eur Urol
publication date: 2023-06-28T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
PubMed Identifier: 37433103
author list: Litton JK, Regan MM, Pusztai L, Rugo HS, Tolaney SM, Garrett-Mayer E, Amiri-Kordestani L, Basho RK, Best AF, Boileau JF, Denkert C, Foster JC, Harbeck N, Jacene HA, King TA, Mason G, O'Sullivan CC, Prowell TM, Richardson AL, Sepulveda KA, Smith ML, Tjoe JA, Turashvili G, Woodward WA, Butler LP, Schwartz EI, Korde LA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. J Clin Oncol. 2023 09 20; 41(27):4433-4442.
journal title abbreviation: J Clin Oncol
publication date: 2023-07-11T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/215505796
PubMed Identifier: 37440239
author list: Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M
published in: JAMA oncology
information resource reference: Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial. JAMA Oncol. 2023 09 01; 9(9):1267-1272.
journal title abbreviation: JAMA Oncol
publication date: 2023-09-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.

Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.
PubMed Identifier: 37268625
author list: Garrido-Castro AC, Regan MM, Niman SM, Nakhlis F, Remolano C, Rosenbluth JM, Block C, Warren LE, Bellon JR, Yeh E, Harrison BT, Troll E, Lin NU, Tolaney SM, Overmoyer B, Lynce F
published in: NPJ breast cancer
information resource reference: Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer. NPJ Breast Cancer. 2023 Jun 02; 9(1):50.
journal title abbreviation: NPJ Breast Cancer
publication date: 2023-06-02T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1589402
type: Authorship
author rank in publication: 13
linked author: Regan, Meredith
linked information resource: Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00.

Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00.
PubMed Identifier: 37733800
author list: Joaquin Garcia A, Rediti M, Venet D, Majjaj S, Kammler R, Munzone E, Gianni L, Thürlimann B, Laáng I, Colleoni M, Loi S, Viale G, Regan MM, Buisseret L, Rothé F, Sotiriou C
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00. Clin Cancer Res. 2023 12 01; 29(23):4908-4919.
journal title abbreviation: Clin Cancer Res
publication date: 2023-12-01T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1616669
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.

Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.
PubMed Identifier: 38155272
author list: Nakhlis F, Niman SM, Ueno NT, Troll E, Ryan S, Yeh E, Warren L, Bellon J, Harrison B, Iwase T, Carisa Le-Petross HT, Saleem S, Teshome M, Whitman GJ, Woodward WA, Overmoyer B, Tolaney SM, Regan M, Lynce F, Layman RM
published in: Breast cancer research and treatment
information resource reference: Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer. Breast Cancer Res Treat. 2024 Apr; 204(2):289-297.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2023-12-28T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 525752
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

Authorship 538464
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Intestinal parasites increase the dietary lysine requirement in chronically undernourished Indian men.

Authorship 1621983
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer.

Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer.
PubMed Identifier: 38242892
author list: McCann KE, Goldfarb SB, Traina TA, Regan MM, Vidula N, Kaklamani V
published in: NPJ breast cancer
information resource reference: Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ Breast Cancer. 2024 Jan 19; 10(1):8.
journal title abbreviation: NPJ Breast Cancer
publication date: 2024-01-19T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
PubMed Identifier: 38297352
author list: Lynce F, Stevens LE, Li Z, Brock JE, Gulvady A, Huang Y, Nakhlis F, Patel A, Force JM, Haddad TC, Ueno N, Stearns V, Wolff AC, Clark AS, Bellon JR, Richardson ET, Balko JM, Krop IE, Winer EP, Lange P, Hwang ES, King TA, Tolaney SM, Thompson A, Gupta GP, Mittendorf EA, Regan MM, Overmoyer B, Polyak K
published in: Breast cancer research : BCR
information resource reference: TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer. Breast Cancer Res. 2024 01 31; 26(1):20.
journal title abbreviation: Breast Cancer Res
publication date: 2024-01-31T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1626396
type: Authorship
author rank in publication: 27
linked author: Regan, Meredith
linked information resource: TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.

Authorship 1629842
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma.

A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma.
PubMed Identifier: 38416426
author list: Chang E, Zhou J, Song C, Gittleman H, Fernandes L, Weinstock C, Atkins MB, Agrawal S, Sridhara R, Gormley N, Tang S, Suzman DL, Amiri-Kordestani L, Kluetz PG, Pazdur R, Rini BI, McDermott DF, Regan MM
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clin Cancer Res. 2024 Aug 01; 30(15):3282-3286.
journal title abbreviation: Clin Cancer Res
publication date: 2024-08-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 552120
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Daily requirement for and splanchnic uptake of leucine in healthy adult Indians.

Authorship 1635995
type: Authorship
author rank in publication: 28
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/235577747

Authorship 1637318
type: Authorship
author rank in publication: 17
linked author: Regan, Meredith
linked information resource: Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.

https://connects.catalyst.harvard.edu/Profiles/profile/235577747
PubMed Identifier: 38513188
author list: Mayer EL, Ren Y, Wagle N, Mahtani R, Ma C, DeMichele A, Cristofanilli M, Meisel J, Miller KD, Abdou Y, Riley EC, Qamar R, Sharma P, Reid S, Sinclair N, Faggen M, Block CC, Ko N, Partridge AH, Chen WY, DeMeo M, Attaya V, Okpoebo A, Alberti J, Liu Y, Gauthier E, Burstein HJ, Regan MM, Tolaney SM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. J Clin Oncol. 2024 Jun 10; 42(17):2050-2060.
journal title abbreviation: J Clin Oncol
publication date: 2024-03-21T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource
label: PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer.

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.
PubMed Identifier: 38471051
author list: Kwak L, Ravi P, Armstrong JG, Beckendorf V, Chin JL, D'Amico AV, Dearnaley DP, Di Stasi SM, Gillessen S, Lukka H, Mottet N, Pommier P, Seiferheld W, Sydes MR, Tombal B, Zapatero A, Regan MM, Xie W, Sweeney CJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials. J Clin Oncol. 2024 Jun 20; 42(18):2132-2138.
journal title abbreviation: J Clin Oncol
publication date: 2024-03-12T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 571821
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article.

Authorship 573394
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma.

Authorship 1640737
type: Authorship
author rank in publication: 16
linked author: Regan, Meredith
linked information resource: Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
PubMed Identifier: 38604810
author list: Atkins MB, Jegede OA, Haas NB, Mcdermott DF, Bilen MA, Stein M, Sosman J, Alter R, Plimack ER, Ornstein MC, Hurwitz M, Peace DJ, Einstein D, Catalano PJ, Hammers H, Regan MM
published in: Journal for immunotherapy of cancer
information resource reference: Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). J Immunother Cancer. 2024 04 11; 12(4).
journal title abbreviation: J Immunother Cancer
publication date: 2024-04-11T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1648694
type: Authorship
author rank in publication: 25
linked author: Regan, Meredith
linked information resource: Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials.

Authorship 1649802
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial.

Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial.
PubMed Identifier: 38754067
author list: Einstein DJ, Regan MM, Stevens JS, McDermott DF, Madan RA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial. J Clin Oncol. 2024 Aug 20; 42(24):2849-2852.
journal title abbreviation: J Clin Oncol
publication date: 2024-05-16T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials.
PubMed Identifier: 38685923
author list: Blondeaux E, Xie W, Carmisciano L, Mura S, Sanna V, De Laurentiis M, Caputo R, Turletti A, Durando A, De Placido S, De Angelis C, Bisagni G, Gasparini E, Rimanti A, Puglisi F, Mansutti M, Landucci E, Fabi A, Arecco L, Perachino M, Bruzzone M, Boni L, Lambertini M, Del Mastro L, Regan MM
published in: EClinicalMedicine
information resource reference: Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials. EClinicalMedicine. 2024 Apr; 70:102501.
journal title abbreviation: EClinicalMedicine
publication date: 2024-03-20T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 335711
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Postoperative atrial tachyarrhythmias in patients undergoing coronary artery bypass graft surgery without cardiopulmonary bypass: a role for intraoperative magnesium supplementation.

Authorship 236564
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.

Authorship 1670232
type: Authorship
author rank in publication: 17
linked author: Regan, Meredith
linked information resource: Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.
PubMed Identifier: 39060019
author list: Mantia CM, Jegede OA, Plimack ER, Powles T, Motzer RJ, Tannir NM, Lee CH, Tomita Y, Voss MH, Choueiri TK, Rini BI, Hammers HJ, Escudier B, Albigès L, Rosenblatt L, Atkins MB, Regan MM, McDermott DF
published in: Journal for immunotherapy of cancer
information resource reference: Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214. J Immunother Cancer. 2024 Jul 25; 12(7).
journal title abbreviation: J Immunother Cancer
publication date: 2024-07-25T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Assistant Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Assistant Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Adult Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Jerome and Nancy Kohlberg Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Jerome and Nancy Kohlberg Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Authorship 46466
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/890961

Authorship 1685771
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Reply to B. Tombal et al.

Authorship 1683766
type: Authorship
author rank in publication: 31
linked author: Regan, Meredith
linked information resource: Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer.

Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer.
PubMed Identifier: 39145953
author list: O'Regan RM, Zhang Y, Fleming GF, Francis PA, Kammler R, Viale G, Dell'Orto P, Lang I, Bellet M, Bonnefoi HR, Tondini C, Villa F, Bernardo A, Ciruelos EM, Neven P, Karlsson P, Müller B, Jochum W, Zaman K, Martino S, Geyer CE, Jerzak KJ, Davidson NE, Coleman RE, Ingle JN, van Mackelenbergh MT, Loi S, Colleoni M, Schnabel CA, Treuner K, Regan MM
published in: JAMA oncology
information resource reference: Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer. JAMA Oncol. 2024 Oct 01; 10(10):1379-1389.
journal title abbreviation: JAMA Oncol
publication date: 2024-10-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Reply to B. Tombal et al.
PubMed Identifier: 39241217
author list: Einstein DJ, Regan MM, Stevens JS, McDermott DF, Madan RA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Reply to B. Tombal et al. J Clin Oncol. 2024 Nov 20; 42(33):3997-3998.
journal title abbreviation: J Clin Oncol
publication date: 2024-09-06T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 339866
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.

Authorship 635925
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial.

Authorship 648798
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancer.

Authorship 655525
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.

Authorship 646238
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response.

Authorship 651425
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: The effect of a controlled 8-week metabolic ward based lysine supplementation on muscle function, insulin sensitivity and leucine kinetics in young men.

Authorship 662462
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Challenges of guarantee-time bias.

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
PubMed Identifier: 21600800
author list: Salami SS, Schmidt F, Laxman B, Regan MM, Rickman DS, Scherr D, Bueti G, Siddiqui J, Tomlins SA, Wei JT, Chinnaiyan AM, Rubin MA, Sanda MG
published in: Urologic oncology
information resource reference: Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Urol Oncol. 2013 Jul; 31(5):566-71.
journal title abbreviation: Urol Oncol
publication date: 2011-05-19T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancer.
PubMed Identifier: 23775974
author list: Rae JM, Regan M, Leyland-Jones B, Hayes DF, Dowsett M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancer. J Clin Oncol. 2013 Jul 20; 31(21):2753-5.
journal title abbreviation: J Clin Oncol
publication date: 2013-06-17T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Challenges of guarantee-time bias.
PubMed Identifier: 23835712
author list: Giobbie-Hurder A, Gelber RD, Regan MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Challenges of guarantee-time bias. J Clin Oncol. 2013 Aug 10; 31(23):2963-9.
journal title abbreviation: J Clin Oncol
publication date: 2013-07-08T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

The effect of a controlled 8-week metabolic ward based lysine supplementation on muscle function, insulin sensitivity and leucine kinetics in young men.
PubMed Identifier: 22524975
author list: Unni US, Raj T, Sambashivaiah S, Kuriyan R, Uthappa S, Vaz M, Regan MM, Kurpad AV
published in: Clinical nutrition (Edinburgh, Scotland)
information resource reference: The effect of a controlled 8-week metabolic ward based lysine supplementation on muscle function, insulin sensitivity and leucine kinetics in young men. Clin Nutr. 2012 Dec; 31(6):903-10.
journal title abbreviation: Clin Nutr
publication date: 2012-04-22T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial.
PubMed Identifier: 11721144
author list: Allsup SJ, Gosney M, Regan M, Haycox A, Fear S, Johnstone FC
published in: Gerontology
information resource reference: Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial. Gerontology. 2001 Nov-Dec; 47(6):311-4.
journal title abbreviation: Gerontology
publication date: 2001-11-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1697946
type: Authorship
author rank in publication: 22
linked author: Regan, Meredith
linked information resource: Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.

Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.
PubMed Identifier: 39446326
author list: Patel SA, Patil D, Smith J, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Michalski JM, Wood DP, Hembroff LA, Spratt DE, Wei JT, Sandler HM, Hamstra DA, Pisters L, Kuban D, Regan MM, Wagner A, Crociani CM, Kaplan I, Sanda MG, Chang P
published in: JAMA network open
information resource reference: Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life. JAMA Netw Open. 2024 10 01; 7(10):e2440747.
journal title abbreviation: JAMA Netw Open
publication date: 2024-10-01T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis.
PubMed Identifier: 39743422
author list: Gupta M, Wells C, Regan MM, Xie W, Navani V, Saliby RM, Basappa NS, Donskov F, Yuasa T, Takemura K, Kollmannsberger CK, Crumbaker M, Lalani AA, Powles T, Ebrahimi H, McKay RR, Lee JL, Kanesvaran R, Choueiri TK, Heng DYC
published in: European urology oncology
information resource reference: Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis. Eur Urol Oncol. 2025 Feb; 8(1):171-178.
journal title abbreviation: Eur Urol Oncol
publication date: 2024-12-31T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1716982
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis.

Authorship 1724925
type: Authorship
author rank in publication: 14
linked author: Regan, Meredith
linked information resource: Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.
PubMed Identifier: 39854658
author list: Luen SJ, Brown LC, van Geelen CT, Savas P, Kammler R, Dell'Orto P, Biasi O, Coates AS, Gelber RD, Thürlimann B, Colleoni M, Fleming GF, Francis PA, Regan MM, Viale G, Loi S
published in: JCO precision oncology
information resource reference: Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials. JCO Precis Oncol. 2025 Jan; 9:e2400599.
journal title abbreviation: JCO Precis Oncol
publication date: 2025-01-24T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 601236
type: Authorship
linked author: Regan, Meredith
linked information resource: Carbonic anhydrase IX (CA IX) and pathologic features as predictors of outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving VEGF-targeted therapy

Authorship 242207
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction.

Authorship 674436
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Dramatic and prolonged PSA response after retreatment with a PSA vaccine.

Dramatic and prolonged PSA response after retreatment with a PSA vaccine.
PubMed Identifier: 23791437
author list: Rojan A, Funches R, Regan MM, Gulley JL, Bubley GJ
published in: Clinical genitourinary cancer
information resource reference: Dramatic and prolonged PSA response after retreatment with a PSA vaccine. Clin Genitourin Cancer. 2013 Sep; 11(3):362-4.
journal title abbreviation: Clin Genitourin Cancer
publication date: 2013-06-20T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 247125
type: Authorship
author rank in publication: 22
linked author: Regan, Meredith
linked information resource: The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.

Authorship 247636
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Threonine requirement of healthy adults, derived with a 24-h indicator amino acid balance technique.

Professor of Medicine, Emeritus
is primary position: true
position in department: Emeritus
position in division: https://connects.catalyst.harvard.edu/Profiles/profile/1229413
sort order: 1
type: Position
HR job title: Professor of Medicine, Emeritus
position in organization: Harvard Medical School

Authorship 679064
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.

Authorship 679632
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.

Authorship 678750
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Evidence for genetic anticipation in nodal osteoarthritis.

Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.
PubMed Identifier: 23958736
author list: Rae JM, Regan MM, Thibert JN, Gersch C, Thomas D, Leyland-Jones B, Viale G, Pusztai L, Hayes DF, Skaar T, Van Poznak C
published in: Journal of the National Cancer Institute
information resource reference: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA. J Natl Cancer Inst. 2013 Sep 04; 105(17):1332-4.
journal title abbreviation: J Natl Cancer Inst
publication date: 2013-08-19T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
PubMed Identifier: 24106899
author list: Moretti E, Desmedt C, Biagioni C, Regan MM, Oakman C, Larsimont D, Galardi F, Piccart-Gebhart M, Sotiriou C, Rimm DL, Di Leo A
published in: Future oncology (London, England)
information resource reference: TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer. Future Oncol. 2013 Oct; 9(10):1477-87.
journal title abbreviation: Future Oncol
publication date: 2013-10-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Evidence for genetic anticipation in nodal osteoarthritis.
PubMed Identifier: 9849310
author list: Wright GD, Regan M, Deighton CM, Wallis G, Doherty M
published in: Annals of the rheumatic diseases
information resource reference: Evidence for genetic anticipation in nodal osteoarthritis. Ann Rheum Dis. 1998 Sep; 57(9):524-6.
journal title abbreviation: Ann Rheum Dis
publication date: 1998-09-01T00:00:00
year: 1998
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 681377
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study.

A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study.
PubMed Identifier: 24145360
author list: Dandamudi UB, Ghebremichael M, Sosman JA, Clark JI, McDermott DF, Atkins MB, Dutcher JP, Urba WJ, Regan MM, Puzanov I, Crocenzi TS, Curti BD, Vaishampayan UN, Crosby NA, Margolin KA, Ernstoff MS
published in: Journal of immunotherapy (Hagerstown, Md. : 1997)
information resource reference: A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study. J Immunother. 2013 Nov-Dec; 36(9):490-5.
journal title abbreviation: J Immunother
publication date: 2013-11-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 299919
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy.

Authorship 683156
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Treatment of rheumatoid hand synovitis with a regional block technique.

Authorship 683280
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.

Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
PubMed Identifier: 8642806
author list: Harron DW, Hasson B, Regan M, McClelland RJ, King DJ
published in: Journal of cardiovascular pharmacology
information resource reference: Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function. J Cardiovasc Pharmacol. 1995; 26 Suppl 2:S48-54.
journal title abbreviation: J Cardiovasc Pharmacol
publication date: 1995-01-01T00:00:00
year: 1995
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment of rheumatoid hand synovitis with a regional block technique.
PubMed Identifier: 8514483
author list: McCarthy CJ, Regan M, Coughlan RJ
published in: Irish journal of medical science
information resource reference: Treatment of rheumatoid hand synovitis with a regional block technique. Ir J Med Sci. 1993 Apr; 162(4):143-4.
journal title abbreviation: Ir J Med Sci
publication date: 1993-04-01T00:00:00
year: 1993
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 693075
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.
PubMed Identifier: 24095609
author list: Regan MM, Pagani O, Fleming GF, Walley BA, Price KN, Rabaglio M, Maibach R, Ruepp B, Coates AS, Goldhirsch A, Colleoni M, Gelber RD, Francis PA
published in: Breast (Edinburgh, Scotland)
information resource reference: Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials. Breast. 2013 Dec; 22(6):1094-100.
journal title abbreviation: Breast
publication date: 2013-10-02T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 209089
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/1167568

Authorship 211878
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.

Authorship 365279
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Cancer-related communication between female patients and male partners scale: A pilot study.

Authorship 173348
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Phase II study of sunitinib in men with advanced prostate cancer.

Authorship 1738404
type: Authorship
author rank in publication: 20
linked author: Regan, Meredith
linked information resource: Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score.

Authorship 1741856
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61-20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial.

Authorship 1742847
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial.

Authorship 1750493
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score.
PubMed Identifier: 40163681
author list: Lynce F, Niman SM, Kai M, Ryan S, Troll E, Li L, Miller KD, Jagsi R, Mason G, Overmoyer BA, Le-Petross HTC, Nakhlis F, Krishnamurthy S, Harrison BT, Sun SX, Yeh ED, Bellon JR, Warren LE, Stauder MC, Regan MM, Woodward WA
published in: Journal of the National Cancer Institute
information resource reference: Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score. J Natl Cancer Inst. 2025 Aug 01; 117(8):1583-1592.
journal title abbreviation: J Natl Cancer Inst
publication date: 2025-08-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61-20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial.
PubMed Identifier: 40049198
author list: Zdenkowski N, Kuper-Hommel MJJ, Niman SM, Francis PA, Baron-Hay S, Fox W, Menzies AM, Angus R, Punie K, Zardawi S, Regan MM, Loi S
published in: The Lancet. Oncology
information resource reference: Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61-20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial. Lancet Oncol. 2025 Mar; 26(3):367-377.
journal title abbreviation: Lancet Oncol
publication date: 2025-03-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial.
PubMed Identifier: 40286474
author list: Biganzoli G, Isnaldi E, Richard F, Marano G, Boracchi P, Maetens M, Floris G, Neven P, Jerusalem G, Munzone E, Hitre E, Gombos A, Thompson A, Aebi S, Kammler R, Dell'Orto P, Viale G, Regan MM, Colleoni M, Biganzoli E, Desmedt C
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial. Eur J Cancer. 2025 Jun 03; 222:115438.
journal title abbreviation: Eur J Cancer
publication date: 2025-04-17T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.
PubMed Identifier: 40100138
author list: Janni W, Friedl TWP, Yab TC, Bidard FC, Cristofanilli M, Hayes DF, Ignatiadis M, Regan MM, Alix-Panabieres C, Barlow WE, Caldas C, Carey LA, Dirix L, Fehm T, Garcia-Saenz JA, Gazzaniga P, Generali D, Gerratana L, Gisbert-Criado R, Jacot W, Jiang Z, Joosse SA, Lianidou E, López López R, Magbanua MJM, Manso L, Mavroudis D, Müller V, Munzone E, Pantel K, Pierga JY, Rack B, Riethdorf S, Rugo HS, Sideras K, Sleijfer S, Smerage J, Stebbing J, Terstappen LWMM, Vidal-Martínez J, Wallwiener M, Giridhar KV, Liu MC
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis. Clin Cancer Res. 2025 Jun 03; 31(11):2196-2209.
journal title abbreviation: Clin Cancer Res
publication date: 2025-06-03T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 246513
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Factors associated with enrollment in cancer genetics research.

Authorship 232347
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice.

Authorship 283870
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.

Authorship 392765
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer.

Authorship 264111
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.

Authorship 71540
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Secondary hormonal therapy in men with castration-resistant prostate cancer.

Authorship 71880
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease.

Authorship 437675
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Threonine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique.

Authorship 454095
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum").

Authorship 292008
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Survey of breast-feeding practices and outcomes in the cystic fibrosis population.

Authorship 258256
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.

Authorship 719388
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.

Authorship 715188
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.

Authorship 710980
type: Authorship
author rank in publication: 12
linked author: Regan, Meredith
linked information resource: Lupus nephritis: a 15-year multi-centre experience in the UK.

Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.
PubMed Identifier: 24076307
author list: Chipman JJ, Sanda MG, Dunn RL, Wei JT, Litwin MS, Crociani CM, Regan MM, Chang P
published in: The Journal of urology
information resource reference: Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol. 2014 Mar; 191(3):638-45.
journal title abbreviation: J Urol
publication date: 2013-09-25T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Lupus nephritis: a 15-year multi-centre experience in the UK.
PubMed Identifier: 23386411
author list: Hui M, Garner R, Rees F, Bavakunji R, Daniel P, Varughese S, Srikanth A, Andres M, Pearce F, Leung J, Lim K, Regan M, Lanyon P
published in: Lupus
information resource reference: Lupus nephritis: a 15-year multi-centre experience in the UK. Lupus. 2013 Mar; 22(3):328-32.
journal title abbreviation: Lupus
publication date: 2013-02-05T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.
PubMed Identifier: 24382757
author list: Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Mendenhall WM, Williams CR, Regan MM, Chipman JJ, Crociani CM, Sandler HM, Sanda MG, Hamstra DA
published in: Cancer
information resource reference: Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 2014 Apr 01; 120(7):1076-82.
journal title abbreviation: Cancer
publication date: 2013-12-30T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Professor of Medicine
is primary position: true
position in department: Medicine
position in division: Oncology
sort order: 1
type: Position
HR job title: Professor of Medicine
position in organization: Dana-Farber Cancer Institute

Victor J. Aresty Professor of Medicine
is primary position: true
position in department: Medicine
position in division: DF Melanoma
sort order: 1
type: Position
HR job title: Victor J. Aresty Professor of Medicine
position in organization: Beth Israel Deaconess Medical Center

DF Melanoma
type: Division
type: Organization

Authorship 729229
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Response.

Response.
PubMed Identifier: 24700799
author list: Rae JM, Leyland-Jones B, Regan M
published in: Journal of the National Cancer Institute
information resource reference: Response. J Natl Cancer Inst. 2014 Apr 03; 106(5).
journal title abbreviation: J Natl Cancer Inst
publication date: 2014-04-03T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 277291
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer.

Authorship 1792954
type: Authorship
author rank in publication: 28
linked author: Regan, Meredith
linked information resource: Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.

Authorship 1795320
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/323045042

Authorship 1809989
type: Authorship
author rank in publication: 21
linked author: Regan, Meredith
linked information resource: Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.

Authorship 1817791
type: Authorship
author rank in publication: 13
linked author: Regan, Meredith
linked information resource: Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database.

Authorship 1824763
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials.

Authorship 1827243
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors.

Authorship 1830903
type: Authorship
author rank in publication: 16
linked author: Regan, Meredith
linked information resource: Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study.

Authorship 1835659
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer.

Authorship 1835358
type: Authorship
author rank in publication: 20
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/323045760

Authorship 1835918
type: Authorship
author rank in publication: 14
linked author: Regan, Meredith
linked information resource: Identifying premenopausal patients with early-stage hormone receptor-positive breast cancer at minimal risk of distant recurrence by breast cancer index.

Authorship 1844204
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1.

Authorship 1847803
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.

Authorship 1849400
type: Authorship
author rank in publication: 32
linked author: Regan, Meredith
linked information resource: Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.

Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer.
PubMed Identifier: 41547594
author list: Valenza C, Partridge AH, Regan MM
published in: Breast (Edinburgh, Scotland)
information resource reference: Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer. Breast. 2026 Feb; 85:104696.
journal title abbreviation: Breast
publication date: 2026-01-12T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Identifying premenopausal patients with early-stage hormone receptor-positive breast cancer at minimal risk of distant recurrence by breast cancer index.
PubMed Identifier: 41637791
author list: O'Regan RM, Ren Y, Zhang Y, Fleming GF, Francis PA, Pagani O, Walley BA, Kammler R, Dell'Orto P, Viale G, Loi S, Colleoni M, Treuner K, Regan MM
published in: Breast (Edinburgh, Scotland)
information resource reference: Identifying premenopausal patients with early-stage hormone receptor-positive breast cancer at minimal risk of distant recurrence by breast cancer index. Breast. 2026 Apr; 86:104714.
journal title abbreviation: Breast
publication date: 2026-01-29T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors.
PubMed Identifier: 40658913
author list: Mantia CM, Jegede OA, McDermott DF, Heng DYC, Xie W, Choueiri TK, Atkins MB, Regan MM
published in: JCO oncology practice
information resource reference: Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors. JCO Oncol Pract. 2025 Jul 14; OP2500089.
journal title abbreviation: JCO Oncol Pract
publication date: 2025-07-14T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials.
PubMed Identifier: 40668757
author list: Chang E, Gittleman H, Song C, Bloomquist E, Fernandes L, Weinstock C, Agrawal S, Gormley N, Tang S, Suzman DL, Amiri-Kordestani L, Pazdur R, Kluetz PG, McDermott DF, Regan MM, Rini BI
published in: JNCI cancer spectrum
information resource reference: The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials. JNCI Cancer Spectr. 2025 Jul 01; 9(4).
journal title abbreviation: JNCI Cancer Spectr
publication date: 2025-07-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.
PubMed Identifier: 40853871
author list: Gerratana L, Reduzzi C, Ren Y, Jeselsohn R, Mahtani RL, Ma CX, DeMichele A, Meisel JL, Miller K, Abdou Y, Riley EC, Qamar R, Sharma P, Reid SA, Ko N, Liu Y, Gauthier E, Burstein HJ, DeMeo M, Tolaney SM, Regan MM, Cristofanilli M, Mayer EL
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study. Clin Cancer Res. 2025 Nov 03; 31(21):4510-4517.
journal title abbreviation: Clin Cancer Res
publication date: 2025-11-03T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1.
PubMed Identifier: 40473108
author list: Peters S, Regan MM, Paz-Ares LG, Reck M, Borghaei H, O'Byrne KJ, Brahmer JR, Penrod JR, Li J, Tracy L, Yuan Y, Bushong J, Lee A, Eccles LJ, Ray S, Ramalingam SS
published in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
information resource reference: Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1. J Thorac Oncol. 2025 Oct; 20(10):1505-1516.
journal title abbreviation: J Thorac Oncol
publication date: 2025-06-03T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.
PubMed Identifier: 40986647
author list: Ribi K, Cole BF, Fleming GF, Walley BA, Francis PA, Abdi E, Burstein HJ, Cheng KL, Chia SKL, Dakhil SR, Davidson NE, Della-Fiorentina SA, Frith AE, Levine E, Lupichuk S, Pritchard K, Salim M, Stearns V, Stewart J, Valero V, van der Westhuizen A, Pagani O, Loi S, Colleoni M, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J
published in: Cancer
information resource reference: Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT. Cancer. 2025 Oct 01; 131(19):e70094.
journal title abbreviation: Cancer
publication date: 2025-10-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.
PubMed Identifier: 40940136
author list: Regan MM, Ascierto PA, Lipson EJ, Palaia J, Moshyk A, Selvan A, Lao CD, Atkins MB, McDermott DF, Potluri R, Ranjan S, Bilthare S, Long GV, Stephen Hodi F, Tawbi H, Schadendorf D
published in: Journal for immunotherapy of cancer
information resource reference: Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047. J Immunother Cancer. 2025 Sep 12; 13(9).
journal title abbreviation: J Immunother Cancer
publication date: 2025-09-12T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study.
PubMed Identifier: 41024110
author list: Fanucci K, Yeh ED, Shi R, Qin L, Bay CP, DiLullo M, Patel A, Moore M, Herbert ZT, Harrison BT, Nakhlis F, Bellon J, Warren L, Guerriero JL, Tolaney SM, Regan M, Overmoyer B, Van Laere S, Lynce F
published in: Breast cancer research : BCR
information resource reference: Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study. Breast Cancer Res. 2025 Sep 29; 27(1):171.
journal title abbreviation: Breast Cancer Res
publication date: 2025-09-29T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database.
PubMed Identifier: 41441993
author list: De Placido P, Troll E, Niman SM, Ryan S, Mason G, Powell M, Hazra A, Wagle N, McGillicuddy M, Lin NU, Tolaney SM, Nakhlis F, Regan MM, Lynce F
published in: Breast cancer research and treatment
information resource reference: Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database. Breast Cancer Res Treat. 2025 Dec 24; 215(2):45.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2025-12-24T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
PubMed Identifier: 41182766
author list: O'Regan RM, Ren Y, Zhang Y, Siuliukina N, Schnabel CA, Kammler R, Viale G, Dell'Orto P, Munzone E, Láng I, Tondini C, Gomez HL, Chini C, Nicoletti SVL, Puglisi F, Zaman K, Goetz MP, Stearns V, Martino S, Salim M, Loibl S, Geyer CE, Bonnefoi HR, Ciruelos EM, Loi S, Colleoni M, Fleming GF, Francis PA, Walley BA, Pagani O, Treuner K, Regan MM
published in: JAMA network open
information resource reference: Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index. JAMA Netw Open. 2025 Nov 03; 8(11):e2540931.
journal title abbreviation: JAMA Netw Open
publication date: 2025-11-03T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/323045042
PubMed Identifier: 41617395
author list: Viray H, M Mantia C, Jegede OA, Atkins MB, Rosenblatt L, Choueiri TK, McDermott DF, Regan MM
published in: Journal for immunotherapy of cancer
information resource reference: Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma. J Immunother Cancer. 2026 Jan 30; 14(1).
journal title abbreviation: J Immunother Cancer
publication date: 2026-01-30T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma.

https://connects.catalyst.harvard.edu/Profiles/profile/323045760
PubMed Identifier: 41538747
author list: Valenza C, Zheng Y, Milano M, Trapani D, Giordano E, Guidi L, Berton Giachetti PPM, Boldrini L, Castellano G, Katrini J, Malagutti B, Antonarelli G, Conforti F, Pagan E, Bagnardi V, Kirkner GJ, Sangalli C, Dibble KE, Colleoni M, Regan MM, Munzone E, Curigliano G, Partridge AH
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study. J Clin Oncol. 2026 Feb 20; 44(6):486-496.
journal title abbreviation: J Clin Oncol
publication date: 2026-01-15T00:00:00
year: 2026
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Authorship 740888
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.
PubMed Identifier: 23127292
author list: Coates AS, Millar EK, O'Toole SA, Molloy TJ, Viale G, Goldhirsch A, Regan MM, Gelber RD, Sun Z, Castiglione-Gertsch M, Gusterson B, Musgrove EA, Sutherland RL
published in: Breast cancer research : BCR
information resource reference: Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX. Breast Cancer Res. 2012 Nov 05; 14(6):R143.
journal title abbreviation: Breast Cancer Res
publication date: 2012-11-05T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Mantia, Charlene
eCommons Login: CM261
first name: Charlene
last name: Mantia
full name: Charlene Mantia, M.D.
has faculty rank: Instructor
photo: https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 129522
person in primary position: Instructor in Medicine
type: Agent
type: Person
preferred title: Instructor in Medicine

Authorship 744654
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
PubMed Identifier: 24881463
author list: Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA
published in: The New England journal of medicine
information resource reference: Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014 Jul 10; 371(2):107-18.
journal title abbreviation: N Engl J Med
publication date: 2014-06-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 393722
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Branched-chain amino acid requirements in healthy adult human subjects.

Authorship 425740
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Professor of Pediatrics (Biostatistics)
is primary position: true
position in department: Pediatrics
position in division: DFCI
sort order: 1
type: Position
HR job title: Professor of Pediatrics (Biostatistics)
position in organization: Dana-Farber Cancer Institute

Authorship 347441
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.

Authorship 474003
type: Authorship
author rank in publication: 12
linked author: Regan, Meredith
linked information resource: Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authorship 538506
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.

Authorship 760753
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Exemestane with ovarian suppression in premenopausal breast cancer.

Exemestane with ovarian suppression in premenopausal breast cancer.
PubMed Identifier: 25271610
author list: Pagani O, Regan MM, Francis PA
published in: The New England journal of medicine
information resource reference: Exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014 10 02; 371(14):1358-9.
journal title abbreviation: N Engl J Med
publication date: 2014-10-02T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 435327
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.

Authorship 440141
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Treatment selection for patients with metastatic renal cell carcinoma.

Authorship 453389
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Inhaled albuterol, but not intravenous lidocaine, protects against intubation-induced bronchoconstriction in asthma.

Authorship 468739
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/868195

Authorship 473914
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/812618

Authorship 484269
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA.

Authorship 508987
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.

Authorship 531960
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance.

Authorship 581534
type: Authorship
linked author: Regan, Meredith
linked information resource: Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC)

Authorship 621664
type: Authorship
linked author: Regan, Meredith
linked information resource: A randomized controlled trial of 503 couples assigned to conventional infertility treatment or an accelerated track to IVF: preliminary results of the fast track and standard treatment (FASTT) trial

Authorship 27035
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/938505

Authorship 28914
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Oxoproline kinetics and oxoproline urinary excretion during glycine- or sulfur amino acid-free diets in humans.

Authorship 627471
type: Authorship
linked author: Regan, Meredith
linked information resource: Combined continuous and discrete outcomes

Authorship 603575
type: Authorship
linked author: Regan, Meredith
linked information resource: First Line treatment with bevacizumab (B) and high dose (HD) bolus aldesleukin (IL-2) in metastatic renal cell carcinoma (mRCC) patients (Pts)

Authorship 454476
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: Association of cystic fibrosis with abnormalities in fatty acid metabolism.

Authorship 420279
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Inotropes improve right heart function in patients undergoing aortic valve replacement for aortic stenosis.

Authorship 4345
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

Authorship 443494
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Kinetics of L-[1-(13)C]leucine when ingested with free amino acids, unlabeled or intrinsically labeled casein.

Authorship 455833
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer.

Authorship 505386
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.

Authorship 464339
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection.

Authorship 267408
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Likelihood models for clustered binary and continuous outcomes: application to developmental toxicology.

Authorship 535765
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer.

Authorship 551736
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Daily requirement for total sulfur amino acids of chronically undernourished Indian men.

Authorship 599397
type: Authorship
linked author: Regan, Meredith
linked information resource: Statistical considerations and challenges

Authorship 64220
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.

Authorship 31371
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.

Authorship 463746
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Melatonin treatment for age-related insomnia.

Authorship 483318
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.

Authorship 510268
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer.

Authorship 535129
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.

Authorship 240251
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/ß-catenin activation in breast cancer.

Authorship 75319
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Interleukin-2 therapy of metastatic renal cell carcinoma: update of phase III trials.

Authorship 612294
type: Authorship
linked author: Regan, Meredith
linked information resource: Models for clustered discrete and continuous outcomes in developmental toxicology [dissertation]

Authorship 312467
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Leucine requirement and splanchnic uptake of leucine in chronically undernourished adult Indian subjects.

Authorship 436190
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Using clinical trial data to tailor adjuvant treatments for individual patients.

Authorship 195308
type: Authorship
author rank in publication: 11
linked author: Regan, Meredith
linked information resource: Inverse relationship between protein intake and plasma free amino acids in healthy men at physical exercise.

Authorship 352136
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/879477

Authorship 503040
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients.

Authorship 38070
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm.

Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate.
PubMed Identifier: 26024527
author list: Pignon JC, Grisanzio C, Carvo I, Werner L, Regan M, Wilson EL, Signoretti S
published in: PloS one
information resource reference: Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate. PLoS One. 2015; 10(5):e0128489.
journal title abbreviation: PLoS One
publication date: 2015-05-29T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 609190
type: Authorship
linked author: Regan, Meredith
linked information resource: Developmental toxicity study

Authorship 241822
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/913569

Authorship 335948
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial.

Authorship 532804
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.

Authorship 583947
type: Authorship
linked author: Regan, Meredith
linked information resource: Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels

Authorship 32377
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/771085

Authorship 325450
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer.

Authorship 543081
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/888713

Authorship 55838
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Effect of cystine on the methionine requirement of healthy Indian men determined by using the 24-h indicator amino acid balance approach.

Authorship 559730
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.

Authorship 791970
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Inflammatory breast cancer and development of brain metastases: risk factors and outcomes.

Authorship 796965
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Adjuvant ovarian suppression in premenopausal breast cancer.

Authorship 807323
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Adjuvant ovarian suppression in premenopausal breast cancer.

Authorship 805618
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

Authorship 785735
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Occupational hearing loss in New York dairy farmers.

Authorship 799971
type: Authorship
author rank in publication: 26
linked author: Regan, Meredith
linked information resource: The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.

Authorship 797127
type: Authorship
author rank in publication: 24
linked author: Regan, Meredith
linked information resource: CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.

Authorship 792540
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate.

Authorship 790085
type: Authorship
author rank in publication: 17
linked author: Regan, Meredith
linked information resource: Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results.

Occupational hearing loss in New York dairy farmers.
PubMed Identifier: 1785614
author list: Marvel ME, Pratt DS, Marvel LH, Regan M, May JJ
published in: American journal of industrial medicine
information resource reference: Occupational hearing loss in New York dairy farmers. Am J Ind Med. 1991; 20(4):517-31.
journal title abbreviation: Am J Ind Med
publication date: 1991-01-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
PubMed Identifier: 25935582
author list: Leyland-Jones B, Gray KP, Abramovitz M, Bouzyk M, Young B, Long B, Kammler R, Dell'Orto P, Biasi MO, Thürlimann B, Lyng MB, Ditzel HJ, Harvey VJ, Neven P, Treilleux I, Rasmussen BB, Maibach R, Price KN, Coates AS, Goldhirsch A, Pagani O, Viale G, Rae JM, Regan MM
published in: Breast cancer research and treatment
information resource reference: CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Breast Cancer Res Treat. 2015 Jun; 151(2):373-84.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2015-05-03T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant ovarian suppression in premenopausal breast cancer.
PubMed Identifier: 25495490
author list: Francis PA, Regan MM, Fleming GF, Láng I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da Prada GA, Burstein HJ, Martino S, Davidson NE, Geyer CE, Walley BA, Coleman R, Kerbrat P, Buchholz S, Ingle JN, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Colleoni M, Viale G, Coates AS, Goldhirsch A, Gelber RD
published in: The New England journal of medicine
information resource reference: Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2015 Jan 29; 372(5):436-46.
journal title abbreviation: N Engl J Med
publication date: 2014-12-11T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.
PubMed Identifier: 25424850
author list: McDermott DF, Cheng SC, Signoretti S, Margolin KA, Clark JI, Sosman JA, Dutcher JP, Logan TF, Curti BD, Ernstoff MS, Appleman L, Wong MK, Khushalani NI, Oleksowicz L, Vaishampayan UN, Mier JW, Panka DJ, Bhatt RS, Bailey AS, Leibovich BC, Kwon ED, Kabbinavar FF, Belldegrun AS, Figlin RA, Pantuck AJ, Regan MM, Atkins MB
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2015 Feb 01; 21(3):561-8.
journal title abbreviation: Clin Cancer Res
publication date: 2014-11-25T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant ovarian suppression in premenopausal breast cancer.
PubMed Identifier: 25901437
author list: Francis PA, Regan MM, Fleming GF
published in: The New England journal of medicine
information resource reference: Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2015 04 23; 372(17):1673.
journal title abbreviation: N Engl J Med
publication date: 2015-04-23T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results.
PubMed Identifier: 24877201
author list: Juarez M, Toms TE, de Pablo P, Mitchell S, Bowman S, Nightingale P, Price EJ, Griffiths B, Hunter J, Gupta M, Bombardieri M, Sutdliffe N, Pitzalis C, Pease C, Andrews J, Emery P, Regan M, Giles I, Isenberg D, Moots R, Collins KS, Ng WF, Kitas GD
published in: Arthritis care & research
information resource reference: Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results. Arthritis Care Res (Hoboken). 2014 May; 66(5):757-64.
journal title abbreviation: Arthritis Care Res (Hoboken)
publication date: 2014-05-01T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource

Inflammatory breast cancer and development of brain metastases: risk factors and outcomes.
PubMed Identifier: 25893587
author list: Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR
published in: Breast cancer research and treatment
information resource reference: Inflammatory breast cancer and development of brain metastases: risk factors and outcomes. Breast Cancer Res Treat. 2015 May; 151(1):225-32.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2015-04-17T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
PubMed Identifier: 25814445
author list: Rae JM, Leyland-Jones B, Regan M, Thompson AM
published in: Journal of the National Cancer Institute
information resource reference: Re: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies. J Natl Cancer Inst. 2015 May; 107(5).
journal title abbreviation: J Natl Cancer Inst
publication date: 2015-03-26T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 583646
type: Authorship
linked author: Regan, Meredith
linked information resource: Impact of patient and physician factors on oncologists’ recommendations for adjuvant chemotherapy in stage III colon cancer

Authorship 596557
type: Authorship
linked author: Regan, Meredith
linked information resource: Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients

DFCI
type: Division
type: Organization

Authorship 275958
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.

Authorship 333966
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Absence of relationship between steroid hormone levels and prostate cancer tumor grade.

Authorship 272405
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.

Authorship 413561
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique.

Authorship 453844
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma.

Authorship 490718
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.

Authorship 497534
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients.

Authorship 515438
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Authorship 534946
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/1125383

Authorship 46199
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Uncertainty and perception of danger among patients undergoing treatment for prostate cancer.

Authorship 501138
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Authorship 809542
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease.

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease.
PubMed Identifier: 26082801
author list: Goldhirsch A, Colleoni M, Regan M
published in: Ecancermedicalscience
information resource reference: Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease. Ecancermedicalscience. 2015; 9:544.
journal title abbreviation: Ecancermedicalscience
publication date: 2015-06-09T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 813911
type: Authorship
author rank in publication: 13
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/59796034

https://connects.catalyst.harvard.edu/Profiles/profile/59796034
PubMed Identifier: 26092816
author list: Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, Pinotti G, Spazzapan S, Ruhstaller T, Puglisi F, Pavesi L, Parmar V, Regan MM, Pagani O, Fleming GF, Francis PA, Price KN, Coates AS, Gelber RD, Goldhirsch A, Walley BA
published in: The Lancet. Oncology
information resource reference: Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet Oncol. 2015 Jul; 16(7):848-58.
journal title abbreviation: Lancet Oncol
publication date: 2015-06-16T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

Authorship 822562
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.

Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.
PubMed Identifier: 25791789
author list: Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR
published in: Annals of surgical oncology
information resource reference: Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management. Ann Surg Oncol. 2015 Aug; 22(8):2483-91.
journal title abbreviation: Ann Surg Oncol
publication date: 2015-03-20T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 439211
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Evaluation of the 8q24 prostate cancer risk locus and MYC expression.

Authorship 828513
type: Authorship
author rank in publication: 13
linked author: Regan, Meredith
linked information resource: Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
PubMed Identifier: 26215945
author list: Metzger Filho O, Giobbie-Hurder A, Mallon E, Gusterson B, Viale G, Winer EP, Thürlimann B, Gelber RD, Colleoni M, Ejlertsen B, Debled M, Price KN, Regan MM, Coates AS, Goldhirsch A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. J Clin Oncol. 2015 Sep 01; 33(25):2772-9.
journal title abbreviation: J Clin Oncol
publication date: 2015-07-27T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 536080
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Relationship between serum adiponectin and prostate cancer grade.

Authorship 68516
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Authorship 95667
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: The daily phenylalanine requirement of healthy Indian adults.

Authorship 402687
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy.

Authorship 846094
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses.

Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses.
PubMed Identifier: 26276228
author list: Hertz DL, Kidwell KM, Thibert JN, Gersch C, Regan MM, Skaar TC, Henry NL, Hayes DF, Van Poznak CH, Rae JM
published in: Molecular oncology
information resource reference: Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses. Mol Oncol. 2015 Nov; 9(9):1868-76.
journal title abbreviation: Mol Oncol
publication date: 2015-07-29T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 448593
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomates.

Authorship 849110
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Predicting benefit of endocrine therapy for early breast cancer.

Authorship 850019
type: Authorship
author rank in publication: 22
linked author: Regan, Meredith
linked information resource: ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.

Predicting benefit of endocrine therapy for early breast cancer.
PubMed Identifier: 26255197
author list: Regan MM
published in: Breast (Edinburgh, Scotland)
information resource reference: Predicting benefit of endocrine therapy for early breast cancer. Breast. 2015 Nov; 24 Suppl 2:S129-31.
journal title abbreviation: Breast
publication date: 2015-08-05T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
PubMed Identifier: 26590813
author list: Leyland-Jones B, Gray KP, Abramovitz M, Bouzyk M, Young B, Long B, Kammler R, Dell'Orto P, Biasi MO, Thürlimann B, Harvey V, Neven P, Arnould L, Maibach R, Price KN, Coates AS, Goldhirsch A, Gelber RD, Pagani O, Viale G, Rae JM, Regan MM
published in: Breast cancer research and treatment
information resource reference: ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer. Breast Cancer Res Treat. 2015 Dec; 154(3):543-55.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2015-11-21T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 855620
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: A proposed minimal rheumatological screening history and examination. The joint answers back.

A proposed minimal rheumatological screening history and examination. The joint answers back.
PubMed Identifier: 2066919
author list: Jones A, Ledingham J, Regan M, Doherty M
published in: Journal of the Royal College of Physicians of London
information resource reference: A proposed minimal rheumatological screening history and examination. The joint answers back. J R Coll Physicians Lond. 1991 Apr; 25(2):111-5.
journal title abbreviation: J R Coll Physicians Lond
publication date: 1991-04-01T00:00:00
year: 1991
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 531915
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Lysine requirements of healthy adult Indian subjects receiving long-term feeding, measured with a 24-h indicator amino acid oxidation and balance technique.

Authorship 616153
type: Authorship
linked author: Regan, Meredith
linked information resource: Outcome of patients after radical prostatectomy: a comparison of prostate cancer diagnosed using extended needle biopsy technique versus non-extended needle biopsy technique

Authorship 862743
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/63649518

Authorship 862758
type: Authorship
author rank in publication: 16
linked author: Regan, Meredith
linked information resource: The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
PubMed Identifier: 26633571
author list: Ignatiadis M, Azim HA, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell'Orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart M, Michiels S, Sotiriou C
published in: JAMA oncology
information resource reference: The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence. JAMA Oncol. 2016 Feb; 2(2):217-24.
journal title abbreviation: JAMA Oncol
publication date: 2016-02-01T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/63649518
PubMed Identifier: 26493064
author list: Regan MM, Pagani O, Francis PA, Fleming GF, Walley BA, Kammler R, Dell'Orto P, Russo L, Szoke J, Doimi F, Villani L, Pizzolitto S, Öhlschlegel C, Sessa F, Peg Cámara V, Rodríguez Peralto JL, MacGrogan G, Colleoni M, Goldhirsch A, Price KN, Coates AS, Gelber RD, Viale G
published in: Breast cancer research and treatment
information resource reference: Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials. Breast Cancer Res Treat. 2015 Nov; 154(2):275-86.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2015-10-22T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.

Authorship 65868
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Statistical issues and challenges.

Authorship 317889
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.

Authorship 879293
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Adjuvant ovarian function suppression and cognitive function in women with breast cancer.

Adjuvant ovarian function suppression and cognitive function in women with breast cancer.
PubMed Identifier: 27092785
author list: Phillips KA, Regan MM, Ribi K, Francis PA, Puglisi F, Bellet M, Spazzapan S, Karlsson P, Budman DR, Zaman K, Abdi EA, Domchek SM, Feng Y, Price KN, Coates AS, Gelber RD, Maruff P, Boyle F, Forbes JF, Ahles T, Fleming GF, Bernhard J
published in: British journal of cancer
information resource reference: Adjuvant ovarian function suppression and cognitive function in women with breast cancer. Br J Cancer. 2016 04 26; 114(9):956-64.
journal title abbreviation: Br J Cancer
publication date: 2016-04-19T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 879777
type: Authorship
author rank in publication: 20
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/64652766

Authorship 879926
type: Authorship
author rank in publication: 26
linked author: Regan, Meredith
linked information resource: Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

https://connects.catalyst.harvard.edu/Profiles/profile/64652766
PubMed Identifier: 26729437
author list: Bellet M, Gray KP, Francis PA, Láng I, Ciruelos E, Lluch A, Climent MA, Catalán G, Avella A, Bohn U, González-Martin A, Ferrer R, Catalán R, Azaro A, Rajasekaran A, Morales J, Vázquez J, Fleming GF, Price KN, Regan MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy. J Clin Oncol. 2016 05 10; 34(14):1584-93.
journal title abbreviation: J Clin Oncol
publication date: 2016-01-04T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.
PubMed Identifier: 27022111
author list: Ribi K, Luo W, Bernhard J, Francis PA, Burstein HJ, Ciruelos E, Bellet M, Pavesi L, Lluch A, Visini M, Parmar V, Tondini C, Kerbrat P, Perelló A, Neven P, Torres R, Lombardi D, Puglisi F, Karlsson P, Ruhstaller T, Colleoni M, Coates AS, Goldhirsch A, Price KN, Gelber RD, Regan MM, Fleming GF
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial. J Clin Oncol. 2016 05 10; 34(14):1601-10.
journal title abbreviation: J Clin Oncol
publication date: 2016-03-28T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 454886
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Regression models and risk estimation for mixed discrete and continuous outcomes in developmental toxicology.

Authorship 494855
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Predicting response to systemic treatments: learning from the past to plan for the future.

Authorship 883227
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Are SOFT and TEXT results practice changing and how?

Are SOFT and TEXT results practice changing and how?
PubMed Identifier: 27107153
author list: Pagani O, Regan MM, Francis PA
published in: Breast (Edinburgh, Scotland)
information resource reference: Are SOFT and TEXT results practice changing and how? Breast. 2016 Jun; 27:122-5.
journal title abbreviation: Breast
publication date: 2016-04-22T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 590330
type: Authorship
linked author: Regan, Meredith
linked information resource: Bivariate dose-response modeling and risk estimation in developmental toxicology

Authorship 90466
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.

Authorship 888380
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.

Authorship 888312
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Factors influencing discharge placement for Locked-In Syndrome survivors.

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.
PubMed Identifier: 27044936
author list: Regan MM, Francis PA, Pagani O, Fleming GF, Walley BA, Viale G, Colleoni M, Láng I, Gómez HL, Tondini C, Pinotti G, Price KN, Coates AS, Goldhirsch A, Gelber RD
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials. J Clin Oncol. 2016 07 01; 34(19):2221-31.
journal title abbreviation: J Clin Oncol
publication date: 2016-04-04T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Factors influencing discharge placement for Locked-In Syndrome survivors.
PubMed Identifier: 18557513
author list: Smith E, Regan M, Delargy M
published in: Irish medical journal
information resource reference: Factors influencing discharge placement for Locked-In Syndrome survivors. Ir Med J. 2008 Apr; 101(4):112-6.
journal title abbreviation: Ir Med J
publication date: 2008-04-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 590842
type: Authorship
linked author: Regan, Meredith
linked information resource: Two latent variable risk assessment approaches for mixed continuous and discrete outcomes from developmental toxicity data

Authorship 591792
type: Authorship
linked author: Regan, Meredith
linked information resource: Quantitative gene expression at the 8q24 prostate cancer risk locus

Assistant Professor
sort order: 2
type: Faculty Rank

Associate Professor
sort order: 1
type: Faculty Rank

Full Professor
sort order: 0
type: Faculty Rank

Instructor
sort order: 4
type: Faculty Rank

Authorship 599691
type: Authorship
linked author: Regan, Meredith
linked information resource: TMPRSS2-ERG fusion prostate cancer prevalence, association with PSA density, and histologic features in a multi-center US cohort of men undergoing prostate biopsy

Authorship 613763
type: Authorship
linked author: Regan, Meredith
linked information resource: Prevalence of TMPRSS2-ERG fusion prostate cancer in men undergoing prostate biopsy in the US

Authorship 892047
type: Authorship
author rank in publication: 16
linked author: Regan, Meredith
linked information resource: Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
PubMed Identifier: 27372069
author list: Pruneri G, Gray KP, Vingiani A, Viale G, Curigliano G, Criscitiello C, Láng I, Ruhstaller T, Gianni L, Goldhirsch A, Kammler R, Price KN, Cancello G, Munzone E, Gelber RD, Regan MM, Colleoni M
published in: Breast cancer research and treatment
information resource reference: Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00. Breast Cancer Res Treat. 2016 07; 158(2):323-31.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2016-07-02T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 568344
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.

Authorship 894608
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center.

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center.
PubMed Identifier: 26778006
author list: Muralidhar V, Regan MM, Werner L, Nakabayashi M, Evan CP, Bellmunt J, Choueiri TK, Elfiky AA, Harshman LC, McKay RR, Pomerantz MM, Sweeney CJ, Taplin ME, Kantoff PW, Nguyen PL
published in: Clinical genitourinary cancer
information resource reference: Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center. Clin Genitourin Cancer. 2016 08; 14(4):e299-305.
journal title abbreviation: Clin Genitourin Cancer
publication date: 2015-12-17T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 9935
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/787758

Authorship 66713
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.

Authorship 95326
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Preoperative serum acid phosphatase and alkaline phosphatase are not predictors of pathological stage and prostate-specific antigen failure after radical prostatectomy.

Authorship 98963
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/1039740

Authorship 481724
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

Authorship 594798
type: Authorship
linked author: Regan, Meredith
linked information resource: Starting at the beginning: Designing clinical investigations

IBCSG Statistical Center - A Breast Cancer Study Resource
end date: 2015-12-31
principal investigator name: REGAN, MEREDITH M
start date: 1997-09-30
type: Grant
sponsor award id: U24CA075362

DF/HCC SPORE in Prostate Cancer
end date: 2019-06-30
principal investigator name: BELTRAN, HIMISHA
start date: 2001-04-01
type: Grant
sponsor award id: P50CA090381

DF/HCC Kidney Cancer SPORE
end date: 2026-08-31
principal investigator name: MCDERMOTT, DAVID
start date: 2003-09-18
type: Grant
sponsor award id: P50CA101942

Co-Principal Investigator
type: Researcher Role
researcher role of: Regan, Meredith
contributes to: DF/HCC SPORE in Prostate Cancer

Co-Principal Investigator
type: Researcher Role
researcher role of: Regan, Meredith
contributes to: DF/HCC Kidney Cancer SPORE

Principal Investigator
type: Researcher Role
researcher role of: Regan, Meredith
contributes to: IBCSG Statistical Center - A Breast Cancer Study Resource

Authorship 911982
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).

The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).
PubMed Identifier: 26409187
author list: Sweeney C, Nakabayashi M, Regan M, Xie W, Hayes J, Keating N, Li S, Philipson T, Buyse M, Halabi S, Kantoff P, Sartor AO, Soule H, Mahal B
published in: Journal of the National Cancer Institute
information resource reference: The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP). J Natl Cancer Inst. 2015 Dec; 107(12):djv261.
journal title abbreviation: J Natl Cancer Inst
publication date: 2015-09-25T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 916261
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.
PubMed Identifier: 27325862
author list: Colleoni M, Gray KP, Gelber S, Láng I, Thürlimann B, Gianni L, Abdi EA, Gomez HL, Linderholm BK, Puglisi F, Tondini C, Kralidis E, Eniu A, Cagossi K, Rauch D, Chirgwin J, Gelber RD, Regan MM, Coates AS, Price KN, Viale G, Goldhirsch A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00. J Clin Oncol. 2016 10 01; 34(28):3400-8.
journal title abbreviation: J Clin Oncol
publication date: 2016-06-20T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 626881
type: Authorship
linked author: Regan, Meredith
linked information resource: Retrospective analysis of Iinterleukin-2 therapy in patients with metastatic renal cell carcinoma who had received prior antiangiogenic therapy

Authorship 331677
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Authorship 332424
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Authorship 343490
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.

Authorship 34808
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered.

Authorship 523308
type: Authorship
author rank in publication: 18
linked author: Regan, Meredith
linked information resource: Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.

Authorship 536987
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma.

Authorship 929975
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.

Authorship 933748
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.

Authorship 934758
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Reply to F. Tomao et al.

Authorship 933697
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.

Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.
PubMed Identifier: 27593476
author list: Chang P, Regan MM, Ferrer M, Guedea F, Patil D, Wei JT, Hembroff LA, Michalski JM, Saigal CS, Litwin MS, Hamstra DA, Kaplan ID, Ciezki JP, Klein EA, Kibel AS, Sandler HM, Dunn RL, Crociani CM, Sanda MG
published in: The Journal of urology
information resource reference: Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. J Urol. 2017 02; 197(2):376-384.
journal title abbreviation: J Urol
publication date: 2016-09-02T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.
PubMed Identifier: 27663760
author list: Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, Garin O, Ferrer M, Hamstra DA, Spratt DE
published in: International journal of radiation oncology, biology, physics
information resource reference: Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):770-777.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2016-08-03T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
PubMed Identifier: 27825388
author list: Johansson H, Gray KP, Pagani O, Regan MM, Viale G, Aristarco V, Macis D, Puccio A, Roux S, Maibach R, Colleoni M, Rabaglio M, Price KN, Coates AS, Gelber RD, Goldhirsch A, Kammler R, Bonanni B, Walley BA
published in: Breast cancer research : BCR
information resource reference: Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Res. 2016 11 08; 18(1):110.
journal title abbreviation: Breast Cancer Res
publication date: 2016-11-08T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Reply to F. Tomao et al.
PubMed Identifier: 27621403
author list: Ribi K, Bernhard J, Luo W, Regan MM, Fleming GF, Francis PA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Reply to F. Tomao et al. J Clin Oncol. 2016 12; 34(34):4189-4190.
journal title abbreviation: J Clin Oncol
publication date: 2016-09-30T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 595315
type: Authorship
linked author: Regan, Meredith
linked information resource: Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels

Authorship 67762
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Why do older women discontinue hormone replacement therapy?

Authorship 195166
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios.

Authorship 326690
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapy.

Authorship 940183
type: Authorship
author rank in publication: 15
linked author: Regan, Meredith
linked information resource: Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
PubMed Identifier: 27663567
author list: Wapnir IL, Gelber S, Anderson SJ, Mamounas EP, Robidoux A, Martín M, Nortier JW, Geyer CE, Paterson AH, Láng I, Price KN, Coates AS, Gelber RD, Rastogi P, Regan MM, Wolmark N, Aebi S
published in: Annals of surgical oncology
information resource reference: Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial. Ann Surg Oncol. 2017 Feb; 24(2):398-406.
journal title abbreviation: Ann Surg Oncol
publication date: 2016-09-23T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 388222
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.

Authorship 940869
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.

Authorship 941277
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Prostate specific antigen doubling time (PSA-DT) and velocity (PSA-V) provide independent prognostic information in androgen independent prostate cancer (AIPC) patients receiving chemotherapy.

Authorship 940774
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Prognostic and predictive values of carbonic anhydrase IX (CAIX) and pathologic features in patients with metastatic clear cell renal cell carcinoma receiving targeted therapy.

Authorship 940970
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/71515962

Authorship 941450
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.

Authorship 942854
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Impact of patient and physician factors on oncologists' recommendations for adjuvant chemotherapy in stage III colon cancer.

Authorship 942157
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Chemo-hormonal therapy for biochemical progression of prostate cancer.

Authorship 942413
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/71516363

Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.
PubMed Identifier: 27988492
author list: Ahern TP, Hertz DL, Damkier P, Ejlertsen B, Hamilton-Dutoit SJ, Rae JM, Regan MM, Thompson AM, Lash TL, Cronin-Fenton DP
published in: American journal of epidemiology
information resource reference: Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity. Am J Epidemiol. 2017 01 15; 185(2):75-85.
journal title abbreviation: Am J Epidemiol
publication date: 2016-12-17T00:00:00
year: 2016
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of patient and physician factors on oncologists' recommendations for adjuvant chemotherapy in stage III colon cancer.
PubMed Identifier: 27954834
author list: Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Impact of patient and physician factors on oncologists' recommendations for adjuvant chemotherapy in stage III colon cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):6051.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/71515962
PubMed Identifier: 27952438
author list: Regan MM, Daskivich TJ, Kantoff PW, Oh WK
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Utility of prostate specific antigen doubling time (PSA-DT) at the start of androgen independent prostate cancer (AIPC) and immediately before chemotherapy in predicting efficacy of taxane chemotherapy. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4640.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Utility of prostate specific antigen doubling time (PSA-DT) at the start of androgen independent prostate cancer (AIPC) and immediately before chemotherapy in predicting efficacy of taxane chemotherapy.

Prognostic and predictive values of carbonic anhydrase IX (CAIX) and pathologic features in patients with metastatic clear cell renal cell carcinoma receiving targeted therapy.
PubMed Identifier: 27963063
author list: Choueiri TK, Regan M, Oh W, Clement J, Amato A, McDermott D, Cho D, Atkins M, Signoretti S
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Prognostic and predictive values of carbonic anhydrase IX (CAIX) and pathologic features in patients with metastatic clear cell renal cell carcinoma receiving targeted therapy. J Clin Oncol. 2009 May 20; 27(15_suppl):e16067.
journal title abbreviation: J Clin Oncol
publication date: 2009-05-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemo-hormonal therapy for biochemical progression of prostate cancer.
PubMed Identifier: 27951992
author list: Taplin M, Xie W, Morganstern D, Bubley G, Ernstoff M, Regan M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Chemo-hormonal therapy for biochemical progression of prostate cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4559.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/71516363
PubMed Identifier: 27962941
author list: Heng DY, Xie W, Regan MM, Cheng T, North S, Knox JJ, Kollmannsberger C, McDermott D, Rini BI, Choueiri TK
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)-targeted agents: Results from a large multicenter study. J Clin Oncol. 2009 May 20; 27(15_suppl):5041.
journal title abbreviation: J Clin Oncol
publication date: 2009-05-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)-targeted agents: Results from a large multicenter study.

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.
PubMed Identifier: 27952436
author list: Nakabayashi M, Xie W, Regan MM, Jackman DM, Kantoff PW, Oh WK
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4646.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Prostate specific antigen doubling time (PSA-DT) and velocity (PSA-V) provide independent prognostic information in androgen independent prostate cancer (AIPC) patients receiving chemotherapy.
PubMed Identifier: 27952453
author list: Daskivich TJ, Regan MM, Kantoff PW, Oh WK
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Prostate specific antigen doubling time (PSA-DT) and velocity (PSA-V) provide independent prognostic information in androgen independent prostate cancer (AIPC) patients receiving chemotherapy. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4616.
journal title abbreviation: J Clin Oncol
publication date: 2006-06-20T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 944477
type: Authorship
author rank in publication: 9
linked author: Regan, Meredith
linked information resource: Follow-up study of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.

Authorship 945825
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Carbonic Anhydrase IX (CAIX) expression predicts for renal cell cancer (RCC) patient response and survival to IL-2 therapy.

Authorship 945106
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Role of CD3? expression and arginase activity in predicting response and survival in metastatic renal cell carcinoma (mRCC) patients receiving IL-2.

Authorship 945865
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Central nervous system vasculitis as a complication of refractory dermatomyositis.

Authorship 944400
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: ESR1 and ESR2 polymorphisms in BIG 1-98 comparing adjuvant letrozole (L) versus tamoxifen (T) or their sequence for early breast cancer.

Authorship 945756
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Identification of a novel urothelial carcinoma (UC) biomarker of lethality.

Authorship 945782
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Concordance of local pathology interpretation (LR) with central pathology review (CR) in primary tumor specimens from patients with renal cancer (RCC).

Identification of a novel urothelial carcinoma (UC) biomarker of lethality.
PubMed Identifier: 28023354
author list: Rosenberg JE, Werner L, Selvarajah S, Weir B, Regan MM, Jacobus SJ, Berman DM, Schutz FA, O'Brien R, Choueiri TK, Barretina J, Signoretti S, Loda M, Guancial EA, Gallardo E, Rojo FG, Lloreta J, Hahn WC, Kantoff PW, Bellmunt J
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Identification of a novel urothelial carcinoma (UC) biomarker of lethality. J Clin Oncol. 2011 May 20; 29(15_suppl):4569.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Carbonic Anhydrase IX (CAIX) expression predicts for renal cell cancer (RCC) patient response and survival to IL-2 therapy.
PubMed Identifier: 28016032
author list: Atkins M, McDermott D, Regan M, Stanbridge E, Upton M, Youmans A, Febbo P, Lechpammer M, Signoretti S
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Carbonic Anhydrase IX (CAIX) expression predicts for renal cell cancer (RCC) patient response and survival to IL-2 therapy. J Clin Oncol. 2004 Jul 15; 22(14_suppl):4512.
journal title abbreviation: J Clin Oncol
publication date: 2004-07-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Role of CD3? expression and arginase activity in predicting response and survival in metastatic renal cell carcinoma (mRCC) patients receiving IL-2.
PubMed Identifier: 28015243
author list: Zea AH, Atkins MB, McDermont D, O'Neil A, Regan M, Hernandez C, Youmans A, Desalvo J, Ochoa A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Role of CD3? expression and arginase activity in predicting response and survival in metastatic renal cell carcinoma (mRCC) patients receiving IL-2. J Clin Oncol. 2004 Jul 15; 22(14_suppl):2535.
journal title abbreviation: J Clin Oncol
publication date: 2004-07-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Follow-up study of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.
PubMed Identifier: 28023914
author list: Nakabayashi M, Xie W, Buckle G, Bubley G, Ernstoff MS, Walsh WV, Morganstern D, Kantoff PW, Regan MM, Taplin M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Follow-up study of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):4657.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Concordance of local pathology interpretation (LR) with central pathology review (CR) in primary tumor specimens from patients with renal cancer (RCC).
PubMed Identifier: 28016044
author list: Carloss E, Regan M, Upton M, Youmans A, McDermott D, Polivy A, Atkins M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Concordance of local pathology interpretation (LR) with central pathology review (CR) in primary tumor specimens from patients with renal cancer (RCC). J Clin Oncol. 2004 Jul 15; 22(14_suppl):4548.
journal title abbreviation: J Clin Oncol
publication date: 2004-07-15T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Central nervous system vasculitis as a complication of refractory dermatomyositis.
PubMed Identifier: 11196527
author list: Regan M, Haque U, Pomper M, Pardo C, Stone J
published in: The Journal of rheumatology
information resource reference: Central nervous system vasculitis as a complication of refractory dermatomyositis. J Rheumatol. 2001 Jan; 28(1):207-11.
journal title abbreviation: J Rheumatol
publication date: 2001-01-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

ESR1 and ESR2 polymorphisms in BIG 1-98 comparing adjuvant letrozole (L) versus tamoxifen (T) or their sequence for early breast cancer.
PubMed Identifier: 28020774
author list: Bouzyk M, Gray KP, Regan MM, Pagani O, Tang W, Kammler R, Maibach R, Viale G, Dell'Orto P, Thurlimann BJ, Hitre E, Lyng M, Ditzel HJ, Neven P, MacGrogan G, Price KN, Gelber RD, Coates AS, Goldhirsch A, Leyland-Jones B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: ESR1 and ESR2 polymorphisms in BIG 1-98 comparing adjuvant letrozole (L) versus tamoxifen (T) or their sequence for early breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):1002.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 950411
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Reply to L. Moscetti.

Reply to L. Moscetti.
PubMed Identifier: 28095153
author list: Colleoni M, Gray KP, Gelber RD, Regan MM, Goldhirsch A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Reply to L. Moscetti. J Clin Oncol. 2017 05 10; 35(14):1628.
journal title abbreviation: J Clin Oncol
publication date: 2017-01-17T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 952525
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Clinical Trial Design and Endpoints for Stage IV Melanoma in the Modern Era.

Clinical Trial Design and Endpoints for Stage IV Melanoma in the Modern Era.
PubMed Identifier: 28114257
author list: Izar B, Regan MM, McDermott DF
published in: Cancer journal (Sudbury, Mass.)
information resource reference: Clinical Trial Design and Endpoints for Stage IV Melanoma in the Modern Era. Cancer J. 2017 Jan/Feb; 23(1):63-67.
journal title abbreviation: Cancer J
publication date: 2017-01-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 955202
type: Authorship
author rank in publication: 10
linked author: Regan, Meredith
linked information resource: Association of DNA repair factors with overall survival in advanced urothelial carcinoma treated with platinum-based chemotherapy.

Authorship 953667
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Nomogram predicting treatment-related sexual dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI).

Authorship 953782
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC).

Authorship 955766
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI).

Authorship 955490
type: Authorship
author rank in publication: 6
linked author: Regan, Meredith
linked information resource: Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI).

Authorship 955840
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/72396414

Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI).
PubMed Identifier: 28146976
author list: Michalski JM, Sanda MG, Litwin MS, Ferrer M, Hamstra DA, Regan MM, Saigal C, Kwan L, Gao T, Klein EA, Kattan MW, Stephenson AJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). J Clin Oncol. 2012 Dec; 30(34_suppl):55.
journal title abbreviation: J Clin Oncol
publication date: 2012-12-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Nomogram predicting treatment-related sexual dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI).
PubMed Identifier: 28146962
author list: Sanda MG, Litwin MS, Ferrer M, Regan MM, Saigal C, Kwan L, Gao T, Klein EA, Kattan MW, Stephenson AJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Nomogram predicting treatment-related sexual dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). J Clin Oncol. 2012 Dec; 30(34_suppl):51.
journal title abbreviation: J Clin Oncol
publication date: 2012-12-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC).
PubMed Identifier: 28136860
author list: Werner L, Bellmunt J, Nikitas N, Stack EC, Lis R, Signoretti S, Loda M, Regan MM, Park RS, O'Brien R, Berman DM, Bamias A, Rosenberg JE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC). J Clin Oncol. 2013 Feb 20; 31(6_suppl):260.
journal title abbreviation: J Clin Oncol
publication date: 2013-02-20T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI).
PubMed Identifier: 28146931
author list: Sanda MG, Litwin MS, Ferrer M, Regan MM, Saigal C, Kwan L, Gao T, Klein EA, Kattan MW, Stephenson AJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI). J Clin Oncol. 2012 Dec; 30(34_suppl):49.
journal title abbreviation: J Clin Oncol
publication date: 2012-12-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Association of DNA repair factors with overall survival in advanced urothelial carcinoma treated with platinum-based chemotherapy.
PubMed Identifier: 28143170
author list: Guancial EA, Werner L, Stack E, Lis R, Signoretti S, Loda M, Gallardo E, Rojo F, Lloreta J, Regan MM, Park R, O'Brien R, Berman DM, Bellmunt J, Rosenberg JE
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Association of DNA repair factors with overall survival in advanced urothelial carcinoma treated with platinum-based chemotherapy. J Clin Oncol. 2012 Feb 10; 30(5_suppl):291.
journal title abbreviation: J Clin Oncol
publication date: 2012-02-10T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/72396414
PubMed Identifier: 28141980
author list: Regan MM, Walley B, Fleming GF, Colleoni M, Lang I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE, Rabaglio-Poretti M, Coates AS, Gelber RD, Goldhirsch A, Francis PA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Randomized comparison of adjuvant aromatase inhibitor (AI) exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Joint analysis of IBCSG TEXT and SOFT trials. J Clin Oncol. 2014 Jun 20; 32(18_suppl):LBA1.
journal title abbreviation: J Clin Oncol
publication date: 2014-06-20T00:00:00
year: 2014
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Randomized comparison of adjuvant aromatase inhibitor (AI) exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Joint analysis of IBCSG TEXT and SOFT trials.

Kinetics of L-[1-(13)C]leucine when ingested with free amino acids, unlabeled or intrinsically labeled casein.
PubMed Identifier: 10827001
author list: Metges CC, El-Khoury AE, Selvaraj AB, Tsay RH, Atkinson A, Regan MM, Bequette BJ, Young VR
published in: American journal of physiology. Endocrinology and metabolism
information resource reference: Kinetics of L-[1-(13)C]leucine when ingested with free amino acids, unlabeled or intrinsically labeled casein. Am J Physiol Endocrinol Metab. 2000 Jun; 278(6):E1000-9.
journal title abbreviation: Am J Physiol Endocrinol Metab
publication date: 2000-06-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
PubMed Identifier: 15625368
author list: McDermott DF, Regan MM, Clark JI, Flaherty LE, Weiss GR, Logan TF, Kirkwood JM, Gordon MS, Sosman JA, Ernstoff MS, Tretter CP, Urba WJ, Smith JW, Margolin KA, Mier JW, Gollob JA, Dutcher JP, Atkins MB
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol. 2005 Jan 01; 23(1):133-41.
journal title abbreviation: J Clin Oncol
publication date: 2005-01-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Interleukin-2 therapy of metastatic renal cell carcinoma: update of phase III trials.
PubMed Identifier: 17026799
author list: McDermott DF, Regan MM, Atkins MB
published in: Clinical genitourinary cancer
information resource reference: Interleukin-2 therapy of metastatic renal cell carcinoma: update of phase III trials. Clin Genitourin Cancer. 2006 Sep; 5(2):114-9.
journal title abbreviation: Clin Genitourin Cancer
publication date: 2006-09-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
PubMed Identifier: 12783301
author list: Sheth S, Shea JC, Bishop MD, Chopra S, Regan MM, Malmberg E, Walker C, Ricci R, Tsui LC, Durie PR, Zielenski J, Freedman SD
published in: Human genetics
information resource reference: Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet. 2003 Aug; 113(3):286-92.
journal title abbreviation: Hum Genet
publication date: 2003-06-03T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.
PubMed Identifier: 15307877
author list: Gelrud A, Sheth S, Banerjee S, Weed D, Shea J, Chuttani R, Howell DA, Telford JJ, Carr-Locke DL, Regan MM, Ellis L, Durie PR, Freedman SD
published in: The American journal of gastroenterology
information resource reference: Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol. 2004 Aug; 99(8):1557-62.
journal title abbreviation: Am J Gastroenterol
publication date: 2004-08-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 961135
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Carbonic anhydrase IX (CA IX) and pathologic features as predictors of outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving VEGF-targeted therapy.

Authorship 960326
type: Authorship
author rank in publication: 5
linked author: Regan, Meredith
linked information resource: Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients.

Authorship 960331
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Retrospective analysis of interleukin-2 therapy in patients with metastatic renal cell carcinoma who had received prior antiangiogenic therapy.

Authorship 964446
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Quantitative gene expression at the 8q24 prostate cancer risk locus.

Authorship 964779
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Association between serum adiponectin and prostate cancer risk.

Authorship 965890
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC).

Authorship 966451
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels.

Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC).
PubMed Identifier: 27948754
author list: Taplin M, Ko Y, Regan MM, Beer TM, Carducci MA, Mathew P, Bubley G, Oh WK, Kantoff PW, Balk SP
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC). J Clin Oncol. 2008 May 20; 26(15_suppl):5068.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Association between serum adiponectin and prostate cancer risk.
PubMed Identifier: 27948194
author list: Jacobus S, Sher DJ, Regan MM, Chamberland J, Oh WK, Mantzoros C
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Association between serum adiponectin and prostate cancer risk. J Clin Oncol. 2008 May 20; 26(15_suppl):5147.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Retrospective analysis of interleukin-2 therapy in patients with metastatic renal cell carcinoma who had received prior antiangiogenic therapy.
PubMed Identifier: 27948868
author list: Schwarzberg T, Regan MM, Liu V, Mier JW, Cho D, Koon H, Bhatt RS, Seery V, Bradley K, Atkins MB, McDermott DF
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Retrospective analysis of interleukin-2 therapy in patients with metastatic renal cell carcinoma who had received prior antiangiogenic therapy. J Clin Oncol. 2008 May 20; 26(15_suppl):5044.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels.
PubMed Identifier: 27948776
author list: Xie W, Oh WK, Regan MM, Abe M, Kantoff PW, Chan J
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels. J Clin Oncol. 2008 May 20; 26(15_suppl):5057.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Quantitative gene expression at the 8q24 prostate cancer risk locus.
PubMed Identifier: 27948778
author list: Pomerantz M, Beckwith C, Regan MM, Xie W, Herman P, Chan J, Ardlie K, Oh WK, Kantoff PW, Freedman ML
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Quantitative gene expression at the 8q24 prostate cancer risk locus. J Clin Oncol. 2008 May 20; 26(15_suppl):5055.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients.
PubMed Identifier: 27947714
author list: Oh WK, Leitzel K, Jacobus S, Vargas R, Regan MM, Hamer PJ, Carney WP, Ali SM, Kantoff PW, Lipton A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients. J Clin Oncol. 2008 May 20; 26(15_suppl):11077.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Carbonic anhydrase IX (CA IX) and pathologic features as predictors of outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving VEGF-targeted therapy.
PubMed Identifier: 27947474
author list: Choueiri TK, Regan MM, Brick AJ, Clement JM, Kwabi C, Shah K, Amato A, McDermott DF, Atkins MB, Signoretti S
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Carbonic anhydrase IX (CA IX) and pathologic features as predictors of outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving VEGF-targeted therapy. J Clin Oncol. 2008 May 20; 26(15_suppl):16042.
journal title abbreviation: J Clin Oncol
publication date: 2008-05-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease.
PubMed Identifier: 10588230
author list: Maslow AD, Regan MM, Haering JM, Johnson RG, Levine RA
published in: Journal of the American College of Cardiology
information resource reference: Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. J Am Coll Cardiol. 1999 Dec; 34(7):2096-104.
journal title abbreviation: J Am Coll Cardiol
publication date: 1999-12-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer.
PubMed Identifier: 17135641
author list: Taplin ME, Xie W, Bubley GJ, Ernstoff MS, Walsh W, Morganstern DE, Regan MM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancer. J Clin Oncol. 2006 Dec 01; 24(34):5408-13.
journal title abbreviation: J Clin Oncol
publication date: 2006-12-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Postoperative atrial tachyarrhythmias in patients undergoing coronary artery bypass graft surgery without cardiopulmonary bypass: a role for intraoperative magnesium supplementation.
PubMed Identifier: 11052432
author list: Maslow AD, Regan MM, Heindle S, Panzica P, Cohn WE, Johnson RG
published in: Journal of cardiothoracic and vascular anesthesia
information resource reference: Postoperative atrial tachyarrhythmias in patients undergoing coronary artery bypass graft surgery without cardiopulmonary bypass: a role for intraoperative magnesium supplementation. J Cardiothorac Vasc Anesth. 2000 Oct; 14(5):524-30.
journal title abbreviation: J Cardiothorac Vasc Anesth
publication date: 2000-10-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
PubMed Identifier: 17525937
author list: Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E
published in: Psycho-oncology
information resource reference: Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 May 24; 16(10).
journal title abbreviation: Psychooncology
publication date: 2007-05-24T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/771085
PubMed Identifier: 20458051
author list: Colleoni M, Cole BF, Viale G, Regan MM, Price KN, Maiorano E, Mastropasqua MG, Crivellari D, Gelber RD, Goldhirsch A, Coates AS, Gusterson BA
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Clin Oncol. 2010 Jun 20; 28(18):2966-73.
journal title abbreviation: J Clin Oncol
publication date: 2010-05-10T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Daily requirement for total sulfur amino acids of chronically undernourished Indian men.
PubMed Identifier: 15213034
author list: Kurpad AV, Regan MM, Varalakshmi S, Gnanou J, Young VR
published in: The American journal of clinical nutrition
information resource reference: Daily requirement for total sulfur amino acids of chronically undernourished Indian men. Am J Clin Nutr. 2004 Jul; 80(1):95-100.
journal title abbreviation: Am J Clin Nutr
publication date: 2004-07-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
PubMed Identifier: 15598980
author list: Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors. J Clin Oncol. 2004 Dec 15; 22(24):4951-7.
journal title abbreviation: J Clin Oncol
publication date: 2004-12-14T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Cysteine kinetics and oxidation at different intakes of methionine and cystine in young adults.
PubMed Identifier: 10648263
author list: Raguso CA, Regan MM, Young VR
published in: The American journal of clinical nutrition
information resource reference: Cysteine kinetics and oxidation at different intakes of methionine and cystine in young adults. Am J Clin Nutr. 2000 Feb; 71(2):491-9.
journal title abbreviation: Am J Clin Nutr
publication date: 2000-02-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios.
PubMed Identifier: 12499331
author list: Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ
published in: The American journal of clinical nutrition
information resource reference: Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am J Clin Nutr. 2003 Jan; 77(1):128-32.
journal title abbreviation: Am J Clin Nutr
publication date: 2003-01-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 975347
type: Authorship
author rank in publication: 16
linked author: Regan, Meredith
linked information resource: Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

Authorship 975034
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Mental health research: developing priorities and promoting its utilization to inform policies and services.

Authorship 976300
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United Kingdom.

Mental health research: developing priorities and promoting its utilization to inform policies and services.
PubMed Identifier: 26442893
author list: Regan M, Gater R, Rahman A, Patel V
published in: Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
information resource reference: Mental health research: developing priorities and promoting its utilization to inform policies and services. East Mediterr Health J. 2015 Sep 28; 21(7):517-21.
journal title abbreviation: East Mediterr Health J
publication date: 2015-09-28T00:00:00
year: 2015
type: Academic Article
type: Article
type: Document
type: Information Resource

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.
PubMed Identifier: 28380313
author list: Borgquist S, Giobbie-Hurder A, Ahern TP, Garber JE, Colleoni M, Láng I, Debled M, Ejlertsen B, von Moos R, Smith I, Coates AS, Goldhirsch A, Rabaglio M, Price KN, Gelber RD, Regan MM, Thürlimann B
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. J Clin Oncol. 2017 Apr 10; 35(11):1179-1188.
journal title abbreviation: J Clin Oncol
publication date: 2017-02-13T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United Kingdom.
PubMed Identifier: 18076861
author list: Taylor-Robinson DC, Regan M, Crowcroft N, Parry JV, Dardamissis E
published in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
information resource reference: Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United Kingdom. Euro Surveill. 2007 Dec 01; 12(12):E5-6.
journal title abbreviation: Euro Surveill
publication date: 2007-12-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.
PubMed Identifier: 14972483
author list: George DJ, Regan MM, Oh WK, Tay MH, Manola J, Decalo N, Duggan S, Dewolf WC, Kantoff PW, Bubley GJ
published in: Urology
information resource reference: Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer. Urology. 2004 Feb; 63(2):327-32.
journal title abbreviation: Urology
publication date: 2004-02-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Cancer-related communication between female patients and male partners scale: A pilot study.
PubMed Identifier: 16308887
author list: Kornblith AB, Regan MM, Kim Y, Greer G, Parker B, Bennett S, Winer E
published in: Psycho-oncology
information resource reference: Cancer-related communication between female patients and male partners scale: A pilot study. Psychooncology. 2006 Sep; 15(9):780-94.
journal title abbreviation: Psychooncology
publication date: 2006-09-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Using clinical trial data to tailor adjuvant treatments for individual patients.
PubMed Identifier: 17719227
author list: Regan MM, Gelber RD
published in: Breast (Edinburgh, Scotland)
information resource reference: Using clinical trial data to tailor adjuvant treatments for individual patients. Breast. 2007 Dec; 16 Suppl 2:S98-104.
journal title abbreviation: Breast
publication date: 2007-08-23T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Daily methionine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique.
PubMed Identifier: 12716672
author list: Kurpad AV, Regan MM, Varalakshmi S, Vasudevan J, Gnanou J, Raj T, Young VR
published in: The American journal of clinical nutrition
information resource reference: Daily methionine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique. Am J Clin Nutr. 2003 May; 77(5):1198-205.
journal title abbreviation: Am J Clin Nutr
publication date: 2003-05-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/787758
PubMed Identifier: 12736227
author list: Joyce RM, Regan M, Ottaway J, Umiel T, Tetreault JC, Levine J, McDermott D, Hurley D, Giallombardo N, Smith T, Lamontagne D, Uhl L, Avigan D
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT). Ann Oncol. 2003; 14 Suppl 1:i21-7.
journal title abbreviation: Ann Oncol
publication date: 2003-01-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource
label: A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).

Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients.
PubMed Identifier: 12960113
author list: Spentzos D, Mantzoros C, Regan MM, Morrissey ME, Duggan S, Flickner-Garvey S, McCormick H, DeWolf W, Balk S, Bubley GJ
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients. Clin Cancer Res. 2003 Aug 15; 9(9):3282-7.
journal title abbreviation: Clin Cancer Res
publication date: 2003-08-15T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/78893
type: Address
address line 1: Dana-Farber Cancer Institute
address line 2: 450 Brookline Avenue
city: Boston
postal code: 02115
state or province: MA

Likelihood models for clustered binary and continuous outcomes: application to developmental toxicology.
PubMed Identifier: 11315004
author list: Regan MM, Catalano PJ
published in: Biometrics
information resource reference: Likelihood models for clustered binary and continuous outcomes: application to developmental toxicology. Biometrics. 1999 Sep; 55(3):760-8.
journal title abbreviation: Biometrics
publication date: 1999-09-01T00:00:00
year: 1999
type: Academic Article
type: Article
type: Document
type: Information Resource

Daily requirement for and splanchnic uptake of leucine in healthy adult Indians.
PubMed Identifier: 11722955
author list: Kurpad AV, Raj T, El-Khoury A, Kuriyan R, Maruthy K, Borgonha S, Chandukudlu D, Regan MM, Young VR
published in: The American journal of clinical nutrition
information resource reference: Daily requirement for and splanchnic uptake of leucine in healthy adult Indians. Am J Clin Nutr. 2001 Dec; 74(6):747-55.
journal title abbreviation: Am J Clin Nutr
publication date: 2001-12-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
PubMed Identifier: 23491275
author list: Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U
published in: The Lancet. Oncology
information resource reference: Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013 Apr; 14(4):297-305.
journal title abbreviation: Lancet Oncol
publication date: 2013-03-11T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection.
PubMed Identifier: 12478120
author list: Ung JO, San Francisco IF, Regan MM, DeWolf WC, Olumi AF
published in: The Journal of urology
information resource reference: The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol. 2003 Jan; 169(1):130-5.
journal title abbreviation: J Urol
publication date: 2003-01-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Lysine requirements of healthy adult Indian subjects, measured by an indicator amino acid balance technique.
PubMed Identifier: 11333843
author list: Kurpad AV, Raj T, El-Khoury A, Beaumier L, Kuriyan R, Srivatsa A, Borgonha S, Selvaraj A, Regan MM, Young VR
published in: The American journal of clinical nutrition
information resource reference: Lysine requirements of healthy adult Indian subjects, measured by an indicator amino acid balance technique. Am J Clin Nutr. 2001 May; 73(5):900-7.
journal title abbreviation: Am J Clin Nutr
publication date: 2001-05-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Intestinal parasites increase the dietary lysine requirement in chronically undernourished Indian men.
PubMed Identifier: 14668277
author list: Kurpad AV, Regan MM, Nazareth D, Nagaraj S, Gnanou J, Young VR
published in: The American journal of clinical nutrition
information resource reference: Intestinal parasites increase the dietary lysine requirement in chronically undernourished Indian men. Am J Clin Nutr. 2003 Dec; 78(6):1145-51.
journal title abbreviation: Am J Clin Nutr
publication date: 2003-12-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm.
PubMed Identifier: 15037431
author list: Klipstein S, Reindollar RH, Regan MM, Alper MM
published in: Fertility and sterility
information resource reference: Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm. Fertil Steril. 2004 Mar; 81(3):714-5.
journal title abbreviation: Fertil Steril
publication date: 2004-03-01T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Regression models and risk estimation for mixed discrete and continuous outcomes in developmental toxicology.
PubMed Identifier: 10949415
author list: Regan MM, Catalano PJ
published in: Risk analysis : an official publication of the Society for Risk Analysis
information resource reference: Regression models and risk estimation for mixed discrete and continuous outcomes in developmental toxicology. Risk Anal. 2000 Jun; 20(3):363-76.
journal title abbreviation: Risk Anal
publication date: 2000-06-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 982517
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: SU-E-T-367: Dosimetric Comparison of VMAT and S&S IMRT Regarding the Dose Delivered to the Skin in Different Cancer Sites.

Authorship 980936
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2.

Authorship 981550
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: SU-E-T-387: Validation of a New System for Patient Specific IMRT QA and Comparison with Other Commerical Systems.

Authorship 982424
type: Authorship
author rank in publication: 7
linked author: Regan, Meredith
linked information resource: Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.

SU-E-T-367: Dosimetric Comparison of VMAT and S&S IMRT Regarding the Dose Delivered to the Skin in Different Cancer Sites.
PubMed Identifier: 28517763
author list: Defoor D, Stathakis S, Regan M, Esquivel C, Mavroidis P, Papanikolaou N
published in: Medical physics
information resource reference: SU-E-T-367: Dosimetric Comparison of VMAT and S&S IMRT Regarding the Dose Delivered to the Skin in Different Cancer Sites. Med Phys. 2013 Jun; 40(6Part16):289.
journal title abbreviation: Med Phys
publication date: 2013-06-01T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

SU-E-T-387: Validation of a New System for Patient Specific IMRT QA and Comparison with Other Commerical Systems.
PubMed Identifier: 28517189
author list: McKinsey R, Stathakis S, Esquivel C, Gutierrez A, Myers P, Nayebi N, Regan M, Papanikolaou N
published in: Medical physics
information resource reference: SU-E-T-387: Validation of a New System for Patient Specific IMRT QA and Comparison with Other Commerical Systems. Med Phys. 2012 Jun; 39(6Part16):3793.
journal title abbreviation: Med Phys
publication date: 2012-06-01T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2.
PubMed Identifier: 28494403
author list: Bartlett JMS, Ahmed I, Regan MM, Sestak I, Mallon EA, Dell'Orto P, Thürlimann B, Seynaeve C, Putter H, Van de Velde CJH, Brookes CL, Forbes JF, Viale G, Cuzick J, Dowsett M, Rea DW
published in: European journal of cancer (Oxford, England : 1990)
information resource reference: HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2. Eur J Cancer. 2017 07; 79:129-138.
journal title abbreviation: Eur J Cancer
publication date: 2017-05-08T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.
PubMed Identifier: 28520829
author list: Sanda MG, Feng Z, Howard DH, Tomlins SA, Sokoll LJ, Chan DW, Regan MM, Groskopf J, Chipman J, Patil DH, Salami SS, Scherr DS, Kagan J, Srivastava S, Thompson IM, Siddiqui J, Fan J, Joon AY, Bantis LE, Rubin MA, Chinnayian AM, Wei JT, Bidair M, Kibel A, Lin DW, Lotan Y, Partin A, Taneja S
published in: JAMA oncology
information resource reference: Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer. JAMA Oncol. 2017 Aug 01; 3(8):1085-1093.
journal title abbreviation: JAMA Oncol
publication date: 2017-08-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/812618
PubMed Identifier: 18668517
author list: Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS
published in: The Prostate
information resource reference: Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy. Prostate. 2008 Oct 01; 68(14):1517-30.
journal title abbreviation: Prostate
publication date: 2008-10-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
PubMed Identifier: 19228531
author list: Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC
published in: Journal of the American College of Surgeons
information resource reference: Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg. 2009 Feb; 208(2):202-9.
journal title abbreviation: J Am Coll Surg
publication date: 2008-12-18T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Treatment selection for patients with metastatic renal cell carcinoma.
PubMed Identifier: 19402069
author list: Atkins MB, Choueiri TK, Cho D, Regan M, Signoretti S
published in: Cancer
information resource reference: Treatment selection for patients with metastatic renal cell carcinoma. Cancer. 2009 May 15; 115(10 Suppl):2327-33.
journal title abbreviation: Cancer
publication date: 2009-05-15T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
PubMed Identifier: 19692688
author list: Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Thürlimann B, Paridaens R, Smith I, Mauriac L, Forbes J, Price KN, Regan MM, Gelber RD, Coates AS
published in: The New England journal of medicine
information resource reference: Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med. 2009 Aug 20; 361(8):766-76.
journal title abbreviation: N Engl J Med
publication date: 2009-08-20T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 985439
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.

The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
PubMed Identifier: 28560598
author list: Nakhlis F, Regan MM, Warren LE, Bellon JR, Hirshfield-Bartek J, Duggan MM, Dominici LS, Golshan M, Jacene HA, Yeh ED, Mullaney EE, Overmoyer B
published in: Annals of surgical oncology
information resource reference: The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. 2017 Sep; 24(9):2563-2569.
journal title abbreviation: Ann Surg Oncol
publication date: 2017-05-30T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.
PubMed Identifier: 17960608
author list: Xie W, Nakabayashi M, Regan MM, Oh WK
published in: Cancer
information resource reference: Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Cancer. 2007 Dec 15; 110(12):2709-15.
journal title abbreviation: Cancer
publication date: 2007-12-15T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.
PubMed Identifier: 14975482
author list: Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM
published in: Journal of the American College of Cardiology
information resource reference: Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004 Feb 18; 43(4):678-83.
journal title abbreviation: J Am Coll Cardiol
publication date: 2004-02-18T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Association of cystic fibrosis with abnormalities in fatty acid metabolism.
PubMed Identifier: 14762183
author list: Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP
published in: The New England journal of medicine
information resource reference: Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med. 2004 Feb 05; 350(6):560-9.
journal title abbreviation: N Engl J Med
publication date: 2004-02-05T00:00:00
year: 2004
type: Academic Article
type: Article
type: Document
type: Information Resource

Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4.
PubMed Identifier: 17070213
author list: Daskivich TJ, Regan MM, Oh WK
published in: The Journal of urology
information resource reference: Prostate specific antigen doubling time calculation: not as easy as 1, 2, 4. J Urol. 2006 Nov; 176(5):1927-37.
journal title abbreviation: J Urol
publication date: 2006-11-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer.
PubMed Identifier: 17255306
author list: Cho D, Signoretti S, Regan M, Mier JW, Atkins MB
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 2):758s-763s.
journal title abbreviation: Clin Cancer Res
publication date: 2007-01-15T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.
PubMed Identifier: 18272916
author list: Ravaioli A, Monti F, Regan MM, Maffini F, Mastropasqua MG, Spataro V, Castiglione-Gertsch M, Panzini I, Gianni L, Goldhirsch A, Coates A, Price KN, Gusterson BA, Viale G
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Ann Oncol. 2008 Apr; 19(4):660-8.
journal title abbreviation: Ann Oncol
publication date: 2008-02-13T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma.
PubMed Identifier: 17956710
author list: Cho D, Signoretti S, Dabora S, Regan M, Seeley A, Mariotti M, Youmans A, Polivy A, Mandato L, McDermott D, Stanbridge E, Atkins M
published in: Clinical genitourinary cancer
information resource reference: Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma. Clin Genitourin Cancer. 2007 Sep; 5(6):379-85.
journal title abbreviation: Clin Genitourin Cancer
publication date: 2007-09-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
PubMed Identifier: 17245695
author list: Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E
published in: Psycho-oncology
information resource reference: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 Oct; 16(10):895-903.
journal title abbreviation: Psychooncology
publication date: 2007-10-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 993573
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
PubMed Identifier: 28654365
author list: Saha P, Regan MM, Pagani O, Francis PA, Walley BA, Ribi K, Bernhard J, Luo W, Gómez HL, Burstein HJ, Parmar V, Torres R, Stewart J, Bellet M, Perelló A, Dane F, Moreira A, Vorobiof D, Nottage M, Price KN, Coates AS, Goldhirsch A, Gelber RD, Colleoni M, Fleming GF
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. J Clin Oncol. 2017 Sep 20; 35(27):3113-3122.
journal title abbreviation: J Clin Oncol
publication date: 2017-06-27T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
PubMed Identifier: 20453196
author list: Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, Macconaill L, Coetzee GA, Regan MM, Freedman ML
published in: Proceedings of the National Academy of Sciences of the United States of America
information resource reference: 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci U S A. 2010 May 25; 107(21):9742-6.
journal title abbreviation: Proc Natl Acad Sci U S A
publication date: 2010-05-07T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

First Line treatment with bevacizumab (B) and high dose (HD) bolus aldesleukin (IL-2) in metastatic renal cell carcinoma (mRCC) patients (Pts)
author list: Ernstoff MS, Regan MM, McDermott DF, Sosman JA, Dutcher JP, Clark JI, Crocenzi TS, Ochoa A,C Atkins MB, for the Cyokine Working Group
published in: Proc Am Soc Clin Oncol
information resource reference: First Line treatment with bevacizumab (B) and high dose (HD) bolus aldesleukin (IL-2) in metastatic renal cell carcinoma (mRCC) patients (Pts). Proc Am Soc Clin Oncol. 2007; 25(18S Part I of II):651s (abstr 15524).
publication date: 2007-01-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Combined continuous and discrete outcomes
author list: Regan MM, Catalano PJ
published in: Aerts M, Geys H, Molenberghs G, Ryan LM, editors. Topics in Modelling of Clustered Data
information resource reference: Combined continuous and discrete outcomes. Aerts M, Geys H, Molenberghs G, Ryan LM, editors. Topics in Modelling of Clustered Data. 2002; 233-261.
publication date: 2002-01-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Preoperative serum acid phosphatase and alkaline phosphatase are not predictors of pathological stage and prostate-specific antigen failure after radical prostatectomy.
PubMed Identifier: 14632848
author list: San Francisco IF, Olumi AF, Yoon JH, Regan MM, DeWolf WC
published in: BJU international
information resource reference: Preoperative serum acid phosphatase and alkaline phosphatase are not predictors of pathological stage and prostate-specific antigen failure after radical prostatectomy. BJU Int. 2003 Dec; 92(9):924-8.
journal title abbreviation: BJU Int
publication date: 2003-12-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 996362
type: Authorship
author rank in publication: 14
linked author: Regan, Meredith
linked information resource: External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.

Authorship 997721
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Trial designs and results supporting treatment de-escalation and escalation.

Trial designs and results supporting treatment de-escalation and escalation.
PubMed Identifier: 28673539
author list: Regan MM, Barry WT
published in: Breast (Edinburgh, Scotland)
information resource reference: Trial designs and results supporting treatment de-escalation and escalation. Breast. 2017 Aug; 34 Suppl 1:S10-S12.
journal title abbreviation: Breast
publication date: 2017-06-30T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
PubMed Identifier: 28463150
author list: Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P, Michalski JM
published in: International journal of radiation oncology, biology, physics
information resource reference: External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):304-317.
journal title abbreviation: Int J Radiat Oncol Biol Phys
publication date: 2017-02-22T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.
PubMed Identifier: 15897568
author list: Atkins M, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Febbo P, Upton M, Lechpammer M, Signoretti S
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res. 2005 May 15; 11(10):3714-21.
journal title abbreviation: Clin Cancer Res
publication date: 2005-05-15T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
PubMed Identifier: 17077359
author list: Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurküla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B
published in: Journal of the National Cancer Institute
information resource reference: Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. J Natl Cancer Inst. 2006 Nov 01; 98(21):1571-81.
journal title abbreviation: J Natl Cancer Inst
publication date: 2006-11-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice.
PubMed Identifier: 17641366
author list: Hakimé A, Hines-Peralta A, Peddi H, Atkins MB, Sukhatme VP, Signoretti S, Regan M, Goldberg SN
published in: Radiology
information resource reference: Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology. 2007 Aug; 244(2):464-70.
journal title abbreviation: Radiology
publication date: 2007-08-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
PubMed Identifier: 18230798
author list: Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, Price KN, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Gusterson BA, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Coates AS
published in: Journal of the National Cancer Institute
information resource reference: Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst. 2008 Feb 06; 100(3):207-12.
journal title abbreviation: J Natl Cancer Inst
publication date: 2008-01-29T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Relationship between serum adiponectin and prostate cancer grade.
PubMed Identifier: 18646046
author list: Sher DJ, Oh WK, Jacobus S, Regan MM, Lee GS, Mantzoros C
published in: The Prostate
information resource reference: Relationship between serum adiponectin and prostate cancer grade. Prostate. 2008 Oct 01; 68(14):1592-8.
journal title abbreviation: Prostate
publication date: 2008-10-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II study of sunitinib in men with advanced prostate cancer.
PubMed Identifier: 19403935
author list: Dror Michaelson M, Regan MM, Oh WK, Kaufman DS, Olivier K, Michaelson SZ, Spicer B, Gurski C, Kantoff PW, Smith MR
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Phase II study of sunitinib in men with advanced prostate cancer. Ann Oncol. 2009 May; 20(5):913-20.
journal title abbreviation: Ann Oncol
publication date: 2009-05-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
PubMed Identifier: 19584163
author list: Mosquera JM, Mehra R, Regan MM, Perner S, Genega EM, Bueti G, Shah RB, Gaston S, Tomlins SA, Wei JT, Kearney MC, Johnson LA, Tang JM, Chinnaiyan AM, Rubin MA, Sanda MG
published in: Clinical cancer research : an official journal of the American Association for Cancer Research
information resource reference: Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res. 2009 Jul 15; 15(14):4706-11.
journal title abbreviation: Clin Cancer Res
publication date: 2009-07-07T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA.
PubMed Identifier: 19647299
author list: Lu B, Maqsodi B, Yang W, McMaster GK, Perner S, Regan M, Bubley GJ, Balk SP, Rubin M, Sanda MG
published in: Urology
information resource reference: Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA. Urology. 2009 Nov; 74(5):1156-61.
journal title abbreviation: Urology
publication date: 2009-08-03T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/868195
PubMed Identifier: 21325445
author list: Karlsson P, Sun Z, Braun D, Price KN, Castiglione-Gertsch M, Rabaglio M, Gelber RD, Crivellari D, Collins J, Murray E, Zaman K, Colleoni M, Gusterson BA, Viale G, Regan MM, Coates AS, Goldhirsch A
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. Ann Oncol. 2011 Oct; 22(10):2216-26.
journal title abbreviation: Ann Oncol
publication date: 2011-02-16T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
PubMed Identifier: 21892704
author list: Chirgwin J, Sun Z, Smith I, Price KN, Thürlimann B, Ejlertsen B, Bonnefoi H, Regan MM, Goldhirsch A, Coates AS
published in: Breast cancer research and treatment
information resource reference: The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Res Treat. 2012 Jan; 131(1):295-306.
journal title abbreviation: Breast Cancer Res Treat
publication date: 2011-09-04T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
PubMed Identifier: 21960707
author list: Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF
published in: Journal of the National Cancer Institute
information resource reference: Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst. 2011 Nov 16; 103(22):1656-64.
journal title abbreviation: J Natl Cancer Inst
publication date: 2011-09-29T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/872233
PubMed Identifier: 22018631
author list: Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B
published in: The Lancet. Oncology
information resource reference: Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncol. 2011 Nov; 12(12):1101-8.
journal title abbreviation: Lancet Oncol
publication date: 2011-10-20T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Authorship 1002733
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.

Authorship 1004525
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
PubMed Identifier: 28838210
author list: Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017 08 01; 28(8):1700-1712.
journal title abbreviation: Ann Oncol
publication date: 2017-08-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.
PubMed Identifier: 28796587
author list: Xie W, Regan MM, Buyse M, Halabi S, Kantoff PW, Sartor O, Soule H, Clarke NW, Collette L, Dignam JJ, Fizazi K, Paruleker WR, Sandler HM, Sydes MR, Tombal B, Williams SG, Sweeney CJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer. J Clin Oncol. 2017 09 20; 35(27):3097-3104.
journal title abbreviation: J Clin Oncol
publication date: 2017-08-10T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1008862
type: Authorship
author rank in publication: 4
linked author: Regan, Meredith
linked information resource: Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al.

Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al.
PubMed Identifier: 28875248
author list: Ribi K, Coates A, Blacher L, Regan MM, Gelber RD, Bernhard J
published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
information resource reference: Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al. Qual Life Res. 2018 01; 27(1):149-152.
journal title abbreviation: Qual Life Res
publication date: 2017-09-05T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/879477
PubMed Identifier: 22006057
author list: Williams SB, Salami S, Regan MM, Ankerst DP, Wei JT, Rubin MA, Thompson IM, Sanda MG
published in: Cancer
information resource reference: Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial. Cancer. 2012 May 15; 118(10):2651-8.
journal title abbreviation: Cancer
publication date: 2011-10-17T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.

Authorship 1009893
type: Authorship
author rank in publication: 1
linked author: Regan, Meredith
linked information resource: Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.
PubMed Identifier: 28911092
author list: Regan MM, Walley BA, Francis PA, Fleming GF, Láng I, Gómez HL, Colleoni M, Tondini C, Pinotti G, Salim M, Spazzapan S, Parmar V, Ruhstaller T, Abdi EA, Gelber RD, Coates AS, Goldhirsch A, Pagani O
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT. Ann Oncol. 2017 Sep 01; 28(9):2225-2232.
journal title abbreviation: Ann Oncol
publication date: 2017-09-01T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Predicting response to systemic treatments: learning from the past to plan for the future.
PubMed Identifier: 16199162
author list: Regan MM, Gelber RD
published in: Breast (Edinburgh, Scotland)
information resource reference: Predicting response to systemic treatments: learning from the past to plan for the future. Breast. 2005 Dec; 14(6):582-93.
journal title abbreviation: Breast
publication date: 2005-09-30T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

The daily phenylalanine requirement of healthy Indian adults.
PubMed Identifier: 16762944
author list: Kurpad AV, Regan MM, Raj TD, Rao VN, Gnanou J, Young VR
published in: The American journal of clinical nutrition
information resource reference: The daily phenylalanine requirement of healthy Indian adults. Am J Clin Nutr. 2006 Jun; 83(6):1331-6.
journal title abbreviation: Am J Clin Nutr
publication date: 2006-06-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/888713
PubMed Identifier: 17512856
author list: Cuzick J, Ambroisine L, Davidson N, Jakesz R, Kaufmann M, Regan M, Sainsbury R
published in: Lancet (London, England)
information resource reference: Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet. 2007 May 19; 369(9574):1711-23.
journal title abbreviation: Lancet
publication date: 2007-05-19T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

https://connects.catalyst.harvard.edu/Profiles/profile/890961
PubMed Identifier: 19633051
author list: Viale G, Giobbie-Hurder A, Gusterson BA, Maiorano E, Mastropasqua MG, Sonzogni A, Mallon E, Colleoni M, Castiglione-Gertsch M, Regan MM, Price KN, Brown RW, Golouh R, Crivellari D, Karlsson P, Öhlschlegel C, Gelber RD, Goldhirsch A, Coates AS
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Ann Oncol. 2010 Feb; 21(2):245-254.
journal title abbreviation: Ann Oncol
publication date: 2009-07-24T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
PubMed Identifier: 21321298
author list: Colleoni M, Giobbie-Hurder A, Regan MM, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Láng I, Smith I, Chirgwin J, Pienkowski T, Wardley A, Price KN, Gelber RD, Coates AS, Goldhirsch A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study. J Clin Oncol. 2011 Mar 20; 29(9):1117-24.
journal title abbreviation: J Clin Oncol
publication date: 2011-02-14T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
PubMed Identifier: 23045588
author list: Ewertz M, Gray KP, Regan MM, Ejlertsen B, Price KN, Thürlimann B, Bonnefoi H, Forbes JF, Paridaens RJ, Rabaglio M, Gelber RD, Colleoni M, Láng I, Smith IE, Coates AS, Goldhirsch A, Mouridsen HT
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial. J Clin Oncol. 2012 Nov 10; 30(32):3967-75.
journal title abbreviation: J Clin Oncol
publication date: 2012-10-08T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients
author list: Oh WK, Leitzel K, Jacobus S, Vargas R, Regan MM, Hamer PJ, Carney WP, Ali SM, Kantoff PW, Lipton A
published in: J Clin Oncol
information resource reference: Elevated plasma TIMP-1 and survival in metastatic castration-resistant prostate cancer patients. J Clin Oncol. 2008; 26(May 20 suppl):abstr 11077.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.
PubMed Identifier: 11486404
author list: Joyce RM, Kraser CN, Tetrealt JC, Giallombardo N, McDermott D, Levine J, Umiel T, Regan M, Hurley D, Uhl L, Avigan D
published in: European journal of haematology. Supplementum
information resource reference: Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant. Eur J Haematol Suppl. 2001 Jul; 64:56-62.
journal title abbreviation: Eur J Haematol Suppl
publication date: 2001-07-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Branched-chain amino acid requirements in healthy adult human subjects.
PubMed Identifier: 16365094
author list: Kurpad AV, Regan MM, Raj T, Gnanou JV
published in: The Journal of nutrition
information resource reference: Branched-chain amino acid requirements in healthy adult human subjects. J Nutr. 2006 01; 136(1 Suppl):256S-63S.
journal title abbreviation: J Nutr
publication date: 2006-01-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Threonine requirement of healthy adults, derived with a 24-h indicator amino acid balance technique.
PubMed Identifier: 11916756
author list: Borgonha S, Regan MM, Oh SH, Condon M, Young VR
published in: The American journal of clinical nutrition
information resource reference: Threonine requirement of healthy adults, derived with a 24-h indicator amino acid balance technique. Am J Clin Nutr. 2002 Apr; 75(4):698-704.
journal title abbreviation: Am J Clin Nutr
publication date: 2002-04-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction.
PubMed Identifier: 12456409
author list: Maslow AD, Regan MM, Panzica P, Heindel S, Mashikian J, Comunale ME
published in: Anesthesia and analgesia
information resource reference: Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction. Anesth Analg. 2002 Dec; 95(6):1507-18, table of contents.
journal title abbreviation: Anesth Analg
publication date: 2002-12-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1019333
type: Authorship
author rank in publication: 8
linked author: Regan, Meredith
linked information resource: https://connects.catalyst.harvard.edu/Profiles/profile/91015934

https://connects.catalyst.harvard.edu/Profiles/profile/91015934
PubMed Identifier: 29045519
author list: Dubsky P, Curigliano G, Burstein HJ, Winer EP, Gnant M, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. Ann Oncol. 2018 01 01; 29(1):281-282.
journal title abbreviation: Ann Oncol
publication date: 2018-01-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.
PubMed Identifier: 16084887
author list: Klipstein S, Regan M, Ryley DA, Goldman MB, Alper MM, Reindollar RH
published in: Fertility and sterility
information resource reference: One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril. 2005 Aug; 84(2):435-45.
journal title abbreviation: Fertil Steril
publication date: 2005-08-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/913569
PubMed Identifier: 18981464
author list: Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell'Orto P, Maiorano E, MacGrogan G, Braye SG, Ohlschlegel C, Neven P, Orosz Z, Olszewski WP, Knox F, Thürlimann B, Price KN, Castiglione-Gertsch M, Gelber RD, Gusterson BA, Goldhirsch A
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol. 2008 Dec 01; 26(34):5569-75.
journal title abbreviation: J Clin Oncol
publication date: 2008-11-03T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Statistical issues and challenges.
PubMed Identifier: 19593507
author list: Regan MM
published in: Cancer treatment and research
information resource reference: Statistical issues and challenges. Cancer Treat Res. 2009; 151:77-90.
journal title abbreviation: Cancer Treat Res
publication date: 2009-01-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet.
PubMed Identifier: 20716625
author list: Kamo N, Dandapani SV, Miksad RA, Houlihan MJ, Kaplan I, Regan M, Greenfield TK, Sanda MG
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet. Ann Oncol. 2011 Mar; 22(3):723-729.
journal title abbreviation: Ann Oncol
publication date: 2010-08-17T00:00:00
year: 2010
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels
author list: Oh WK, Chan JM, Xie W, Abe M, Regan MM, Kantoff PK.
published in: 2008 Genitourinary Cancers Symposium 2008, Feb 14-16 2008, San Francisco, CA (Abstract 46).
information resource reference: Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels. 2008 Genitourinary Cancers Symposium 2008, Feb 14-16 2008, San Francisco, CA (Abstract 46). 2008.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Retrospective analysis of Iinterleukin-2 therapy in patients with metastatic renal cell carcinoma who had received prior antiangiogenic therapy
author list: Schwarzberg T, Regan MM, Liu V, Mier JW, Cho D, Koon H, Bhatt RS, Seery V, Bradley K, Atkins MB, McDermott DF
published in: J Clin Oncol
information resource reference: Retrospective analysis of Iinterleukin-2 therapy in patients with metastatic renal cell carcinoma who had received prior antiangiogenic therapy. J Clin Oncol. 2008; 26(May 20 suppl):abstr 5044.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Threonine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique.
PubMed Identifier: 12324292
author list: Kurpad AV, Raj T, Regan MM, Vasudevan J, Caszo B, Nazareth D, Gnanou J, Young VR
published in: The American journal of clinical nutrition
information resource reference: Threonine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique. Am J Clin Nutr. 2002 Oct; 76(4):789-97.
journal title abbreviation: Am J Clin Nutr
publication date: 2002-10-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.
PubMed Identifier: 19826129
author list: Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol. 2009 Dec 01; 27(34):5794-9.
journal title abbreviation: J Clin Oncol
publication date: 2009-10-13T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1028626
type: Authorship
author rank in publication: 31
linked author: Regan, Meredith
linked information resource: Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
PubMed Identifier: 29158011
author list: Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A
published in: The Lancet. Oncology
information resource reference: Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2018 01; 19(1):127-138.
journal title abbreviation: Lancet Oncol
publication date: 2017-11-17T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
PubMed Identifier: 21410629
author list: Misra D, Xie W, Regan MM, Ross RW, Lee GS, Germain D, Kantoff PW, Oh WK
published in: BJU international
information resource reference: Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy. BJU Int. 2011 Oct; 108(7):1086-91.
journal title abbreviation: BJU Int
publication date: 2011-03-16T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.
PubMed Identifier: 21606417
author list: Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg WD, Balk S, Brown M, Taplin ME, Oh WK, Lee GS, Kantoff PW
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2011 Jun 20; 29(18):2565-73.
journal title abbreviation: J Clin Oncol
publication date: 2011-05-23T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer.
PubMed Identifier: 16515994
author list: San Francisco IF, Regan MM, Dewolf WC, Olumi AF
published in: The Journal of urology
information resource reference: Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. J Urol. 2006 Apr; 175(4):1341-5; discussion 1345-6.
journal title abbreviation: J Urol
publication date: 2006-04-01T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
PubMed Identifier: 16720872
author list: Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN
published in: Radiology
information resource reference: Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology. 2006 Jul; 240(1):82-9.
journal title abbreviation: Radiology
publication date: 2006-05-23T00:00:00
year: 2006
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/938505
PubMed Identifier: 18083065
author list: Rasmussen BB, Regan MM, Lykkesfeldt AE, Dell'Orto P, Del Curto B, Henriksen KL, Mastropasqua MG, Price KN, Méry E, Lacroix-Triki M, Braye S, Altermatt HJ, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Gusterson BA, Thürlimann B, Coates AS, Viale G
published in: The Lancet. Oncology
information resource reference: Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial. Lancet Oncol. 2008 Jan; 9(1):23-8.
journal title abbreviation: Lancet Oncol
publication date: 2007-12-20T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
PubMed Identifier: 19036418
author list: Sher DJ, Mantzoros C, Jacobus S, Regan MM, Lee GS, Oh WK
published in: Urology
information resource reference: Absence of relationship between steroid hormone levels and prostate cancer tumor grade. Urology. 2009 Feb; 73(2):356-61; discussion 361-2.
journal title abbreviation: Urology
publication date: 2008-11-26T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.
PubMed Identifier: 19152438
author list: Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK
published in: Cancer
information resource reference: Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy. Cancer. 2009 Mar 01; 115(5):981-7.
journal title abbreviation: Cancer
publication date: 2009-03-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
PubMed Identifier: 22496589
author list: Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JY, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan MM, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H, Rubin MA
published in: Proceedings of the National Academy of Sciences of the United States of America
information resource reference: Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. Proc Natl Acad Sci U S A. 2012 Apr 24; 109(17):6686-91.
journal title abbreviation: Proc Natl Acad Sci U S A
publication date: 2012-04-10T00:00:00
year: 2012
type: Academic Article
type: Article
type: Document
type: Information Resource

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
PubMed Identifier: 23312463
author list: Heng DY, Xie W, Regan MM, Harshman LC, Bjarnason GA, Vaishampayan UN, Mackenzie M, Wood L, Donskov F, Tan MH, Rha SY, Agarwal N, Kollmannsberger C, Rini BI, Choueiri TK
published in: The Lancet. Oncology
information resource reference: External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol. 2013 Feb; 14(2):141-8.
journal title abbreviation: Lancet Oncol
publication date: 2013-01-09T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Two latent variable risk assessment approaches for mixed continuous and discrete outcomes from developmental toxicity data
author list: Geys H, Regan MM, Catalano PJ, Molenberghs G
published in: J Agric Biol Environ Stat
information resource reference: Two latent variable risk assessment approaches for mixed continuous and discrete outcomes from developmental toxicity data. J Agric Biol Environ Stat. 2001; 6(3):340-55.
publication date: 2001-01-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource

Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapy.
PubMed Identifier: 17905110
author list: Daskivich TJ, Regan MM, Oh WK
published in: Urology
information resource reference: Distinct prognostic role of prostate-specific antigen doubling time and velocity at emergence of androgen independence in patients treated with chemotherapy. Urology. 2007 Sep; 70(3):527-31.
journal title abbreviation: Urology
publication date: 2007-09-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer.
PubMed Identifier: 18281655
author list: Ross RW, Oh WK, Xie W, Pomerantz M, Nakabayashi M, Sartor O, Taplin ME, Regan MM, Kantoff PW, Freedman M
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer. J Clin Oncol. 2008 Feb 20; 26(6):842-7.
journal title abbreviation: J Clin Oncol
publication date: 2008-02-20T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 1032245
type: Authorship
author rank in publication: 20
linked author: Regan, Meredith
linked information resource: A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.

Authorship 1034893
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Reply to Y. Zhu et al.

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.
PubMed Identifier: 29228091
author list: Gennari A, Sun Z, Hasler-Strub U, Colleoni M, Kennedy MJ, Von Moos R, Cortés J, Vidal MJ, Hennessy B, Walshe J, Parraga KA, Ribi K, Bernhard J, Murillo SM, Pagani O, Barbeaux A, Borstnar S, Rabaglio-Poretti M, Maibach R, Regan MM, Jerusalem G
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. Ann Oncol. 2018 03 01; 29(3):661-668.
journal title abbreviation: Ann Oncol
publication date: 2018-03-01T00:00:00
year: 2018
type: Academic Article
type: Article
type: Document
type: Information Resource

Reply to Y. Zhu et al.
PubMed Identifier: 29267131
author list: Xie W, Regan MM, Sweeney CJ
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Reply to Y. Zhu et al. J Clin Oncol. 2018 02 10; 36(5):515-516.
journal title abbreviation: J Clin Oncol
publication date: 2017-12-21T00:00:00
year: 2017
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.
PubMed Identifier: 19633053
author list: Regan MM, O'Donnell EK, Kelly WK, Halabi S, Berry W, Urakami S, Kikuno N, Oh WK
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials. Ann Oncol. 2010 Feb; 21(2):312-318.
journal title abbreviation: Ann Oncol
publication date: 2009-07-24T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.
PubMed Identifier: 21900597
author list: Sun T, Oh WK, Jacobus S, Regan M, Pomerantz M, Freedman ML, Lee GS, Kantoff PW
published in: Cancer prevention research (Philadelphia, Pa.)
information resource reference: The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness. Cancer Prev Res (Phila). 2011 Dec; 4(12):2044-50.
journal title abbreviation: Cancer Prev Res (Phila)
publication date: 2011-09-07T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.
PubMed Identifier: 19836788
author list: Eyre SJ, Ankerst DP, Wei JT, Nair PV, Regan MM, Bueti G, Tang J, Rubin MA, Kearney M, Thompson IM, Sanda MG
published in: The Journal of urology
information resource reference: Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection. J Urol. 2009 Dec; 182(6):2653-8.
journal title abbreviation: J Urol
publication date: 2009-12-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.
PubMed Identifier: 21335417
author list: Viale G, Regan MM, Dell'Orto P, Mastropasqua MG, Maiorano E, Rasmussen BB, MacGrogan G, Forbes JF, Paridaens RJ, Colleoni M, Láng I, Thürlimann B, Mouridsen H, Mauriac L, Gelber RD, Price KN, Goldhirsch A, Gusterson BA, Coates AS
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Ann Oncol. 2011 Oct; 22(10):2201-7.
journal title abbreviation: Ann Oncol
publication date: 2011-02-18T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.
PubMed Identifier: 23453899
author list: Crivellari D, Gray KP, Dellapasqua S, Puglisi F, Ribi K, Price KN, Láng I, Gianni L, Spazzapan S, Pinotti G, Lüthi JM, Gelber RD, Regan MM, Colleoni M, Castiglione-Gertsch M, Maibach R, Rabaglio M, Coates AS, Goldhirsch A
published in: Breast (Edinburgh, Scotland)
information resource reference: Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. Breast. 2013 Apr; 22(2):130-137.
journal title abbreviation: Breast
publication date: 2013-02-28T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
PubMed Identifier: 19632176
author list: Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Jänne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS, Brown M
published in: Cell
information resource reference: Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell. 2009 Jul 23; 138(2):245-56.
journal title abbreviation: Cell
publication date: 2009-07-23T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/ß-catenin activation in breast cancer.
PubMed Identifier: 23306204
author list: Wang H, He L, Ma F, Regan MM, Balk SP, Richardson AL, Yuan X
published in: The Journal of biological chemistry
information resource reference: SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/ß-catenin activation in breast cancer. J Biol Chem. 2013 Mar 01; 288(9):6478-87.
journal title abbreviation: J Biol Chem
publication date: 2013-01-10T00:00:00
year: 2013
type: Academic Article
type: Article
type: Document
type: Information Resource

Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.
PubMed Identifier: 17476141
author list: Nakabayashi M, Ling J, Xie W, Regan MM, Oh WK
published in: Cancer journal (Sudbury, Mass.)
information resource reference: Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer. Cancer J. 2007 Mar-Apr; 13(2):125-9.
journal title abbreviation: Cancer J
publication date: 2007-03-01T00:00:00
year: 2007
type: Academic Article
type: Article
type: Document
type: Information Resource

The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum").
PubMed Identifier: 8614162
author list: Oster G, Delea TE, Huse DM, Regan MM, Colditz GA
published in: Medical care
information resource reference: The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum"). Med Care. 1996 May; 34(5):389-402.
journal title abbreviation: Med Care
publication date: 1996-05-01T00:00:00
year: 1996
type: Academic Article
type: Article
type: Document
type: Information Resource

Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma.
PubMed Identifier: 19238017
author list: Cho DC, Puzanov I, Regan MM, Schwarzberg T, Seery V, Lee MY, Liu V, Bhatt R, Koon H, Mier JW, Sosman JA, Atkins MB, McDermott DF
published in: Journal of immunotherapy (Hagerstown, Md. : 1997)
information resource reference: Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma. J Immunother. 2009 Feb-Mar; 32(2):181-5.
journal title abbreviation: J Immunother
publication date: 2009-02-01T00:00:00
year: 2009
type: Academic Article
type: Article
type: Document
type: Information Resource

Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.
PubMed Identifier: 21367958
author list: Pomerantz MM, Werner L, Xie W, Regan MM, Lee GS, Sun T, Evan C, Petrozziello G, Nakabayashi M, Oh WK, Kantoff PW, Freedman ML
published in: Cancer prevention research (Philadelphia, Pa.)
information resource reference: Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality. Cancer Prev Res (Phila). 2011 May; 4(5):719-28.
journal title abbreviation: Cancer Prev Res (Phila)
publication date: 2011-03-02T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Prediction of erectile function following treatment for prostate cancer.
PubMed Identifier: 21934053
author list: Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG
published in: JAMA
information resource reference: Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14.
journal title abbreviation: JAMA
publication date: 2011-09-21T00:00:00
year: 2011
type: Academic Article
type: Article
type: Document
type: Information Resource

Inverse relationship between protein intake and plasma free amino acids in healthy men at physical exercise.
PubMed Identifier: 10780942
author list: Forslund AH, Hambraeus L, van Beurden H, Holmbäck U, El-Khoury AE, Hjorth G, Olsson R, Stridsberg M, Wide L, Akerfeldt T, Regan M, Young VR
published in: American journal of physiology. Endocrinology and metabolism
information resource reference: Inverse relationship between protein intake and plasma free amino acids in healthy men at physical exercise. Am J Physiol Endocrinol Metab. 2000 May; 278(5):E857-67.
journal title abbreviation: Am J Physiol Endocrinol Metab
publication date: 2000-05-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

Intravenously infused 13C-leucine is retained in fasting healthy adult men.
PubMed Identifier: 12097668
author list: Kurpad AV, Regan MM, Raj T, Maruthy K, Gnanou J, Young VR
published in: The Journal of nutrition
information resource reference: Intravenously infused 13C-leucine is retained in fasting healthy adult men. J Nutr. 2002 Jul; 132(7):1906-8.
journal title abbreviation: J Nutr
publication date: 2002-07-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy.
PubMed Identifier: 12394769
author list: Bubley GJ, Balk SP, Regan MM, Duggan S, Morrissey ME, Dewolf WC, Salgami E, Mantzoros C
published in: The Journal of urology
information resource reference: Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy. J Urol. 2002 Nov; 168(5):2249-52.
journal title abbreviation: J Urol
publication date: 2002-11-01T00:00:00
year: 2002
type: Academic Article
type: Article
type: Document
type: Information Resource

Leucine requirement and splanchnic uptake of leucine in chronically undernourished adult Indian subjects.
PubMed Identifier: 12663284
author list: Kurpad AV, Regan MM, Raj T, Varalakshmi S, Gnanou J, Thankachan P, Young VR
published in: The American journal of clinical nutrition
information resource reference: Leucine requirement and splanchnic uptake of leucine in chronically undernourished adult Indian subjects. Am J Clin Nutr. 2003 Apr; 77(4):861-7.
journal title abbreviation: Am J Clin Nutr
publication date: 2003-04-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
PubMed Identifier: 16153200
author list: Nakabayashi M, Regan MM, Lifsey D, Kantoff PW, Taplin ME, Sartor O, Oh WK
published in: BJU international
information resource reference: Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer. BJU Int. 2005 Oct; 96(6):783-6.
journal title abbreviation: BJU Int
publication date: 2005-10-01T00:00:00
year: 2005
type: Academic Article
type: Article
type: Document
type: Information Resource

Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC)
author list: Taplin M, Ko Y, Regan MM, Beer TM, Carducci MA, Mathew P, Bubley G, Oh WK, Kantoff PW, Balk SP
published in: J Clin Oncol
information resource reference: Phase II trial of ketoconazole, hydrocortisone, and dutasteride (KHAD) for castration resistant prostate cancer (CRPC). J Clin Oncol. 2008; 26(May 20 suppl):abstr 5068.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels
author list: Oh W, Chan J, Xie W, Regan MM, Abe M, Kantoff P
published in: J Clin Oncol
information resource reference: Effect of a germline polymorphism in the manganese superoxide dismutase (MnSOD) gene on the association of clinically aggressive prostate cancer with plasma selenium levels. J Clin Oncol. 2008; 26(May 20 suppl):abstr 5057.
publication date: 2008-01-01T00:00:00
year: 2008
type: Academic Article
type: Article
type: Document
type: Information Resource

Oxoproline kinetics and oxoproline urinary excretion during glycine- or sulfur amino acid-free diets in humans.
PubMed Identifier: 10780943
author list: Metges CC, Yu YM, Cai W, Lu XM, Wong S, Regan MM, Ajami A, Young VR
published in: American journal of physiology. Endocrinology and metabolism
information resource reference: Oxoproline kinetics and oxoproline urinary excretion during glycine- or sulfur amino acid-free diets in humans. Am J Physiol Endocrinol Metab. 2000 May; 278(5):E868-76.
journal title abbreviation: Am J Physiol Endocrinol Metab
publication date: 2000-05-01T00:00:00
year: 2000
type: Academic Article
type: Article
type: Document
type: Information Resource

https://connects.catalyst.harvard.edu/Profiles/profile/996619
PubMed Identifier: 11602764
author list: Parker RA, Regan MM, Reimann KA
published in: Journal of virology
information resource reference: Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics. J Virol. 2001 Nov; 75(22):11234-8.
journal title abbreviation: J Virol
publication date: 2001-11-01T00:00:00
year: 2001
type: Academic Article
type: Article
type: Document
type: Information Resource
label: Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics.

Authorship 100401
type: Authorship
author rank in publication: 3
linked author: Regan, Meredith
linked information resource: Physicians' experiences with BRCA1/2 testing in community settings.

Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma.
PubMed Identifier: 12712468
author list: Oh WK, Tully P, Kantoff PW, Regan MM
published in: Cancer
information resource reference: Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma. Cancer. 2003 May 01; 97(9):2171-9.
journal title abbreviation: Cancer
publication date: 2003-05-01T00:00:00
year: 2003
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 101636
type: Authorship
author rank in publication: 2
linked author: Regan, Meredith
linked information resource: Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer.

Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.
PubMed Identifier: 7695464
author list: Menzin J, Colditz GA, Regan MM, Richner RE, Oster G
published in: Archives of internal medicine
information resource reference: Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery. Arch Intern Med. 1995 Apr 10; 155(7):757-64.
journal title abbreviation: Arch Intern Med
publication date: 1995-04-10T00:00:00
year: 1995
type: Academic Article
type: Article
type: Document
type: Information Resource